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Chapter 1
General introduction
Aim and outline of this thesis 
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Obesity, a serious threat to human health, is caused by a complex interplay 
between genetic susceptibility, physical inactivity and nutrient overconsumption1. 
Since the beginning of the 1980s the prevalence of obesity has more than doubled, 
with nowadays more than 1.4 billion adults being overweight (BMI > 25 kg/m2) and 
more than 500 million being obese (BMI>30 kg/m2) (WHO Fact sheet N0311, March 
2013). Especially in women, the prevalence of obesity has increased dramatically, 
resulting in 33% more obese women than obese men (WHO Fact sheet N0311, March 
2013). Obesity is associated with several metabolic- and cardiovascular risk factors 
such as insulin resistance, dyslipidemia, low-grade inflammation, and hypertension. 
Many obese subjects ultimately develop type 2 diabetes mellitus2 and cardiovascular 
diseases (CVD)3. Interestingly, some 30% of women with obesity have a healthy 
metabolic and cardiovascular phenotype.4 They have a cardiovascular disease risk 
similar to their lean counterparts.5 The remaining 70% of the obese women have at 
least one, but often multiple, cardiovascular disease risk factors. Subjects with at 
least three metabolic or cardiovascular risk factors are classified as people with the 
metabolic syndrome.6 Treatment of the metabolic syndrome is of utmost importance. 
Increasing physical activity levels by an exercise training program improves risk 
factors associated with the metabolic syndrome and hence reverses the metabolic 
syndrome.7-11 However, the molecular mechanisms behind the positive effects of 
exercise training on e.g. insulin resistance are still largely unknown. With modern 
technologies in human genetic research, such as the development of high throughput 
RNA gene expression microarrays, expression levels of virtually all know genes 
can be analysed in a single experiment. Gene expression microarray analysis is, 
therefore, a rapid and comprehensive approach for the first identification of exercise-
induced molecular changes.
The aim of this thesis is to gain more insight into the molecular mechanism of 
insulin resistance and the molecular mechanisms of exercise-induced improvements 
in insulin resistance and arterial remodeling. These studies were performed in women 
with the metabolic syndrome. This introduction provides some background on the 
metabolic syndrome in women and the existence of the intriguing metabolically 
healthy obese phenotype. Furthermore, the effects of exercise training on molecular 
mechanisms of insulin resistance and arterial remodeling will be described. Finally 
the aim, outline and methods applied in this thesis are presented.
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Metabolic syndrome
Already in the 1920s, Kylin noticed clustering of hypertension, 
hyperglycaemia and gout in some of his patients.12 In 1988’s Banting lecture, Reaven 
first mentioned the term metabolic syndrome or syndrome-X. But it was not until 
1998 before an internationally recognised definition was proposed by the WHO13 
and shortly thereafter by the National Cholesterol Education Program’s Adult 
Treatment Panel III (NCEP ATPIII)14. In 2009, a joint interim statement of several 
leading authorities on the criteria and cut-off points of the metabolic syndrome was 
proposed, which is currently used as the definition of the metabolic syndrome.6 
Women with the metabolic syndrome are defined as having at least three out of five 
cardiovascular and/or metabolic risk factors including 1) waist circumference above 
88 cm (European population), 2) hypertension defined as a blood pressure above 
130/85 mmHg and/or use of anti-hypertensive medications, 3) HDL cholesterol levels 
below 1.3 mmol/l, 4) triglyceride levels above 1.7 mmol/l, and 5) fasting glucose level 
above 5.6 mmol/l.6 With the growing pandemic of obesity the prevalence of subjects 
with the metabolic syndrome is concurrently rising. The latest NHANES (National 
Health and Nutrition Examination Survey) data from the USA report a prevalence of 
32.5% among adult women.15 Although the prevalence of the metabolic syndrome is 
lower in Europe compared to the USA, in the Netherlands still one out of six adults 
(14%) fulfil the metabolic syndrome criteria.16 The metabolic syndrome is associated 
with important adverse medical, social, and economic outcomes. Subjects with the 
metabolic syndrome are not only at risk for developing diabetes (relative risk 5.0)17-19 
and cardiovascular diseases (relative risk 2.5)3, 20 but are also at increased risk for the 
development of cancer21, and even premature death (relative risk 2.8)22. 
The unifying and most accepted hypothesis to describe the pathophysiology 
of the metabolic syndrome is insulin resistance (Figure 1).23 Obesity, and more 
specifically abdominal visceral obesity, seems crucial for the development of insulin 
resistance and the occurrence of the metabolic syndrome. This explains why waist 
circumference is one variable of the metabolic syndrome. In subjects with visceral 
obesity an abundance of circulating fatty acids contribute to the development of 
insulin resistance. Circulating free fatty acids increase hepatic glucose production 
and diminish the inhibition of glucose production by insulin. Upon reaching insulin 
sensitive tissue such as muscle tissue, responsible for disposal of 50-75% of the oral 
ingested glucose, fatty acids induce insulin resistance by modifying downstream 
signaling. The major affected downstream signaling pathway is phosphatidylinositol 
3-kinase (PI-3K) which normally contributes to the translocation of GLUT4 to the 
membrane. With increased circulating fatty acid flux to the liver, increased production 
of triglyceride-rich very low-density lipoproteins (VLDL) occurs. In insulin resistant 
subjects, insulin subsequently promotes the biosynthesis of triglycerides in the liver 
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and enhances lipolysis in adipocytes which further increases plasma fatty acid 
concentration. Due to the hypertriglyceridemia, the HDL particle becomes smaller, 
resulting in an increased clearance of HDL from the circulation. The relation 
between insulin resistance and hypertension is well established through several 
mechanisms including increased plasma catecholamines and enhanced sympathetic 
nervous system activity. In normal-weight subjects, insulin acts as a vasodilator but 
in the presence of insulin resistance this effect can be lost, thereby increasing blood 
pressure. Insulin also increases the renal sodium reabsorption in subjects with the 
metabolic syndrome inducing plasma volume expansion, and hence, hypertension. 
Finally, increased adipocyte mass leads to an increased angiotensin production, 
decreasing natriuresis, leading to hypertension. 
Figure 1
Pathophysiology of the metabolic syndrome (insulin resistance).
Adapted from Eckel23
In the last decade, the importance of adipose tissue as an endocrine organ 
secreting numerous bioactive peptides including pro- and anti-inflammatory 
cytokines has been established. Recent studies have demonstrated a strong link 
between chronic low-grade inflammation markers such as high-sensitive C-reactive 
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protein (hs-CRP), tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and 
the inflammasome, and the development of insulin resistance and the metabolic 
syndrome.24-27 These important results were obtained in insulin-reactive tissue such 
as fat. Since skeletal muscle tissue accounts for the majority (50-75%) of insulin-
induced glucose uptake, investigating the role of skeletal muscle inflammatory genes 
that correlate with insulin resistance might generate new insights into the molecular 
mechanism of insulin resistance.
Metabolically healthy obese phenotype
Although obesity is strongly associated with the development of several 
metabolic- and cardiovascular risk factors, interestingly some 30% of obese 
women have a ‘metabolically healthy obese phenotype’.4 Despite their obesity, 
they have a similar 10 years cardiovascular disease risk compared to their lean 
counterparts5 in contrast to obese women with the metabolic syndrome, who have 
an almost 3-fold increased risk for cardiovascular disease events 3. In recent years, 
several hypotheses have been postulated regarding this metabolic healthy obese 
phenotype including higher physical fitness levels28, different fat tissue distribution 
and fat metabolic activity29, 30, higher birth weight31, and early onset of obesity32. 
Large epidemiological studies have shown that obese individuals who are in the 
higher range of physical fitness or physical activity levels, are more likely to have 
a metabolic healthy phenotype 4, 33, 34. Bouchard et al. reported similar findings in 
women with the metabolically healthy obese phenotype who performed a faster 
and 6-min walk test over a longer distance compared to obese women with risk 
factors35. Unfortunately, almost all of these studies used subjective self-reported 
questionnaires or general prediction models to determine physical activity levels and 
physical fitness, respectively. Besides physical fitness, the metabolic activity of fat 
tissue, including the inflammatory cytokine response 29, 30 and the specific location of 
fat tissue, have been proposed as possible explanations for the metabolically healthy 
obese phenotype 32, 36. Since there seems to be an association between fitness level 
and subclinical inflammatory profile in obese subjects 37, investigating the role of 
physical fitness simultaneous with the inflammation profile in metabolically healthy 
obese women and in obese women with the metabolic syndrome might improve our 
understanding of the metabolically healthy obese phenotype. Understanding of the 
physiological mechanisms why some obese women seem to be protected against the 
detrimental effects of obesity might help to optimize strategies to prevend obesity-
associated risk factors.
Chapter 1
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Exercise training in women with the metabolic syndrome
Having the metabolic syndrome has major consequences, so treatment of 
the metabolic syndrome is clearly of utmost importance. Increasing physical activity 
levels with an exercise training program can improve the individual risk factors 
(insulin resistance, blood pressure, lipid profile) associated with the metabolic 
syndrome38-41 and hence reverse the metabolic syndrome.7-11, 42 Relatively few 
studies have investigated the effects of exercise training in metabolic syndrome per 
se. Already brisk walking for 30 minutes a day, which is the current international 
physical activity guideline/recommendation for adults43, can prevent the metabolic 
syndrome.44, 45 A few weeks of intensive endurance exercise training even reverses 
the metabolic syndrome in approximately 40% of the subjects.7, 8 Although the 
beneficial effects of exercise training on the human metabolic and cardiovascular 
system are strongly established, the mechanisms behind these positive effects of 
exercise training are still partly unknown. In a prospective study of apparently 
healthy women, the beneficial effects of exercise training on cardiovascular disease 
risk could only partly be explained by improvements of traditional cardiovascular 
risk factors such as haemostatic and inflammation factors, hypertension, lipid 
profile, body weight and insulin resistance (Figure 2).46 Approximately 40% of the 
beneficial effects of exercise could not be explained by changes in the traditional 
risk factors: the so called ‘risk factor gap’. Several hypothesis have been postulated 
to explain this risk factor gap. The vascular endothelium emerged as a key factor 
since a blunted endothelial function is a risk factor for cardiovascular disease and 
an enhanced endothelial function appears to be protective against cardiovascular 
disease.47, 48 Another hypothesis postulated to explain this risk factor gap is related 
to the autonomic nervous system. There is a variety of evidence that an altered 
autonomic function can have a profound effect on cardiovascular disease, but this 
hypothesis is beyond the scope of this thesis.49 
With emerging new technologies in human genetic research, such as high 
throughput RNA microarrays, expression levels of virtually all know genes can be 
analysed in a single experiment. This provides the opportunity to identify whole 
genome transcriptional responses to stimuli such as exercise training. Exercise 
training induces chronic adaptations in i.a. skeletal muscle tissue such as an increase 
in aerobic ATP generation, less glucose utilization (more fats) and improved insulin 
sensitivity50. Therefore, comparing skeletal muscle RNA gene expression before 
and after an exercise training program may lead to the identification of novel genes 
and molecular signaling pathways. This will hopefully generate new hypothesis 
regarding the beneficial effects of exercise training that can explain the ‘risk factor 
gap’. 
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Effects of physical activity on insulin resistance 
Regular physical activity leads to a number of adaptations in skeletal muscle 
tissue that allow the muscle to utilize substrates for ATP production more efficiently 
and to become more responsive to insulin. Three major skeletal muscle adaptations 
are 1) a switch in muscle fiber type IIb to type IIx and IIa, and in some cases to slow-
twitch oxidative fiber type I, 2) an increase in mitochondrial activity and content, 
and 3) an increase in GLUT4 protein expression.51 Although the effects of exercise 
training on whole body insulin sensitivity have been extensively studied over the 
last decades7, 52, 53, the molecular mechanisms that underlie this important beneficial 
effect are only partly understood. Exercise, just like insulin, increases glucose 
uptake in skeletal muscle through translocation of glucose transporter proteins (i.a. 
Figure 2.
Unknown factors
41%
Homocysteine
0,4%
Diabetes
5%
BMI
5%
Novel lipids
8%
Traditional lipids
10%
Hypertension
14%
Inflammation / 
hemostatic factors
17%
 Exercise-induced improvements in risk factors associated with a reduction in CVD events. 
Adapted from Mora46
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GLUT4) from the intracellular compartment to the surface of the cell.54 However, the 
intracellular molecular signaling pathways that lead to this translocation of GLUT4 to 
the membrane are distinct between insulin and exercise. Insulin binds to the α-subunit 
of the insulin receptor, resulting in auto-phosphorylation of tyrosine residues in the 
receptor β-subunit, tyrosine phosphorylation of the insulin receptor substrates IRS-
1 and ISR-2, and activation of phosphatidylinositol 3-kinase which subsequently 
activates the Akt/PKB and PKCλ cascades leading to GLUT4 translocation (Figure 
3). Exercise does not seem to activate these proximal signaling steps, and other 
signaling molecules have been proposed to explain the beneficial effects of exercise, 
such as AMP-activated protein kinase (AMPK), peroxisome-proliferator-activated 
receptor-γ coactivator 1α (PGC-1α), calcineurin, AS160 and p38 MAPK seem to 
be involved.54, 55 There is  probably no single factor that accounts for the enhanced 
muscle insulin sensitivity for glucose uptake after exercise training. Most probably, 
a combination of plasma factors, muscle fibre type composition, mitochondrial 
capacity, and intracellular pathways are involved. Microarrays are a powerful 
tool to study these molecular mechanisms comprehensively. Previous microarray 
studies have provided differentially expressed genes and gene cluster analysis (i.a. 
Gene Ontology terms) when comparing healthy insulin sensitive subjects with 
insulin resistant subjects56-58 or comparing strength trained versus endurance trained 
athletes59. Few studies have focused on skeletal muscle gene expression after an 
exercise training program but either these were performed in healthy insulin sensitive 
individuals60 or following a relatively short training period (weeks)61. Focusing on 
differential gene expression in skeletal muscle of insulin resistant women with the 
metabolic syndrome and in insulin sensitive lean women after a prolonged exercise 
training (months), taking into account their improvement in insulin sensitivity, might 
identify novel function of genes and molecular signaling pathways. 
Effect of physical activity on arterial remodeling
The beneficial effects of exercise training on the human cardiovascular 
system have also strongly been established. Exercise training decreases the risk for 
cardiovascular diseases62, 63, and a higher physical fitness confers cardioprotection.64 
Approximately 60% of this decreased risk can be explained by the exercise-induced 
improvements in traditional cardiovascular risk factors.46 One hypothesis postulated 
as an explanation for the remaining 40%, the so called ‘risk factor gap’, is a direct 
effects of exercise on the vessel wall. The intima-media thickness (IMT), the 
thickness of the tunica intima and tunica media – the two innermost layers of the 
arterial wall, is a validated surrogate marker for atherosclerosis65 and an increased 
carotid IMT has been associated with increased risk for both cardiac66 and peripheral 
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vascular events.67 Subjects with the metabolic syndrome are known to have an 
increased arterial wall thickness68, 69, which seems more pronounced in women.70 
Already a few weeks of exercise training can decrease arterial wall thickness in 
healthy men71, 72 and in young obese subjects.73, 74 The exercise-induced arterial 
Figure 3.
Insulin Receptor Signaling
 Schematic overview of insulin receptor signaling pathway depicting current complex knowledge 
about insulin signaling. Insulin activates numerous signaling partners and cascades ultimately leading 
to GLUT4 translocation to the plasma membrane enabling glucose uptake. Insulin signaling also has 
growth and mitogenic effects, insulin signaling inhibits gluconeogenesis in the liver and, promotes 
fatty acid synthesis. Adapted from https://www.cellsignal.com/pathways/glucose-metabolism.jsp
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remodeling is probably induced by increased vascular shear stress during repeated 
bouts of exercise.75 The blood flow-generated endothelial shear stress induces 
altered gene expression in endothelial cells and induces the release of several factors 
which can influence the vascular endothelium and the underlying vascular smooth 
muscles (Figure 4). The molecular mechanisms that cause these vascular changes are 
gradually elucidated.76 One key factor is nitric oxide release induced by shear stress 
via phosphorylation of endothelial NO Synthase by AKT (V-AKT murine thymoma 
viral oncogene homolog 1).77 Nitric oxide diffuses to the underlying vascular smooth 
muscle cell and subsequently induces vasodilation. Also a role for growth factors 
such as vascular endothelial growth factor (VEGF), transforming growth factor beta-
1 (TGFβ-1), extracellular matrix proteins, and anti-oxidative enzymes in response to 
exercise has been established.78-80 
Gene expression microarrays are a powerful tool to study these molecular 
mechanisms comprehensively. Microarrays have previously been used to study 
changes in vascular gene expression after exercise in animal models.81-84 In humans, 
Figure 4.
Schematic overview of current knowledge about the molecular effects of exercise-induced shear stress 
regulating vascular structure and function. 
Adapted from Whyte-Laughlin76
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gene expression microarrays have been used to study changes in muscular gene 
expression after exercise.61, 85, 86 But only few studies in humans have linked results 
of microarrays with vascular remodeling after exercise training.78 Identification of 
differentially expressed vascular-related genes after an exercise training program 
may increase the understanding of arterial wall remodeling.
Outline of this thesis
The aim of this thesis is to obtain more insight into the molecular mechanism of 
insulin resistance and the molecular mechanisms of exercise-induced improvements 
in insulin resistance and arterial remodeling in humans, with a special interest in 
women with the metabolic syndrome. To answer these study questions, a number of 
human-translational studies will be performed.
Women with the metabolic syndrome often display insulin resistance. 
This obesity-induced insulin resistance is thought to arise from a defective signal 
transduction along the insulin signaling cascade, and a strong link with chronic low-
grade inflammation has been established. Since insulin resistance is predominantly 
located in skeletal muscle tissue, the aim of chapter 2 is to identify differentially 
expressed inflammatory genes in skeletal muscle tissue of insulin resistant women 
with the metabolic syndrome compared to healthy controls. Identification of these 
key players may increase our understanding of the link between obesity induced 
low-grade skeletal muscle inflammation and insulin resistance in the context of the 
metabolic syndrome.
Interestingly, 30% of the women with obesity have a healthy metabolic 
phenotype. Despite a high body fat percentage they are insulin sensitive and they 
have a 10 years cardiovascular disease risk similar to their lean counterparts.5 
Several hypotheses have been postulated regarding this metabolically healthy obese 
phenotype. In chapter 3 we investigate whether physical fitness and a low-grade 
inflammatory profile can explain the metabolically healthy obese phenotype. 
While physical inactivity is associated with the development of insulin 
resistance, exercise training effectively counteracts this development by stimulating 
the insulin signaling cascade. To gain more insight into the molecular mechanisms 
behind the development and prevention of insulin resistance, the aim of the 
studies described in chapter 4 is to assess muscular gene expression after physical 
deconditioning compared to muscular gene expression after an exercise training 
program. Genes that are downregulated after deconditioning and upregulated after 
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exercise training are the most interesting, because such genes may play a role in 
the detrimental effects of physical inactivity as well as  in the beneficial effects of 
regular exercise.
Exercise training can reverse the metabolic syndrome and the accompanying 
insulin resistance. In chapter 5a the use of HOMA-IR, in assessing insulin 
resistance after an exercise training program, is discussed. Although the beneficial 
effects of regular exercise on insulin sensitivity are well established, the molecular 
mechanisms are only partly understood. In chapter 5b we study the effects of an 
exercise training program on insulin sensitivity in insulin resistant women with the 
metabolic syndrome and in insulin sensitive lean women. By comparing the exercise-
induced changes in skeletal muscle gene expression between insulin resistant and 
insulin sensitive women, we aim to identify key genes responsible for the exercise-
induced improvement in insulin sensitivity.
Women with the metabolic syndrome are prone to develop atherosclerosis 
and cardiovascular disease. Exercise training induces arterial remodeling, such as 
a decrease in IMT, and can hence reverse the atherosclerotic process. This arterial 
remodeling is believed to result from increased vascular shear stress during repeated 
bouts of exercise. The blood flow-generated shear stress induces altered gene 
expression in endothelial cells enabling arterial remodeling to occur. In chapter 
6 the effects of exercise training on central and peripheral conduit artery intima-
media thickness and diameter will be investigated. To identify important genes 
and molecular pathways involved in exercise-induced arterial remodeling, we will 
perform muscle gene expression microarrays and relate the results to functional 
changes in vascular function. 
Finally a general discussion of the findings and future perspectives will be 
provided in chapter 7 and a summary in chapter 8.
Methods applied in this thesis
Physical inactivity model and exercise interventions
Comparing physical deconditioning to exercise training
To exclude whole-body systemic effects and to identify specifically effects 
on skeletal muscle, we have used in the thesis unique human in vivo models for 
local inactivity and for local exercise training. Unilateral lower limb suspension is 
a proven model for local deconditioning87, 88. One leg of the subjects is suspended 
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and unloaded from all weight bearing for a period of three weeks. The effectiveness 
of this model is monitored by measuring skin temperature and calf circumference. 
The model for local exercise training used in this thesis was training of subjects 
with a spinal cord lesion above thoracic level 12. These subjects underwent twenty 
30-minute sessions of functional electrical stimulation exercise training using a 
computer-controlled leg cycle ergometer over an eight weeks’ time period.
Exercise training protocol
The aims of the exercise interventions applied in this thesis were to induce 
improvements in cardio-respiratory fitness, in the metabolic profile including 
insulin resistance, to decrease low-grade inflammatory status, and to induce arterial 
remodeling. Therefore, women trained for six months, three times a week under the 
supervision of a professional trainer. Training consisted of cycling exercise on a 
ergometer (Lode, Groningen, the Netherlands) starting with a 10 minute warming-
up, followed by 30 minutes of exercise at 65% of the individual heart rate reserve 
and finished off with a cooling-down of 5 minutes. As exercise tolerance improved, 
the training intensity was increased by 5% to a maximum of 85% of the heart rate 
reserve.
Methods 
Cardio-respiratory fitness test
Women performed a maximal exercise test on an electrically braked leg-
cycling ergo meter (Lode, Angio 300, Groningen, the Netherlands) using an 
incremental protocol to assess their cardio-respiratory fitness. Workload increased 
by 10 W per minute, starting at 10 W, until exhaustion. A gas-analyzer was used 
to measure oxygen consumption continuously (Jaeger Benelux BV, Breda, the 
Netherlands). Maximal oxygen consumption (VO2max) was analyzed as the mean 
of the last minute of the exercise bout. 
Hyperinsulinaemic euglycaemic clamp
Peripheral tissue sensitivity to exogenous insulin was measured using 
a 120 minutes hyperinsulinaemic euglycaemic clamp.89, 90 Insulin was infused 
intravenously in a dose of 430 pmol ∙ m-2 ∙ min-1 (60 mU ∙ m-2 ∙ min-1) and arterialized 
plasma glucose concentrations were clamped at 5 mmol∙l-1 by a variable glucose 
20% (≈ 200mg × ml-1) infusion rate, adjusted depending on plasma glucose level 
measurements at 5-minute intervals. Plasma glucose was measured in duplicate by 
the glucose oxidation method (Beckman Glucose Analyzer 2, Beckman Instruments 
Inc, Fullerton, CA 92634, USA). Insulin was measured in duplicate against 
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International Standard 83/500 by an in-house radio-immunoassay (RIA) using 
an anti-human insulin antiserum raised in guinea pig and radio-iodinated human 
insulin as a tracer. Whole body glucose disposal during the euglycaemic clamp was 
expressed as M-value:
= Mean glucose infusion T90-120 min (mg×min-1)/weight (kg)
Dexa scan
Total body mass, body fat percentage, and body fat distribution was measured 
by total body Dexa scan (QDR 4500 densitometer, Hologic Inc. Waltham, MA).
Echo-Doppler ultrasound
Baseline diameter of the common carotid artery, brachial artery, common 
femoral artery and superficial femoral artery and intima-media thickness (IMT) 
of the common carotid artery and common femoral artery were measured using 
high resolution echo ultrasonography (Picus, Pie Medical Benelux, Maastricht, the 
Netherlands or T3000, Terason, Burlington, MA, USA). Baseline blood flow (i.e. red 
blood cell velocity) was measured by the Doppler technique (WAKI e, Atys, France 
or Terason ). IMT was defined as the distance from lumen-intima interface to media-
adventitia interface91 and normalized for lumen diameter size (IMT/lumen).91, 92 
Muscle biopsies
A percutaneous needle muscle biopsy was obtained from the right vastus 
lateralis muscle using the Bergström technique. On the day of the skeletal muscle 
biopsy, subjects consumed a standardized breakfast consisting of 250 kcal energy 
(79 % carbohydrates, 11.2 % protein, 9.8 % fat). After local anesthesia of the skin 
with lidocaine 1%, a small incision was made through the skin and fascia and ~100 
mg of muscle tissue taken via the biopsy needle. The removed muscle tissue was 
immediately frozen in liquid nitrogen and will be stored at -800C until further 
analysis. 
Microarray gene expression
From the muscle biopsies total RNA was isolated and purified. RNA gene 
expression profiling was performed using Affymetrix GeneChip Human Gene 1.0 
ST arrays (Affymetrix Inc., Santa Clara, CA, USA). The average fluorescence 
intensity of all genes was calculated using the Robust Multiarray Analysis (RMA) 
Algorithm93. The Affymetrix CEL-files were imported into Partek (Genomic Suite 
Software version 6.4, Partek Inc., St Louis, MO, USA) where only core probe sets 
were extracted and normalized using the RMA logarithm with GC background 
correction. Transcript summaries were calculated using the mean intensities of 
the corresponding probe sets, representing the quantitative gene expression levels. 
General introduction 
27
The Database for Annotation Visualization and Integrated Discovery functional 
annotation tool (DAVID, http:david.abcc.ncifcrf.gov)) was used as an integrated 
biological knowledgebase and analytical tool to systematically extract biological 
meaning from large gene list.94 Gene lists of interest were analyzed using DAVID 
with main focus on the enrichment in GO-terms (Gene Ontology terms) of biological 
processes (GOTERM_BP_FAT) and Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathways.94 
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Cd97   CD97 molecule
DXA   Dual-Energy X-ray Absorptiometry
FC   Fold Change
FFA   Free Fatty Acids
GO   Gene Ontology
Hdac9  Histone Deacetylase 9
hs-CRP  High-Sensitivity C-Reactive Protein
IL-1ß  Interleukin 1ß 
IL-1Ra  IL-1 Receptor Antagonist
Il6r   Interleukin 6 Receptor
MEF2  Myocyte Enhancing Factor 2
PEG   Polyethylene Glycol
RIN   RNA Integrity Number
RMA   Robust Multiarray Analysis
UBC  Ubiquitin C
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Abstract
 The metabolic syndrome, a combination of interrelated metabolic risk factors, 
is associated with insulin resistance and promotes the development of cardiovascular 
diseases and type 2 diabetes mellitus. There is a close link between inflammation 
and metabolic disease, but the responsible mechanisms remain elusive. The aim of 
this study was to identify differentially expressed genes in insulin resistant skeletal 
muscle tissue of women with the metabolic syndrome compared to healthy controls. 
Women with the metabolic syndrome (n=19) and healthy controls (n=20) were 
extensively phenotyped, insulin sensitivity was measured using a hyperinsulinaemic 
euglycaemic clamp and a skeletal muscle biopsy was obtained. Gene expression 
levels were compared between the two groups by microarrays. The upregulated 
genes in skeletal muscle of the women with the metabolic syndrome were primarily 
enriched for inflammatory response-associated genes. The three most significantly 
upregulated of this group, interleukin 6 receptor (Il6r), histone deacetylase 9 
(Hdac9), and CD97 molecule (Cd97) were significantly correlated with insulin 
resistance. Taken together, these findings suggest an important role for a number of 
inflammatory-related genes in the development of skeletal muscle insulin resistance.
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Introduction
 The metabolic syndrome is a combination of interrelated metabolic risk 
factors that directly promote the development of cardiovascular diseases 1 and 
type 2 diabetes mellitus 2. The pathophysiology of the metabolic syndrome can be 
characterized by peripheral insulin resistance, which may be caused by excessive 
central adiposity and/or sedentarism. It has been recognized that a pro-inflammatory 
state contributes to disease development and progression 3. In support of such a 
relationship is the observation that metabolic and immune response pathways are 
evolutionary integrated and partially overlapping, and it is clear that the immune 
system plays a role in the development of metabolic diseases 4. 
 Recent studies demonstrate a strong link between chronic low-grade 
inflammation and the development of insulin resistance, in which pro-inflammatory 
cytokines like interleukin 1ß (IL-1ß), IL-6 and the inflammasome play an important 
role 5-7. Circulating mononuclear cells also demonstrate an aberrant expression of 
insulin signaling pathways components in obese subjects and upregulation of pro-
inflammatory mediators 8. These important results were obtained in insulin reactive 
tissues like fat and circulating cells, while skeletal muscle accounts for the majority 
(50-75%) of insulin-induced glucose uptake. It has been hypothesized that adipose 
tissue secretes inflammatory signals that affect target organs like the muscle. 
However, the underlying molecular mechanisms that link inflammation with skeletal 
muscle insulin resistance are largely unknown. A closer examination of skeletal 
muscle inflammatory genes that correlate with insulin resistance may generate new 
insights.
 Gene expression microarray analysis provides the opportunity to assess all 
known genes in a single experiment, thereby indicating the direction for further 
research. Only a few previous studies have assessed mRNA gene expression in muscle 
of insulin resistant and diabetes subjects 9-12 but no study has been performed in women 
with the metabolic syndrome. Both men and women are at risk for developing the 
metabolic syndrome, but women with the metabolic syndrome have higher levels of 
circulating high-sensitivity c-reactive protein (hs-CRP) and IL-1 receptor antagonist 
(IL-1Ra) than men 13. This suggests that especially in women chronic low-grade 
inflammation may play an important role in disease progression. This adds to the 
raising awareness that cardiovascular disease in women is underdiagnosed because 
of its atypical presentation, and the chronic low grade inflammation may play a role 
in the microvascular pathophysiology observed in women.
 The aim of this study, therefore, was to identify differentially expressed 
inflammatory genes in insulin resistant skeletal muscle tissue of women with the 
metabolic syndrome compared to healthy controls. Identification of these key players 
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may increase our understanding of the link between obesity induced low-grade 
skeletal muscle inflammation and insulin resistance in the metabolic syndrome. 
Methods
Ethical approval
 This study was approved by the Medical Ethical Committee of the Radboud 
University Nijmegen Medical Centre, and was conducted in accordance with the 
Declaration of Helsinki (2000). All participants provided a written informed consent.
Subjects
 Nineteen women with the metabolic syndrome and twenty healthy lean women 
participated in this study. Metabolic syndrome was defined as having at least three 
out of five criteria as defined in the Joint Scientific Statement for Harmonizing the 
Metabolic Syndrome 14, being 1. waist circumference > 88 cm, 2. triglycerides > 1,7 
mmol/l, 3. HDL-cholesterol < 1,3 mmol/l, 4. hypertension > 130/85 mmHg and/or 
using antihypertensive medication and, 5. fasting glucose > 6,1 mmol/l. Lean healthy 
women were defined as having a BMI < 25 kg/m2 and the absence of all metabolic 
syndrome criteria. Exclusion criteria were a medical history of known diabetes and/
or cardiovascular diseases, liver or renal diseases, smoking, and consumption of 
more than two standardized units (10 grams) of alcohol  per day. 
Study design
 After initial screening, subjects visited the department on two separate days. 
On day one, after an overnight fast the subjects had a standardized 250 kcal breakfast 
(79 % carbohydrates, 11.2 % protein, 9.8 % fat) to avoid any dietary effects, at 
least 2 h before a percutaneous needle biopsy was obtained from the vastus lateralis 
muscle 15. This tissue was immediately frozen in liquid nitrogen and subsequently 
stored at -80 °C until further analysis. At the second visit, which was at least seven 
days after the first visit, anthropometric measurements including a dual-energy 
X-ray absorptiometry (DXA) scan, fasting blood sampling and a 2 h, 60mU/m2/min 
hyperinsulinaemic euglycaemic clamp were performed 16. 
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Subject characteristics 
 Resting blood pressure and heart rate were measured twice after a 10 min 
supine resting period using a manual sphygmomanometer. Waist circumference was 
measured midway between the lower rib margin and iliac crest. Hip circumference 
was measured at the level of widest circumference over greater trochanters. Waist-
to-hip ratio was calculated as waist circumference divided by hip circumference. 
 Table 1. Physical characteristics of the women with the metabolic syndrome 
 (MS, n=19) and the healthy controls (C, n=20).
MS C P value
Age, yrs 52 ± 7 49 ± 11 0.31
Weight, kg 94.7 ± 14.4 63.7 ± 7.8 < 0.001
BMI, kg/m2 34.5 ± 4.0 22.1 ± 2.0 < 0.001
Waist circumference, cm 108.6 ± 9.8 79.1 ± 7.1 < 0.001
Waist-to-hip ratio 0.92 ± 0.07 0.80 ± 0.06 < 0.001
Systolic pressure, mmHg 138 ± 11 120 ± 13 < 0.001
Diastolic pressure, mmHg 85 ± 6 76 ± 7 < 0.001
Heart rate, bpm 70 ± 10 62 ± 6 0.006
Total fat mass, % 41.3 ± 3.9 28.0 ± 5.4 < 0.001
Trunk fat mass, % 42.3 ± 4.3 25.0 ± 7.5 < 0.001
 Values are mean±SD. Bpm=beats per min.
Blood plasma measurements 
 Fasting venous blood samples were used to determine glucose and lipids via 
standard laboratory methods. Insulin was measured in duplicate against International 
Standard 83/500 by an in-house radio-immunoassay (RIA) using a guinea pig anti-
human insulin antiserum and radio-iodinated human insulin as a tracer. Bound/
free separation was carried out by addition of sheep anti-guinea-pig antiserum and 
precipitation by means of polyethylene glycol (PEG). Between- and within-run 
coefficients of variation were 4.6% and 5.8% respectively, at a level of 33mU/L. 
Adipocytokines, adiponectin and leptin were measured in duplicate by using DuoSet 
ELISA development system kits (R&D systems, Minneapolis, USA), free fatty 
acids (FFA) using Cobas Mira Plus (Roche Diagnostics Ltd., Basal, Switzerland), 
inflammatory markers C-reactive protein (CRP) by Dako high-sensitivity ELISA 
(Glostrup, Denmark) and interleukin 6 (IL-6) by Luminex assay (Austin, Texas, 
Inflammatory genes and insulin resistance
41
USA). A total body DXA scan was performed to determine body fat percentage, fat 
distribution and lean body mass (QDR 4500 densitometer, Hologic Inc. Waltham, 
MA). 
Hyperinsulinaemic euglycaemic clamp
 Peripheral tissue sensitivity to exogenous insulin was measured using a 
hyperinsulinaemic euglycaemic clamp 16. After an overnight fast, insulin (Actrapid, 
Novo-Nordisk, Copenhagen, Denmark) was infused intravenously in a dose of 
430 pmol m-2 min-1 (=60 mU m-2 min-1) for 120 min in a supine position in a 
quiet temperature-controlled room (22 – 24 °C) at 8.30 A.M.. Body surface area 
was calculated according to the formula of Du Bois et al. 17. Insulin 50 U/mL was 
diluted to a concentration of 1 U/m in 50 ml 0.9% NaCl containing 2 ml blood 
from the subject. Venous plasma glucose concentrations were clamped at 5 mmol/l 
by a variable 20% glucose infusion rate, adjusted depending on arterialized venous 
plasma glucose levels measured at 5 min intervals. Venous plasma samples were 
immediately centrifuged for 10 sec, and glucose was measured in duplicate by the 
glucose oxidation method (Beckman Glucose Analyzer 2, Beckman Instruments 
Inc, Fullerton, CA 92634, USA). During the last 30 min, glucose infusion rate and 
glucose concentration in the arterialized blood had a coefficient of variation of <5%, 
confirming a proper steady state situation. Whole body glucose disposal (M-value) 
during the last 30 min of the euglycaemic clamp was calculated. 
Gene expression microarrays
 Total RNA was isolated and purified from muscle biopsies and the RNA 
concentration and purity were measured with a Nanodrop spectrophotometer 
(Thermo Scientific, Waltham, MA, USA). To guarantee good quality microarray 
analysis and validation, we proceeded with RNA from the six women with the 
metabolic syndrome and six healthy controls having the largest RNA yield. These 
numbers were based on previous studies that successfully identified differentially 
expressed insulin signaling genes in human skeletal muscle tissue 18. RNA integrity 
was analyzed on an Agilent Bioanalyser (Santa Clara, CA, USA) and the average 
RNA integrity number (RIN) for all samples was 7.8. Gene expression profiling 
was performed using Affymetrix GeneChip Human Gene 1.0 ST arrays (Affymetrix 
Inc., Santa Clara, CA, USA), according to the manufacturer’s instruction. The 
Affymetrix GeneChip Whole Transcript Sense Target Labeling Assay was used 
to generate amplified and biotinylated sense-strands DNA targets from the entire 
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expressed genome (100 ng of total RNA). The manufacturer’s manual was followed 
for the hybridization, washing, and scanning steps (version 4, P/N 701880 Rev.4). 
Arrays were hybridized by rotating them at 60 rpm in the Affymetrix GeneChip 
hybridization oven at 45 °C for 17 h. After hybridization, the arrays were washed 
in the Affymetrix GeneChip Fluidics station FS 450. Arrays were scanned using the 
GeneChip scanner 3000 7G system. For quality control, the average fluorescence 
intensity of all genes was calculated using the Robust Multiarray Analysis (RMA) 
Algorithm 19, including a quantile normalization and using a background correction 
for GC-content. To check overall data quality, the positive (exonic) and negative 
(intronic) control probe sets were used to calculate the area under the curve which 
ranged from 0.83 to 0.85, indicating good quality samples. The protocol used was 
compliant with the MIAME guidelines and data have been submitted to the Gene 
Expression Omnibus (GEO) repository under no. GSE43760.
Reverse transcription quantitative PCR (RT-qPCR) validation
 For reverse transcription quantitative PCR (RT-qPCR) validation of the 
microarray results, RNA used for the microarrays was transcribed to cDNA using 
the superscript III first-strand synthesis supermix for qRT-PCR (Invitrogen, Paisley, 
UK) according to the manufacturers protocol. Ubiquitin C (Ubc) was used as a stable 
reference gene. Intron-spanning primers were designed using NCBI Primer-BLAST 
and purchased from Biolegio (Malden, The Netherlands). Primer nucleotide sequences 
(5’>3’) were as follows: Hdac9 forward GGATCAAAGCTCTCCACCCC and reverse 
TGGGCTCAGAGGCAGTTTTT; Il6r forward AGTGTCGGGAGCAAGTTCAG 
and reverse GGCTGCAAGATTCCACAACC; Cd97 forward 
CCCCAGATACTGCTGGTTGG and reverse CAGGTCCCAAGAAGCTCCAG; 
and Ubc forward TAGTTCCGTCGCAGCCGGGA and reverse 
GCATTGTCAAGTGACGATCACAGCG. Sybr green-based RT-qPCR was 
performed using a CFX96 Real-Time PCR Detection System (Bio-Rad). For each 
primer pair the melt curve, efficiency, and no template controls were assessed to 
check primer specificity. The comparative CT quantification (ΔΔCt method) was 
used to compare changes in gene expression. 
Statistical analysis
 Differences in anthropometric variables between women with the metabolic 
syndrome and healthy lean women were assessed by a two-tailed unpaired Student’s 
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t-test (Statistical Package for Social Sciences 16.0, SPSS Inc., Chicago, Illinois, 
USA). Correlations were assessed by a Pearson correlation coefficient.
 The Affymetrix CEL-files were imported into Partek® (Genomic Suite 
Software, version 6.4 Copyright © 2008 Partek Inc., St Louis, MO, USA) where 
only core probe sets were extracted and normalized using the RMA logarithm 
with GC background correction. Transcript summaries were calculated using the 
mean intensities of the corresponding probe sets, representing the quantitative 
gene expression levels. To identify differentially expressed genes between the 
women with the metabolic syndrome and healthy lean women a one-way analysis 
of variance (ANOVA) was performed. The resulting p-values were corrected for 
multiple-testing with the Benjamini-Hochberg false discovery rate procedure 20. The 
p-value, together with the Fold Change (FC) of every annotated gene, was exported 
to Microsoft Office Excel. 
 The gene list of interest (all > 1.3 fold upregulated genes) was analyzed using 
the Database for Annotation Visualization and Integrated Discovery functional 
annotation tool (DAVID, http://david.abcc.ncifcrf.gov) with main focus on the 
enrichment in GO-terms of biological processes (GOTERM_FAT) 21, 22. 
 To assess differences in the RT-qPCR results, an unpaired Student’s t-test 
was performed on the dCt values of the women with the metabolic syndrome versus 
healthy lean women. To visualize the fold-changes, the average gene expression 
levels of the healthy lean women was set at 1 and the average 2^-ddCt value of the 
women with the metabolic syndrome was calculated. 
 The level of statistical significance was defined at α=0.05 and data are 
presented as mean ± SD.
Results 
Physical characteristics
 The physical characteristics of the 19 women with the metabolic syndrome 
and the 20 healthy controls are presented in Table 1. The groups were age-matched, 
but as expected the women with the metabolic syndrome had a significantly higher 
body weight, BMI, waist circumference, waist-to-hip ratio, systolic and diastolic 
blood pressure, heart rate, and percentage of total and trunk fat mass.
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Blood plasma levels
 Insulin sensitivity (M-value) was significantly lower in women with the 
metabolic syndrome (Table 2). Calculation of the M-value per kg fat free mass 
instead of per total body weight resulted in equal relative values (r2=0.98). There was 
a significant negative correlation between the percentage of total fat mass and insulin 
sensitivity (r2=0.58, p=0.004). The levels of total cholesterol, triglycerides, LDL-C, 
apolipoprotein B, leptin and hs-CRP were significantly higher in women with the 
metabolic syndrome, while HDL-C and adiponectin levels were lower (Table 2).
 Table 2. Blood plasma levels of metabolic and inflammatory factors in women 
 with the metabolic syndrome (MS, n=19) and healthy controls (C, n=20).
MS C P value
M-value, mg min-1 kg-1 3.82 ± 1.71 8.63 ± 1.71 < 0.001
Total cholesterol, mmol/l 6.25 ± 1.18 4.91 ± 0.77 < 0.001
Triglycerides, mmol/l 1.99 ± 0.80 0.84 ± 0.28 < 0.001
HDL-C, mmol/l 1.20 ± 0.26 1.63 ± 0.33 < 0.001
LDL-C, mmol/l 4.19 ± 1.03 2.90 ± 0.66 < 0.001
Resistin, ng/ml 5.43 ± 1.75 4.80 ± 2.48 0.37
Apolipoprotein B, mg/l 1416 ± 424 758 ± 220 < 0.001
Leptin, ng/ml 65.9 ± 31.3 18.0 ± 9.8 < 0.001
Adiponectin, µg/ml 3.46 ± 1.00 5.07 ± 1.94 0.003
hs-CRP, ng/ml 4.92 ± 7.38 0.55 ± 0.29 0.02
Interleukin-6, pg/ml
< 3.0 (17x)
 3.0 (1x)
 6.0 (1x)
n.d.(1x)
 < 3.0 (17x)
4.0 (1x)
Free fatty acid, mmol/l 0.61 ± 0.23 0.58 ± 0.24 0.70
 Values are mean±SD, n.d. not determined
Skeletal muscle gene expression
 Skeletal muscle gene expression levels were compared between six women 
with the metabolic syndrome versus six healthy controls. The physical characteristics 
and blood plasma levels of this subgroup are provided in supplemental tables 1 and 
2, respectively. The two subgroups were representative for the whole group and 
remained statistically significant different regarding physical characteristics and 
M-value. Of the 28,870 genes assessed on the microarray, no single gene reached 
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statistical significant differential expression between groups after stringent correction 
for multiple testing. Therefore, we focused on biological processes and pathways that 
were overrepresented in the list of genes with the highest fold-changes. All genes with 
more than 1.3-fold change were selected for further analysis, resulting in a list of 456 
up- and 150 downregulated genes. Apparently, the metabolic syndrome is associated 
with more transcriptional up- than downregulation. The list of upregulated genes 
was most significantly enriched for the relatively general gene ontology (GO) term 
‘defense response’ (Table 3, GO:0006952). 
 Table 3. Enrichment in biological process GO-terms in the list of genes with more than 
 1.3-fold upregulation in women with the metabolic syndrome versus lean women. 
 Listing is according to significance. 
Gene Ontology term (upregulated in MS) F.E. P value
GO:0006952~defense response 3.1 1.49E-05
GO:0006954~inflammatory response 3.7 2.72E-04
GO:0045637~regulation of myeloid cell differentiation 8.5 3.38E-04
GO:0045321~leukocyte activation 4.3 4.75E-04
GO:0009611~response to wounding 2.9 4.79E-04
GO:0001775~cell activation 3.8 5.35E-04
GO:0009617~response to bacterium 4.5 7.20E-04
GO:0030595~leukocyte chemotaxis 11.7 8.58E-04
GO:0048511~rhythmic process 5.5 9.37E-04
GO:0060326~cell chemotaxis 11.1 1.12E-03
GO:0050900~leukocyte migration 8.6 1.48E-03
GO:0002237~response to molecule of bacterial origin 6.3 4.25E-03
GO:0006935~chemotaxis 4.4 5.57E-03
GO:0042330~taxis 4.4 5.57E-03
GO:0010033~response to organic substance 2.3 7.77E-03
GO:0006955~immune response 2.3 8.33E-03
GO:0001932~regulation of protein amino acid phosphorylation 4.1 9.09E-03
GO:0032496~response to lipopolysaccharide 6.4 9.40E-03
GO:0048534~hemopoietic or lymphoid organ development 3.3 9.51E-03
GO:0034097~response to cytokine stimulus 6.2 9.51E-03
GO:0030097~hemopoiesis 3.5 1.09E-02
GO:0002274~myeloid leukocyte activation 8.3 1.53E-02
GO:0002520~immune system development 3.1 1.57E-02
GO:0016477~cell migration 3.1 1.57E-02
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GO:0045638~negative regulation of myeloid cell differentiation 10.9 1.58E-02
GO:0022610~biological adhesion 2.2 1.58E-02
GO:0007155~cell adhesion 2.2 1.65E-02
GO:0050730~regulation of peptidyl-tyrosine phosphorylation 6.4 1.71E-02
GO:0002763~positive regulation of myeloid leukocyte differentiation 15.1 1.90E-02
GO:0045639~positive regulation of myeloid cell differentiation 9.9 1.99E-02
GO:0046649~lymphocyte activation 3.5 2.04E-02
GO:0050830~defense response to Gram-positive bacterium 13.6 2.62E-02
GO:0006928~cell motion 2.4 2.76E-02
GO:0002366~leukocyte activation during immune response 9.1 2.81E-02
GO:0002263~cell activation during immune response 9.1 2.81E-02
GO:0048870~cell motility 2.8 2.90E-02
GO:0051674~localization of cell 2.8 2.90E-02
GO:0006468~protein amino acid phosphorylation 2.1 2.97E-02
GO:0007626~locomotory behavior 3.0 3.03E-02
GO:0016310~phosphorylation 2.0 3.84E-02
GO:0002761~regulation of myeloid leukocyte differentiation 8.0 4.20E-02
GO:0006968~cellular defense response 6.2 4.24E-02
GO:0006796~phosphate metabolic process 1.8 4.27E-02
GO:0006793~phosphorus metabolic process 1.8 4.27E-02
GO:0042742~defense response to bacterium 4.4 4.81E-02
GO:0031399~regulation of protein modification process 2.8 4.95E-02
 F.E. = Fold Enrichment; p-value = Benjamini-Hochberg corrected
 This was better specified by the second term ‘inflammatory response’ 
(GO:0006954), of which all 22 responsible genes were also present in ‘defense 
response’ (that contained 13 additional genes). These 22 upregulated genes are listed 
in Table 4. 
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 Table 4. The 22 upregulated genes responsible for the enriched GO term ‘inflammatory 
 response’, listed according to significance.
Gene 
symbol Gene Name
Fold 
change
P 
value
HDAC9 histone deacetylase 9 1.6 < 0.01
IL6R interleukin 6 receptor 1.5 0.03
CD97 CD97 molecule 1.3 0.03
S100A8 S100 calcium binding protein A8 2.2 0.09
TLR6 toll-like receptor 6 1.5 0.10
LYZ lysozyme (renal amyloidosis) 1.8 0.10
S100A12 S100 calcium binding protein A12 1.8 0.11
ITGB2
integrin, beta 2 (complement component 3 receptor 3 
and 4 subunit)
1.4 0.14
CCR7 chemokine (C-C motif) receptor 7 1.3 0.15
ALOX5 arachidonate 5-lipoxygenase 1.5 0.16
CXCR2 interleukin 8 receptor, beta 1.7 0.16
PROK2 prokineticin 2 1.5 0.17
S100A9 S100 calcium binding protein A9 1.4 0.18
ITGAL
integrin, alpha L (antigen CD11A (p180), lymphocyte 
function-associated antigen 1; alpha polypeptide)
1.4 0.19
SERPINA1
serpin peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 1
1.6 0.20
CXCR1 interleukin 8 receptor, alpha 1.4 0.23
CR1
complement component (3b/4b) receptor 1 (Knops 
blood group)
1.3 0.24
CCL5 chemokine (C-C motif) ligand 5 1.3 0.25
LYN
v-yes-1 Yamaguchi sarcoma viral related oncogene 
homolog
1.3 0.34
AOAH acyloxyacyl hydrolase (neutrophil) 1.4 0.39
FOS
v-fos FBJ murine osteosarcoma viral oncogene 
homolog
1.5 0.41
LBP lipopolysaccharide binding protein 1.3 0.52
To visualize a possible link of these genes with insulin sensitivity, we correlated the 
microarray fluorescence intensity of the three most significantly upregulated genes 
with the M-value (fig. 1A-C), which resulted in a significant correlation for all three 
genes. RT-qPCR validation of these genes confirmed upregulation of Hdac9 and Il6r 
(Fig. 2). 
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Figure 1. 
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Correlation of insulin sensitivity (M-value) and skeletal muscle gene expression levels of the three 
most upregulated inflammatory-related genes Il6r (A), Hdac9 (B), and Cd97 (C) in women with the 
metabolic syndrome (n=6) and healthy controls (n=6). 
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Figure 2. 
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RT-qPCR validation of Il6r, Hdac9 and Cd97 upregulation in women with the metabolic syndrome 
(n=6) versus healthy controls (n=6). *p<0.05
Discussion
 The main finding of our study is that expression of genes involved in 
inflammatory pathways is upregulated in skeletal muscle of women with the 
metabolic syndrome, who are insulin resistant and have chronic low-grade systemic 
inflammation. This suggests the existence of a close link between obesity and 
skeletal muscle inflammation and insulin resistance. Correlation of the three most 
significantly upregulated inflammatory genes, Hdac9, Il6r, and Cd97, with insulin 
sensitivity suggests an important role for these genes in the development of skeletal 
muscle insulin resistance.
 For this study we selected women that fulfill the criteria of the metabolic 
syndrome. By definition, these women are obese, which is reflected by a BMI of >30 
and an elevated waist circumference. Most important for our study, the women with 
the metabolic syndrome were more than 2-fold more insulin resistant than the healthy 
control subjects, as determined by the gold standard hyperinsulinaemic euglycaemic 
clamp technique. The high negative correlation of total body fat percentage with 
insulin sensitivity is in line with the idea that adipose tissue plays an important role 
in the pathophysiology of the metabolic syndrome. Also blood plasma levels had 
the expected profile with elevated levels of total cholesterol, triglycerides, LDL-C, 
apolipoprotein B, leptin, and the inflammation marker hs-CRP, and lower HDL-C 
and adiponectin than controls. Apolipoprotein B has been proposed as an indicator to 
identify patients with the metabolic syndrome that are at higher cardiovascular risk 
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23. Leptin is an adipose tissue-derived inflammatory mediator that strongly resembles 
IL-6 24. Recently, it has been demonstrated that a high level of hs-CRP, IL-6, or a low 
level of adiponectin is associated with an increased risk for the metabolic syndrome 
25. Our findings thus confirm the association of elevated blood plasma levels of 
adipose tissue-derived inflammatory molecules with the metabolic syndrome.
 The effect of these altered blood plasma levels on skeletal muscle insulin 
resistance was further investigated using gene expression microarrays. The 
metabolic syndrome was mainly associated with the upregulation of genes and these 
were enriched for GO-terms related to inflammation. The three most significantly 
upregulated genes responsible for the GO-term ‘inflammatory response’ were 
HDAC9, IL6R, and CD97, and their expression levels significantly correlated with 
insulin resistance. The potential role of these three genes in the development of 
skeletal muscle insulin resistance is discussed below.
 The expression of the interleukin 6 receptor (Il6r) gene demonstrated 
the highest negative correlation with insulin sensitivity in our study. It has been 
recognized for a long time that elevated blood plasma levels of IL-6 are associated 
with the metabolic syndrome, but these levels are still below the detection limit 
of our assay 26. In mice, it has been demonstrated that treatment with IL-6 causes 
skeletal muscle insulin resistance, associated with deficient insulin signaling and 
increased levels of intramuscular fatty acyl-CoA 27. In contrast to our findings on the 
mRNA level, a recent study reports a marked downregulation of the IL6 receptor 
protein in skeletal muscle tissue of obese subjects with and without diabetes 28. 
This apparent discrepancy between IL-6 receptor mRNA and protein levels has 
previously been noticed in human exercise physiology studies. Skeletal muscle 
produces IL-6 during exercise, and it has been demonstrated that exercise training 
results in upregulation of IL-6 receptor mRNA levels 29. However, this effect on IL-6 
receptor mRNA is probably independent of IL-6 plasma levels, since infusion of 
IL-6 resulted in upregulation of the IL-6 receptor protein, but not mRNA levels. This 
is supported by the observation that Il6 knock-out mice are also able to upregulate 
IL-6 receptor mRNA after exercise 30. It will thus be interesting to further investigate 
the mechanisms that are responsible for the IL-6 receptor mRNA upregulation in 
women with the metabolic syndrome.
 Histone deacetylase 9 (Hdac9) has been associated with inflammation and 
cell-cycle regulation since it can bind to B-cell CLL/lymphoma 6 (BCL6) in the 
transcriptional regulation of B-cell activation and differentiation 31 Hdac9 knock-out 
studies in mice have indicated an important role for this gene in the transcriptional 
regulation of skeletal muscle fiber type 32, 33. The slow (type I) fiber type is maintained 
by the transcription factor myocyte enhancing factor 2 (MEF2) and HDAC9 
binds to MEF2, thereby inhibiting its function. Knock-out of this class of histone 
deacetylases in mice resulted in the loss of Mef2 repression and consequently the 
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transition of fast to slow fiber type. We found an upregulation of Hdac9 in skeletal 
muscle tissue of insulin resistant women with the metabolic syndrome. It has been 
demonstrated that skeletal muscle tissue of subjects with type 2 diabetes contains less 
slow and more fast fibers 34 and this change in fiber type may contribute to increased 
insulin resistance. In addition, it will be interesting to further study the potential 
role of histone deacetylase-mediated epigenetic modifications in the development 
of the metabolic syndrome. We thus identified Hdac9 due to its association with 
inflammation, but its role in fiber type determination may provide an alternative 
explanation and novel insight in the development of insulin resistance in women 
with the metabolic syndrome.
 CD97 molecule (CD97) is a seven plasma membrane spanning glycoprotein, 
mainly expressed on activated lymphocytes at sites of tissue inflammation 35. To 
our knowledge, CD97 has not directly been linked with insulin resistance yet, and 
also the role of lymphocytes in the development of skeletal muscle insulin signaling 
remains elusive. It has been demonstrated in adipose tissue in a mouse model that the 
infiltration of lymphocytes represents an important initial step in tissue inflammation 
and the subsequent development of insulin resistance 36. The upregulation of Cd97 
in our study suggests that the infiltration of lymphocytes may also be involved in the 
development of skeletal muscle insulin resistance in humans.
With the results of the present study it can be hypothesized that central adiposity 
and associated chronic low-grade inflammation result in chronic elevated levels of 
circulating inflammatory markers. This probably also includes IL-6, and IL-6 receptor 
mRNA levels are upregulated, but elucidation of the underlying mechanisms requires 
further research. At the same time, a transition takes place from slow insulin sensitive 
to fast, more insulin resistant, skeletal muscle fibers. In addition, lymphocytes may 
infiltrate the muscle and initiate tissue inflammation. Like in adipose tissue, the 
infiltration of lymphocytes in the muscle tissue may theoretically also play a role in 
the development of skeletal muscle insulin resistance. 
Limitations
Gene expression analysis was performed in only six subjects from each group, 
which limited the statistical power of the initial microarray analysis. However, 
the subgroups were completely representative for the whole group, and additional 
analysis using gene ontology terms resulted in the identification of inflammatory 
genes of which the expression level correlated with insulin resistance. This study 
provides associations, which not necessarily implies a cause and effect relationship. 
The groups also differed in other parameters like BMI, thereby limiting the possibility 
to determine the exact contribution of insulin resistance to the observed correlations.
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 Gene expression microarrays are a powerful tool to assess the expression level 
of many genes at once, but do not provide information on the cell type distribution 
in the biopsy. From this study it is not possible to conclude whether one specific cell 
type (e.g. leukocytes or myocytes) was responsible for the increased expression of 
inflammatory genes, or that more cells of a specific type (e.g. leukocytes) infiltrated 
the muscle tissue.
 In conclusion, we report that the gene expression in skeletal muscle tissue of 
women with the metabolic syndrome is mainly enriched for inflammatory response-
related genes. Specifically Il6r, Hdac9, and Cd97 gene expression negatively 
correlated with insulin sensitivity. This suggests a role for these three inflammatory 
genes in the development of skeletal muscle insulin resistance in women with the 
metabolic syndrome. Further delineation of these pathways may eventually lead to 
the development of therapeutic interventions to treat insulin resistance. 
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 Supplemental table 1. Physical characteristics of the women with the metabolic 
 syndrome (MS, n=6) and the healthy controls (C, n=6).
MS C P value
Age, yrs 58 ± 4 50 ± 9 0.06
Weight, kg 103.1 ± 9.3 64.5 ± 6.0 < 0.001
BMI, kg/m2 36.2 ± 2.1 22.2 ± 1.0 < 0.001
Waist circumference, cm 111.8 ± 11.5 77.6 ± 4.4 < 0.001
Waist-to-hip ratio 0.92 ± 0.10 0.78 ± 0.04 0.01
Systolic pressure, mmHg 142 ± 12 117 ± 8 0.001
Diastolic pressure, mmHg 84 ± 6 75 ± 5 0.02
Heart rate, bpm 69 ± 5 59 ± 5 0.006
Total fat mass, % 40.0 ± 1.4 28.1 ± 4.5 < 0.001
Trunk fat mass, % 40.4 ± 3.8 24.9 ± 6.8 < 0.001
 Values are mean±SD. Bpm=beats per min.
 Supplemental table 2. Blood plasma levels of metabolic and inflammatory factors in 
 women with the metabolic syndrome (MS, n=6) and healthy controls C, (n=6).
MS C P value
M-value, mg min-1 kg-1 3.13 ± 1.96 8.59 ± 2.06 < 0.001
Total cholesterol, mmol/l 6.62 ± 1.41 4.87 ± 0.47 0.03
Triglycerides, mmol/l 2.12 ± 1.06 0.98 ± 0.23 0.05
HDL-C, mmol/l 1.26 ± 0.36 1.53 ± 0.32 0.21
LDL-C, mmol/l 4.50 ± 1.35 2.90 ± 0.23 0.03
Resistin, ng/ml 4.30 ± 1.26 5.52 ± 3.47 0.45
Apolipoprotein B, mg/l 1559 ± 273 721 ± 183 < 0.001
Leptin, ng/ml 71.5 ± 48.6 13.4 ± 4.1 0.03
Adiponectin, µg/ml 3.45 ± 1.29 4.32 ± 0.46 0.17
hs-CRP, ng/ml 4.51 ± 4.25 0.68 ± 0.28 0.08
Free fatty acid, mmol/l 0.58 ± 0.17 0.47 ± 0.16 0.29
 Values are mean±SD.
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Abstract
Objective: To investigate whether physical fitness and/or fat distribution 
and inflammation profile may explain why approximately 30% of the women with 
obesity are protected against obesity-related disorders. Method: Ten metabolically 
healthy obese women and ten age- and weight-matched women with the metabolic 
syndrome were enrolled. Physical fitness (VO
2max
), daily physical activity levels 
(METs, steps per day), insulin sensitivity (clamp), body fat distribution (DXA 
scan) and, inflammation markers and adipokines were determined. Results: The 
metabolically healthy obese women had a 17% higher VO
2max
 (25.1 ± 3.9 vs 21.5 ± 3.1 
ml ∙ min-1 ∙ kg-1, p=0.04) and tended to take more steps per day (7388 ± 1440 vs 5927 
± 1301, p=0.06) than women with the metabolic syndrome. Despite equivalent levels 
of fat mass, metabolically healthy obese women had significantly lower circulating 
TNF-α levels compared to women with the metabolic syndrome (3.55 ± 3.83 vs 0.43 
± 0.97 ng/ml, p=0.03). No differences were seen in insulin sensitivity, adipokines, 
and inflammatory markers between both groups. Conclusion: Metabolically healthy 
obese women have a higher cardio-respiratory fitness and lower TNF-α levels, which 
may partly explain why these women are protected from the detrimental effects of 
obesity compared to obese women with the metabolic syndrome. 
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Introduction
Obesity is caused by a complex interplay between genetic predisposition 
and environmental lifestyle factors such as food overconsumption and physical 
inactivity1. While 70% of the obese people (BMI > 30 kg/m2) have at least one 
metabolic and/or cardiovascular risk factor, approximately  30% is metabolically 
healthy 2. Obese women with a healthy metabolic profile have a 10 years incidence 
of cardiovascular disease (CVD) events similar to their lean counterparts 3 while 
obese women with the metabolic syndrome have an almost 3-fold increased risk for 
CVD events 4. With the worldwide growing prevalence of obesity, understanding 
the physiological mechanisms why some obese women seem to be protected against 
the detrimental effects of obesity is clearly of utmost importance. In recent years, 
several hypotheses have been postulated regarding this metabolic healthy obese 
phenotype. Large epidemiological studies have shown that obese individuals who 
are in the higher range of physical fitness or physical activity levels, are more 
likely to have a metabolic healthy phenotype 2, 5, 6. Recently Ortega et al. showed 
that the metabolically healthy but obese subjects had a better physical fitness than 
metabolically abnormal subjects7. Bouchard et al. found similar findings in women 
with the metabolically healthy obese phenotype who performed a faster and further 
6-min walk test compared to obese women with risk factors8. Unfortunately, 
almost all of these studies used self-reported questionnaires or prediction models 
to determine physical activity levels and physical fitness, respectively. Besides 
physical fitness, the metabolic activity of fat tissue, including the inflammatory 
cytokine response 9, 10 and the specific location of fat tissue, have been proposed as 
possible explanations for the metabolically healthy obese phenotype 11, 12. Since there 
seems to be an association between fitness level and subclinical inflammatory profile 
in obese subjects 13, investigating the role of physical fitness simultaneous with the 
inflammation profile in metabolically healthy obese women and in obese women 
with the metabolic syndrome might improve our understanding of the metabolically 
healthy obese phenotype. In this cross-sectional study we hypothesize that increased 
physical fitness, using the ‘gold standard’ maximal oxygen uptake, more than fat 
distribution or inflammatory profile may explain why these ‘metabolically healthy 
obese’ women seem to be protected against obesity-related disorders.
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Methods
Subjects
Ten women with the metabolic syndrome and ten age- and weight-
matched metabolically healthy obese women were recruited for this study through 
advertisements in local newspapers (table I). Metabolic syndrome was defined 
according to the Joint Interim Statement for Harmonizing the Metabolic syndrome 
14 as having at least three out of five criteria 15, including waist circumference > 
88 cm, triglycerides > 1,7 mmol/l, HDL-cholesterol < 1,3 mmol/l, hypertension > 
130/85 mmHg and/or using antihypertensive medication and, fasting glucose > 5,6 
mmol/l. Metabolically healthy obese was defined as having a BMI > 30 kg/m2 and a 
waist circumference above 88 cm, but without any other risk factor, so applying to 
only one criterion of the metabolic syndrome definition. Accordingly, the Metabolic 
Syndrome z-score (MS z-score) was calculated for both obesity groups as described 
previously 16. Exclusion criteria were a medical history of diabetes, cardiovascular 
diseases, liver or renal diseases and, performing regular physical activity > 5 hours a 
week. Before participation, a written informed consent was obtained. This study was 
approved by the Medical Ethical Committee of the Radboud University Nijmegen 
Medical Centre, and was conducted in accordance with the Declaration of Helsinki 
(2000).
Anthropometrics and biochemical parameters
A questionnaire was used to gather information about the duration of 
obesity, menopausal status, and the use of diet supplements. Height, weight, 
waist circumference, blood pressure, resting heart rate, plasma lipids, and glucose 
were measured by standard methods. A total body DXA scan determined body 
fat percentage, and body fat distribution (QDR 4500 densitometer, Hologic Inc. 
Waltham, MA). Peripheral tissue sensitivity to exogenous insulin was measured using 
a hyperinsulinaemic (insulin infusion dose of 430 pmol ∙ m-2 ∙ min-1) euglycaemic 
clamp as previously described 17. Adiponectin, and leptin were measured in duplicate 
by using DuoSet ELISA development system kits (R&D systems, Minneapolis, USA), 
high-sensitive C-reactive protein (hsCRP) via enzyme-immunoassay according to the 
instructions from the manufacturer (Dako Glastrup, Denmark), and tumor necrosis 
factor-alpha (TNF-α) in duplicate by using DuoSet ELISA development system kits 
(R&D systems, Minneapolis, USA). 
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Physical fitness and daily activity levels
Women performed a maximal exercise test on an leg-cycling ergo meter 
(Lode, Angio 300, Groningen, the Netherlands) using an incrementing protocol to 
assess their cardio-respiratory fitness.  Workload increased by 10 W per minute, 
starting at 10 W, until exhaustion. A gas-analyzer was used to measure oxygen 
consumption continuously (Jaeger Benelux BV, Breda, the Netherlands). Maximal 
oxygen consumption (VO
2max
) was analyzed as the mean of all values that were 
obtained during the last minute of the exercise test. Women had to meet at least 
two of the three following criteria to fulfill the definition of good quality VO
2max
-
test. One, a heart rate in excess of 90% of age predicted maximum (220 – age); 
two, identification of a plateau (<150 ml increase) in VO2 despite further increase in 
workload; three, a respiratory exchange ratio of ≥ 1.10.
A SenseWear Pro 3 Armband® (Body Media, Inc., Pittsburgh, PA, USA) was 
worn 24/7 and was used to objectively determine the Metabolic Equivalent of Task 
(METs) and number of steps taken each day.  From each 24 hour interval, data were 
analyzed from 0700 to 2300 h with a minimum on-body time of 85 %. At least four 
days had to fulfill these criteria to be used for analysis.
Statistical methods
All data are reported as mean ± SD, while statistical significance was assumed 
at P≤0.05. Statistical analyses were performed using SPSS 18.0 (SPSS, Chicago, 
Illinois). Differences between groups were analysed by an unpaired Student’s t-test. 
A binary backward logistic regression (Wald) analysis was used to identify which 
factor was the strongest predictor to have the metabolically healthy obese phenotype. 
Parameters that were significantly different between metabolically healthy obese 
women and metabolic syndrome women in the univariate analysis were selected for 
this regression model. All Odds Ratios were presented with their 95% confidence 
interval (CI). 
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Results
Table I shows characteristics of the metabolically healthy obese women and 
women with the metabolic syndrome. Both groups differed significantly in criteria 
of the metabolic syndrome definition, i.e. systolic blood pressure, triglycerides and 
HDL-cholesterol. No differences between groups were observed for duration of 
obesity, menopausal status, fasting glucose, insulin, BMI, waist circumference and 
diastolic blood pressure. Metabolically healthy obese women had a significantly 
lower MS z-score than women with the metabolic syndrome. The insulin sensitivity 
(M-value) was comparable between both groups. Metabolically healthy obese women 
had a significantly lower resting heart rate compared with women with the metabolic 
syndrome despite the fact that 6 out of 10 women in the metabolic syndrome group 
used β-blockers.
Physical fitness and physical activity
VO
2max
 was significantly higher in the metabolically healthy obese women 
compared to women with the metabolic syndrome (fig. IA). No difference was found 
in METs and minutes per day spend performing activities above an activity level of 
three METs. However, when assessing daily physical activity levels by number of 
steps taken each day, metabolically healthy obese women tended to take 25% more 
steps each day compared to women with the metabolic syndrome (p=0.06)(table I). 
Body fat distribution and inflammation
Quantity and distribution of body fat were similar between metabolically 
healthy obese women and women with the metabolic syndrome, as were total body 
fat mass, fat mass located on the trunk or on the extremities (table I). Metabolically 
healthy obese women had higher circulating levels of TNF-α (fig. IB). No differences 
were measured in resistin, apolipoprotein B, leptin, adiponectin and hsCRP between 
both groups (table I). 
Using cardio-respiratory fitness (VO
2max
) and TNF-α as co-variate input 
factors in the binary backward logistic regression (Wald) analysis, cardio-respiratory 
fitness appeared to be the strongest predictor for having the metabolically healthy 
obese phenotype (Odds Ratio=1.6, CI 1.0 – 2.4, p-value=0.04).
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 Table I. Differences between women with the metabolic healthy obese (MHO) 
 phenotype and with the metabolic syndrome (MS).
MHO MS P value
Age (yrs) 50 ± 5 52 ± 7 0.47
Duration of obesity (yrs) 18 ± 11 22 ± 10 0.42
Number of postmenopausal women 3 3 -
Number of MS features 1 4 < 0.00
MS z-score -1.05 ± 1.22 2.60 ± 1.94 < 0.00
Body composition
Weight (kg) 91.7 ± 9.3 90.6 ± 9.4 0.81
BMI (kg/m2) 32.9 ± 3.0 33.7 ± 2.7 0.53
Waist circumference (cm) 103 ± 5 106 ± 5 0.11
Total body fat mass (%) 39.9 ± 3.1 42.1 ± 4.5 0.22
Trunk fat mass (%) 39.9 ± 2.5 42.9 ± 4.8 0.10
Blood pressure
SBP (mmHg) 124 ± 11 136 ± 13 0.04
DBP (mmHg) 81 ± 5 83 ± 8 0.47
HRrest (bpm) 61 ± 4 69 ± 9 0.03
Blood markers
Triglycerides (mmol/l) 1.16 ± 0.26 2.08 ± 0.67 < 0.00
HDL-C (mmol/l) 1.52 ± 0.19 1.15 ± 0.16 < 0.00
Glucose (mmol/l) 5.2 ± 0.2 5.3 ± 0.7 0.62
Insulin (mE/L) 13.0 ± 3.9 12.4 ± 3.1 0.59
M-value (μmol/min/kg) 28.0 ± 7.1 26.0 ± 8.0 0.57
Resistin (ng/ml) 6.2 ± 2.3 5.5 ± 1.9 0.45
Apolipoprotein B (mg/L) 1389 ± 335 1398 ± 425 0.96
Leptin (ng/ml) 65.8 ± 27.6 61.1 ± 21.0 0.69
Adiponectin (μg/ml) 4.19 ± 1.13 3.72 ± 1.11 0.37
hsCRP (ng/ml) 2.09 ± 1.80 5.93 ± 9.78 0.25
TNFα (ng/ml) 0.43 ± 0.97 3.55 ± 3.83 0.03
Physical fitness
VO
2max 
( ml/min/kg) 25.1 ± 3.9 21.5 ± 3.1 0.04
METs, (-) 1.35 ± 0.14 1.29 ± 0.12 0.34
METs > 3 (min) 68 ± 30 50 ± 19 0.23
Number of steps per day 7388 ± 1440 5927 ± 1301 0.06 
 Values are means ± SD; MHO, metabolically healthy obese; MS, metabolic syndrome; MS z-score, 
 metabolic syndrome z –score; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic 
 blood pressure; HRrest, resting heart rate; bpm, beats per minute; HDL-C, HDL-cholesterol: hsCRP, 
 high sensitivity C-reactive protein; TNFα, tumor necrosis factor alpha; VO
2max
, maximal oxygen 
 uptake; METs, Metabolic Equivalent of Task.
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Figure I.
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Discussion
In this study we found that metabolically healthy obese women have a higher 
VO
2max
 compared to age- and weight-matched obese women with the metabolic 
syndrome. Our regression model reinforced this finding and revealed that VO
2max 
was the strongest predictor for having the metabolically healthy obese phenotype. In 
addition, the metabolically healthy obese women appeared physically more active as 
they tended to take more steps per day than the metabolic syndrome women. We did 
not observe a difference in total body fat mass nor in fat distribution between both 
groups but we did find lower circulating TNF-α levels in the metabolically healthy 
obese women, which suggests a lower inflammatory profile of fat tissue.
Previous studies assessing physical fitness used questionnaires, self-reported 
physical activity scoring systems or predictions of cardio-respiratory fitness and 
activity levels. These cross-sectional studies reported that with higher levels of cardio-
respiratory fitness, the prevalence of the metabolic syndrome is lower 5, 18 and this 
association between physical fitness and prevalence of metabolic syndrome actually 
seems to apply for any given level of body weight 19. Two recent studies, both using 
a surrogate marker for physical fitness, confirmed the hypothesis that metabolically 
healthy but obese subjects have a better physical fitness than metabolically abnormal 
obese subjects 7, 8.  Our results, using the ‘gold standard’ VO
2max 
for determination of 
cardio-respiratory fitness, demonstrate that metabolically healthy obese women do 
have a higher VO
2max
 and, in addition, this parameter appeared to be the strongest 
predictor of the metabolically healthy obese phenotype. Two other studies found no 
difference in VO
2max
 between metabolically healthy obese and obese subjects “at-
risk”. However, these two studies classified their subjects as metabolically healthy 
obese solely on insulin sensitivity 9, 12, whereas we used the Joint Interim Statement 
definition of the metabolic syndrome 14 to define our obese women. The important 
benefit of this approach is the ability to accurately determine the total cardio-
metabolic health of the groups. Our findings suggest that VO
2max
 is one of the factors 
in the phenotype development of subjects with obesity. It appears that the difference 
in physical fitness between the obesity groups may contribute to the normal blood 
pressure and cholesterol profile, but does not influence the insulin sensitivity since 
the M-value did not differ between the obesity groups. As waist circumference did 
not differ between the groups, the only metabolic syndrome criteria they have in 
common, waist circumference probably explains the similar insulin sensitivity. 
This is in agreement with results from the Diabetes Prevention Program Research 
Group who showed that waist circumference is the strongest predictor of risk for 
developing diabetes 20. Although physical fitness can positively influence insulin 
sensitivity this may only count for a certain threshold of physical fitness level. 
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Even though our metabolically healthy obese women have a higher physical fitness 
compared to women with the metabolic syndrome, their fitness level is still below the 
average value of lean women. Apparently, a small difference in low physical fitness 
may positively affect blood pressure and cholesterol profile including higher HDL 
levels, but not insulin sensitivity.  The lower resting heart rate in the metabolically 
healthy obese women, despite the fact that 6 out of 10 metabolic syndrome women 
used a β-blocker, might be interrelated with the better cardio-respiratory fitness 
in these women but may also reflect a more favorable autonomic nervous system 
activity. A lower resting heart rate, suggesting a lower sympathetic nervous system 
activity, has previously been linked to the metabolically healthy obese phenotype in 
postmenopausal women 21.  
Since chronic subclinical inflammation and physical fitness have opposing 
relationships with obesity 13, we simultaneously determined physical fitness and the 
inflammation profile. We found that metabolically healthy obese women had 73% 
lower circulating TNF-α levels compared to metabolic syndrome women, suggesting 
that metabolically healthy obese women have a more favorable inflammation profile. 
Also hsCRP appeared numerically lower in the metabolically healthy obese group, 
but this difference did not reach statistical significance. One previous study assessed 
TNF-α levels in metabolically healthy obese subjects compared to obese subjects 
with the metabolic syndrome. Although this study was performed in older mainly 
black women they also found lower TNF-α levels in the metabolically healthy obese 
group 10. The lower TNF-α levels found in our metabolically healthy obese women 
cannot be explained by their quantity of fat tissue or degree of insulin resistance 
since both variables did not differ between groups (table 1). Our results suggest that 
in obese women TNF-α levels may be influenced by VO
2max
 which corresponds with 
the fact that exercise training can lower TNF-α levels in diabetic patients 22. 
There are a few limitations of this study which need to be considered. 
First, this study had a cross-sectional design which does not allow to draw causal 
conclusions. However, exercise intervention studies in obese subjects with multiple 
cardiovascular risk factors confirm that even without weight loss, improving physical 
fitness level can reverse these risk factors 23, 24. Secondly, we selected middle-aged 
women for this study with different menopausal status. The post-menopausal status 
is associated with an increased risk of the metabolic syndrome 25 and is related 
with changes in individual criteria of the metabolic syndrome such as an increase 
in abdominal adiposity. Although we are aware of this influence we believe this 
did not affect our results since the distribution of menopausal status and trunk fat 
mass percentage were equal in both groups. Finally, by using the DXA scan we 
could determine abdominal trunk fat and peripheral fat located on the extremities, 
but we were not able to discriminate between subcutaneous and visceral abdominal 
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fat tissue while specifically visceral abdominal fat can be related to systemic markers 
of inflammation 11, 26 and consequently with the metabolic phenotype. 
Perspectives
The results of the present study show that a higher physical fitness and lower 
circulating TNF-α levels may partly explain why metabolically healthy obese women 
are protected against the detrimental effects of obesity, despite corresponding levels 
of adipose tissue mass, compared to obese women with the metabolic syndrome. Our 
findings support previous studies which used surrogate markers for physical fitness 
7, 8. In addition, our results show that VO
2max
 appears to be a stronger predictor than 
TNF-α for having the metabolically healthy obese phenotype. Primary prevention 
by increasing fitness levels in  obese women, might prevent the massive medical 
and economic burden associated with obesity and is therefore of utmost importance. 
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Abbreviations
AIS   ASIA Impairment Scale
AMPK  AMP-activated protein kinase
ANOVA analysis of variance
AS160  Akt  substrate of 160 kDa
DAVID  database for annotation, visualization and integrated discovery
ECLIA   electrochemiluminescence immunoassay
FA   fatty acid
FABP3   fatty acid binding protein 3
FES   functional electrical stimulation
GLUT4  glucose transporter type 4
GO   gene ontology
HADH   hydroxyacyl-CoA dehydrogenase
HbA1c   glycosylated hemoglobin
HOMA-IR  homeostasis model assessment of insulin resistance
IRS1/2   insulin receptor substrate 1/2
RMA  robust microarray analysis
UBC   ubiquitin C
ULLS   unilateral limb suspension
OXPHOS  oxidative phosphorylation
PKC  protein kinase C
RT-qPCR reverse transcription quantitative PCR
SCI  spinal cord injury
SLC25A20  solute carrier 25 (carnitine/acylcarnitine translocase), 
  family member A20
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Abstract
 Physical deconditioning is associated with the development of chronic 
diseases, including type 2 diabetes and cardiovascular disease. Exercise training 
effectively counteracts these developments, but the underlying mechanisms are 
largely unknown. To gain more insight in these mechanisms, muscular gene expression 
levels were assessed after physical deconditioning and after exercise training of 
the lower limbs in humans using gene expression microarrays. In order to exclude 
systemic effects, we used human models for local physical inactivity (three weeks of 
unilateral limb suspension) and for local exercise training (six weeks of functional 
electrical stimulation exercise of the extremely deconditioned legs of individuals 
with a spinal cord injury). The most interesting subset of genes, those downregulated 
after deconditioning as well as upregulated after exercise training, contained 18 
genes related to both the ‘insulin action’ and ‘adipocytokine signaling’ pathway. 
Of these genes, the three with strongest up/downregulation were the muscular fatty 
acid binding protein 3 (FABP3), the fatty acid oxidizing enzyme hydroxyacyl-CoA 
dehydrogenase (HADH), and the mitochondrial fatty acid transporter solute carrier 
25 family member A20 (SLC25A20). The expression levels of these genes were 
confirmed using RT-qPCR. The results of the present study indicate an important 
role for a decreased transport and metabolism of fatty acids which provides a link 
between physical activity levels and insulin signaling in relation to physical (in)
activity.
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Introduction
The human genome has evolved based on a physically active lifestyle, but 
our society has become increasingly sedentary. Physical inactivity has detrimental 
health consequences, including the development of insulin resistance, and eventually 
type 2 diabetes and cardiovascular disease1, 2. Recently, it has been demonstrated 
that even a two week reduction in daily activity level can be sufficient to increase 
insulin resistance in healthy subjects, as does nine days of strict bed rest3, 4. On the 
other end of the spectrum, a single bout of exercise can reduce insulin resistance5, 
regular physical activity reduces the risk of developing diabetes6, 7, and significant 
exercise effects have been reported in diabetics8, making exercise a powerful tool in 
the prevention and management of type 2 diabetes. 
Skeletal muscle accounts for the majority of insulin-induced glucose uptake. 
Binding of insulin to its receptor on the cellular plasma membrane leads, via the 
activation of intracellular insulin receptor substrate 1 and 2 (IRS1/2), to translocation 
of the Glut4 glucose transporter to the plasma membrane. Obesity research has 
demonstrated that elevated levels of free fatty acids in the blood plasma can inhibit 
insulin signaling directly, or via elevated intramyocellular levels of triglycerides and 
free fatty acids that attenuate the insulin signaling pathway9. In addition, an impaired 
oxidation of intracellular fatty acids may result in an even larger accumulation of 
intracellular fatty acids and subsequent inhibition of insulin signaling10. On the other 
hand, exercise can effectively stimulate the insulin signaling cascade5. However, 
it is still unknown how the molecular mechanisms behind the development and 
prevention of insulin resistance exactly work. Gene expression profiling of skeletal 
muscle tissue after physical deconditioning and exercise training may provide more 
insight in the regulation of these mechanisms.
Gene expression microarray analysis is a rapid and comprehensive approach 
for the first identification of molecular changes in muscle tissue. Using this 
technique, the expression level of virtually all known genes can be analyzed in a 
single experiment. Microarrays have been used to study the expression levels of 
insulin-related genes in human models for deconditioning and exercise training3, 11, 
but systemic effects probably play an important role in these bed rest and exercise 
interventions. In order to exclude systemic effects and to enable us to solely study the 
muscular effects of the interventions, we used unique human in vivo models for local 
inactivity and local exercise training. The aim of this study was to identify genes 
related to the insulin signaling pathway that demonstrated an opposite responses 
to deconditioning versus exercise training. Such genes may be responsible for the 
detrimental effects of physical inactivity versus the beneficial effects of regular 
exercise. 
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Materials and methods
Experimental design
Unilateral lower limb suspension (ULLS) deconditioning: 
As a model for local deconditioning, the right leg of six healthy males was 
suspended and unloaded from all weight bearing for a period of three weeks 
as described before12, 13. To evaluate effectiveness of the ULLS model, calf 
skin temperature and calf circumference were measured before and after the 
intervention.
Functional electrical stimulation (FES) exercise training: 
As a model for local exercise training, eight subjects with SCI received eight weeks 
of FES exercise training of their paralyzed legs using a computer-controlled leg 
cycle ergometer (Ergys 2, Therapeutic Alliances Inc, Fairborn, OH, USA)14-16. Self-
adhesive 50 x 90 mm surface electrodes (Stimex, Pierenkemper, Wetzlar, Germany) 
were placed on the hamstring, gluteal, and quadriceps muscles on both legs of 
each subject. Electrical stimulation was applied using a coordinated sequence 
of monophasic square wave pulses (450 µs, 30 Hz) permitting cyclic patterns 
of muscle contraction resulting in leg cycling. The device was programmed to 
gradually increase the stimulation current amplitude to a maximum of 140 mA, 
in order to achieve a target pedaling rate of ~50 rpm. Pedal resistance could be 
altered with 1/8 kp increments, corresponding to ~6.1 W at 50 rpm. Resistance was 
reduced when pedaling rate dropped below 45 rpm and the stimulation was stopped 
when pedaling rate dropped below 35 rpm. During the training period, subjects 
performed 2-3 training sessions per week of 30 min each, resulting in a total of 
20 sessions per person. When 30 min exercise was not realized in one run, up to 5 
runs were performed until 30 min of cumulated active exercise was achieved. FES-
cycling as adopted in our study results in elevations in heart rate for the duration 
of the exercise bout (up to 30 minutes), but also leads to significant and steady-
state elevations in oxygen consumption and improvement in other cardiovascular 
parameters14, 17. This indicates that FES-cycling as adopted in our study can be 
regarded as an aerobic type of exercise. As a surrogate measure for lower limb 
fitness level, the total work (in kJ) achieved by a subject during a single bout of 
FES cycling was assessed during the first and the last training session.
Before and after both interventions, systemic insulin resistance and leg 
muscular gene expression levels were determined. Muscle biopsies after ULLS 
deconditioning were obtained before the leg was reactivated. To avoid an acute 
exercise effect, biopsies after FES exercise were obtained 24-48 h after the last 
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exercise bout, since the expression level of most metabolic genes returns to baseline 
within 24 hours following exercise18. 
Subjects
Subject characteristics are provided in Table 1. Seven SCI subjects had a 
complete lesion, varying between C5 and T11 (ASIA Impairment Scale (AIS) 
A), while one subject had an incomplete lesion at C5 (AIS B). All lesions were 
traumatic and existed for at least four years. None of the participants had any 
known cardiovascular disease, diabetes or cardiovascular risk factors such as 
hypercholesterolemia and hypertension. The study was approved by the ethics 
committee of the Radboud University Nijmegen Medical Centre, and conformed to 
the principles outlined in the declaration of Helsinki. All subjects provided written 
informed consent prior to testing.
 Table 1. Baseline characteristics of healthy subjects before deconditioning (n=6), and 
 subjects with a spinal cord injury (SCI) before exercise training (n=8)
Healthy subjects Subjects with SCI
Age, years 21 ± 0 39 ± 3*
Body mass, kg 79 ± 4 72 ± 5
Body mass index, kg/m2 22 ± 1 22 ± 1
Systolic blood pressure, mmHg 126 ± 3 117 ± 6
Diastolic blood pressure, mmHg 79 ± 2 75 ± 3
Resting heart rate, bpm 64 ± 4 62 ± 2
 Values are mean ± SEM. SCI = spinal cord injury; bpm = beats per minute. 
  *p<0.05 for unpaired t-test SCI vs. controls.
Insulin resistance
Blood samples were obtained before and after both interventions. Fasting 
glucose levels were determined using standard laboratory techniques, and fasting 
insulin levels were determined with an electrochemiluminescence immunoassay 
(ECLIA) on the E170 module of a modular analytics EVO analyzer (Roche, 
Mannheim, Germany) before and after deconditioning (n=5) and exercise training 
(n=8). Insulin resistance was calculated according to the homeostasis model 
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assessment of insulin resistance (HOMA-IR) method19, 20, using the equation 
HOMA-IR = glucose (mmol/l) x insulin (mU/l) / 22.5.
Muscle biopsy and RNA isolation
 Muscle biopsies were obtained from the vastus lateralis before and after the 
interventions using the Bergström technique21. The skin was locally anaesthetized 
with 1% (w/v) lidocaine, a small incision was made through the skin and fascia, and 
muscle specimens were immediately frozen in liquid nitrogen and stored at -80°C. 
Frozen muscle biopsy samples were ground using a mortar and pestle, placed in 
RNA-Bee, which contains phenol and guanidine thiocyanate (Tel-test, Friendswood, 
TX, USA), and homogenized using an T25 ultra-turrax dispenser (IKA, Staufen, 
Germany). RNA was isolated using phenol/chloroform extraction, and purified 
according to the RNeasy mini kit clean-up protocol including an on-column DNase 
digestion (Qiagen, Hilden, Germany). The RNA concentration and purity were 
measured with a Nanodrop spectrophotometer (Thermo Scientific, Waltham, MA, 
USA) and RNA integrity was analyzed on an Agilent Bioanalyzer (Santa Clara, CA, 
USA). For the deconditioning samples the RIN was between 6.8 and 7.9, and for 
the exercise samples the RIN was between 8.0 and 8.7, both indicating good RNA 
quality.
Gene expression microarray analysis
Gene expression analysis was performed before and after deconditioning 
(for three individuals separately plus one cDNA pool of the other three subjects), 
and three separate SCI individuals before and after exercise training. From the 
other SCI subjects we obtained insufficient RNA, which probably relates to the 
dramatic changes in muscle mass and composition (lots of intramuscular fat) after a 
SCI, which is further discussed in the limitations section. Total RNA (100 ng) was 
amplified and labeled according to the Affymetrix GeneChip whole transcript sense 
target labeling assay, and hybridized on Affymetrix GeneChip Human Gene 1.0 ST 
arrays (Affymetrix, Santa Clara, CA, USA)22. Arrays were scanned, processed, and 
imported into Genomic Suite software (Version 6.4, Partek, St. Louis, MO, USA). 
Probe sets were normalized using the robust microarray analysis (RMA) algorithm 
including background correction for GC content. The mean intensity of probe sets 
belonging to one gene was calculated, representing the quantitative gene expression 
levels. Differences in gene expression between groups were calculated and results 
were exported to Microsoft Excel for further analysis.
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Gene lists of interest were analyzed for enriched gene ontology (GO) terms 
for biological processes at the most specific level available (GOTERM_BP_FAT) 
using the web-based database for annotation, visualization and integrated discovery 
(DAVID)23, 24. To summarize extensive lists, functional annotation clustering of the 
enriched GO terms was performed as indicated. Alternatively, gene lists of interest 
were analyzed using Pathway studio 7.1 software (Ariadne, Rockville, MD, USA). 
The microarray data have been submitted to the Gene Expression Omnibus (GEO) 
repository under number GSE33886. And are accessible for review at: 
http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?token=dhcpzsgwiskecpi&acc=GSE33886.
Reverse transcription quantitative PCR (RT-qPCR) validation of microarray results
For reverse transcription quantitative PCR (RT-qPCR) validation of the 
microarray results, RNA used for the microarrays was available for two healthy 
controls and three individuals with SCI before and after the interventions. Of 
these samples, 200 ng RNA was transcribed to cDNA using the superscript III 
first-strand synthesis supermix for qRT-PCR (Invitrogen, Paisley, UK) according 
to the manufacturers protocol. Based on the microarray results, ubiquitin C 
(UBC) was selected as a stable reference gene. Intron-spanning primers were 
designed using NCBI Primer-BLAST and purchased from Biolegio (Malden, 
The Netherlands). Primer nucleotide sequences (5’>3’) were as follows: fatty 
acid binding protein 3 (FABP3) forward (TGGGACGGGCAAGAGACCACA), 
FABP3 reverse (TGCCGTGGGTGAGTGTCAGGA), hydroxyacyl-CoA 
dehydrogenase (HADHB) forward (CACCTGAGCTCCCTGCGGTT), 
HADHB reverse (TCGGTCTGCAGAGTGGCCCAT), solute 
carrier 25 (carnitine/acylcarnitine translocase), family member 
A20 (SLC25A20) forward (TGCTGAGGGAGCTGATCCGGG), 
SLC25A20 reverse (AACAGGCCGCATTGGCTGGG), UBC 
forward (TAGTTCCGTCGCAGCCGGGA), and UBC reverse 
(GCATTGTCAAGTGACGATCACAGCG). Sybr green-based RT-qPCR was 
performed using a CFX96 Real-Time PCR Detection System (Bio-Rad). For each 
primer pair the melt curve, efficiency, and no template controls were assessed to check 
primer specificity. The comparative CT quantification (ΔΔCt method) corrected for 
primer efficiency was used to compare changes in gene expression. 
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Statistical analysis
Subject characteristics, glucose/insulin levels and HOMA-IR are given 
as mean ± S.E.M. and differences between the groups and between post and pre 
intervention were assessed using a two-tailed t-test. 
To assess differences in gene expression between groups, the corrected 
intensity of individual genes were used for an analysis of variance (ANOVA) on 1) 
After deconditioning versus before deconditioning, and 2) After exercise training 
versus before exercise training, using Partek Genomic Suite. The focus of this study 
was on biological processes and pathways instead of individual genes, and therefore 
unadjusted p-values (p<0.05) were used. Enriched GO terms were considered 
significant if p<0.05 after Benjamini-Hochberg correction for multiple testing.
To validate the microarray data, a Pearson correlation coefficient was 
calculated on the fold-changes of FABP3, HADHB, and SLC25A20 as determined 
with RT-qPCR versus the fold-changes as determined with gene expression 
microarrays.
Results
Effectiveness of the interventions
Deconditioning by ULLS resulted in a significant decrease of 2.3±0.1 °C in 
calf skin temperature and a significant decrease of 1.2±0.4 cm in calf circumference 
of the suspended leg (pre 28.1±0.2, post 25.8±0.2 °C, P<0.001 and pre 37.7±0.9, 
post 36.5±0.7 cm, P=0.028, respectively). This indicates that ULLS deconditioning 
was effective.
The exercise training period was successfully completed by all eight subjects 
with SCI. Work during FES exercise increased significantly after training (median 
(25%-75%): pre: 0 kJ (0-2.2), post: 11.0 kJ (5.5-19.7), P=0.008). This indicates that 
FES exercise training was effective in improving condition of the paralyzed muscles 
in SCI individuals. 
Systemic insulin resistance, as determined by the HOMA-IR, was not 
affected by ULLS deconditioning, nor by FES exercise training (Table 2).
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 Table 2. Fasting glucose and insulin levels, and deduced insulin resistance (HOMA-IR) 
 before and after deconditioning of healthy subjects (n=5) and exercise training of 
 subjects with a spinal cord injury (n=8)
Deconditioning Exercise training
Before After Before After
Glucose (mmol/L) 4.7 ± 0.1 4.7 ± 0.1 4.7 ± 0.1 4.7 ± 0.2
Insulin (mU/L) 4.9 ± 1.0 6.6 ± 0.6 12.1 ± 4.6 9.7 ± 2.9
Insulin resistance (HOMA-IR) 1.0 ± 0.2 1.4 ± 0.1 2.7 ± 1.1 2.1 ± 0.7
 Values are mean±SEM. HOMA-IR = homeostasis model assessment of insulin resistance
Gene expression microarray analysis
Gene expression levels were analyzed for a subgroup of the participants. We 
identified 2,166 genes with an altered expression level after deconditioning (1,372 
down- and 794 upregulated), and 2,397 genes after exercise training (1,172 up- and 
1,225 downregulated) (Fig. 1). Further analysis revealed an overlap in 112 genes that 
were upregulated after exercise training and downregulated after deconditioning and 
59 genes that showed the opposite response. In addition, we found upregulation after 
both interventions in 35 genes and downregulation in 36 genes. 
Effect of the interventions on biological processes
To gain insight in the biological implication of the observed changes in gene 
expression, lists of up- and downregulated genes were analyzed for overrepresented 
biological process gene ontology (GO) terms and summarized using functional 
annotation clustering (Table 3). The list of genes upregulated after deconditioning 
was not enriched for any GO term, while the list of genes downregulated after 
deconditioning was significantly enriched for 15 clusters of GO terms that are 
mainly related to cellular respiration. The list of upregulated genes after exercise 
training was enriched for the GO term cluster ‘generation of precursor metabolites 
and energy’. The list of genes downregulated after exercise training was enriched for 
GO terms related to RNA splicing and chromosome organization. 
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Figure 1
Schematic representation of the microarray results. Number of genes up- and downregulated after 
deconditioning and exercise training, and overlap between these gene lists (p<0.05).
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 Table 3. The most significant gene ontology (GO) terms representing the overrepresented  
 clusters in the lists of genes up- and downregulated after deconditioning and exercise 
 training
DOWNREGULATED AFTER DECONDITIONING
Gene ontology term F.E. P value
GO:0006091 generation of precursor metabolites and 
energy 5.2 7.2E-34
GO:0006119 oxidative phosphorylation 7.2 8.2E-19
GO:0006631 fatty acid metabolic process 3.7 6.7E-10
GO:0006732 coenzyme metabolic process 3.8 5.7E-08
GO:0006090 pyruvate metabolic process 5.9 1.0E-04
GO:0006006 glucose metabolic process 3.0 4.3E-04
GO:0010565 regulation of cellular ketone metabolic 
process 4.3 2.5E-03
GO:0046486 glycerolipid metabolic process 2.7 2.9E-03
GO:0015718 monocarboxylic acid transport 4.6 3.2E-03
GO:0055085 transmembrane transport 1.7 8.1E-03
GO:0015908 fatty acid transport 5.4 2.6E-02
GO:0003012 muscle system process 2.4 2.8E-02
GO:0046474 glycerophospholipid biosynthetic process 3.3 3.9E-02
UPREGULATED AFTER EXERCISE TRAINING
Gene ontology term F.E. p-value
GO:0006091 generation of precursor metabolites and 
energy 2.4 3.0E-03
DOWNREGULATED AFTER EXERCISE 
TRAINING
Gene ontology term F.E. p-value
GO:0008380 RNA splicing 3.8 8.6E-14
GO:0051028 mRNA transport 3.9 2.2E-03
GO:0051276 chromosome organization 1.9 2.3E-02
            F.E. = Fold enrichment
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Biological processes and pathways affected by both interventions
Analysis of the overlapping gene lists, being the genes that responded to 
deconditioning as well as exercise training, resulted in significantly enriched GO 
terms only for the 112 genes that were downregulated after deconditioning as well as 
upregulated after exercise training (Table 4). These 112 genes were further analyzed 
for overrepresented “Ariadne signaling pathways”. This resulted in two significantly 
enriched pathways, namely “insulin action” (P=5.5E-07, 18 of 905 members present) 
and “adipocytokine signaling” (P=1.0E-03, 12 of 780 members present). The 12 
genes of the second pathway completely overlapped with the 18 genes of the first, 
and are all listed in table 5.
 Table 4. Overrepresented gene ontology terms in the overlap between the lists of 
 ‘downregulated after deconditioning’ and ‘upregulated after exercise training’ 
Gene ontology term F.E. P value
GO:0006091 generation of precursor metabolites and energy 9.3 1.7E-08
GO:0055114 oxidation reduction 5.4 9.7E-07
GO:0045333 cellular respiration 14.1 3.6E-04
GO:0022900 electron transport chain 12.0 8.0E-04
GO:0006119 oxidative phosphorylation 12.2 2.8E-03
GO:0015980 energy derivation by oxidation of organic compounds 9.5 3.0E-03
GO:0006631 fatty acid metabolic process 6.9 1.6E-02
GO:0006732 coenzyme metabolic process 7.8 2.4E-02
GO:0006006 glucose metabolic process 7.8 2.4E-02
GO:0016054 organic acid catabolic process 9.3 3.9E-02
GO:0046395 carboxylic acid catabolic process 9.3 3.9E-02
GO:0015908 fatty acid transport 24.5 4.2E-02
    F.E. = Fold enrichment
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 Table 5. Fold-change of all 18 genes downregulated after deconditioning and 
 upregulated after exercise training that belong to the “insulin action” and 
 “adipocytokine signaling” pathways
Gene 
symbol
Name Deconditioning
Exercise 
training
FABP3
fatty acid binding protein 3, muscle and 
heart (mammary-derived growth inhibitor)
-1.89 2.47
HADHB
hydroxyacyl-CoA dehydrogenase/3-keto-
acyl-CoA thiolase/enoyl-CoA hydratase 
(trifunctional protein), beta subunit
-1.25 1.87
SLC25A20
solute carrier family 25 (carnitine/acylcar-
nitine translocase), member 20
-1.56 1.44
LDHD lactate dehydrogenase D -1.59 1.28
PDK2 pyruvate dehydrogenase kinase, isozyme 2 -1.42 1.38
DLST
dihydrolipoamide S-succinyltransferase 
(E2 component of 2-oxo-glutarate com-
plex)
-1.40 1.34
PET112L PET112-like (yeast) -1.36 1.32
MRPS2 mitochondrial ribosomal protein S2 -1.46 1.18
MRPS18B mitochondrial ribosomal protein S18B -1.42 1.21
PC pyruvate carboxylase -1.25 1.35
MRPL33 mitochondrial ribosomal protein L33 -1.25 1.32
MRPL12 mitochondrial ribosomal protein L12 -1.33 1.22
ENO3 enolase 3 (beta, muscle) -1.37 1.16
PECI 
(ECI2)
enoyl-CoA delta isomerase 2 -1.28 1.24
GPI glucose-6-phosphate isomerase -1.23 1.26
HADHA
hydroxyacyl-CoA dehydrogenase/3-keto-
acyl-CoA thiolase/enoyl-CoA hydratase 
(trifunctional protein), alpha subunit
-1.18 1.30
EIF3K
eukaryotic translation initiation factor 3, 
subunit K
-1.27 1.13
NR2F2
nuclear receptor subfamily 2, group F, 
member 2
-1.06 1.18
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Reverse transcription quantitative PCR (RT-qPCR) validation
 Of the 18 genes associated with insulin and adopocytokine signaling, RT-
qPCR analysis was performed to assess the expression levels of the three genes 
that demonstrated the strongest up- and downregulation after exercise training and 
deconditioning, respectively. The fold-changes of FABP3, HADHB, and SLC25A20 
as determined with RT-qPCR demonstrated a significant correlation with the fold-
changes determined with the gene expression microarrays, thereby confirming the 
microarray findings (Fig. 2).
Figure 2.
r2=0.93
p<0.0001
Fold change qPCR
Correlation qPCR-microarray
3
2
2
3
-3       -2                      2          3         4          5
F
ol
d 
ch
an
ge
 m
ic
ro
ar
ra
y
RT-qPCR validation of the microarray results. Correlation of the expressional changes of 
FABP3, HADHB, and SLC20A25 after deconditioning (n=2) and exercise training (n=3), as determined 
with RT-qPCR versus gene expression microarrays. The origin of this graph 
represents a -1 or 1-fold difference (=unchanged expression).
Discussion
In order to study only the local effects of physical inactivity and activity and 
minimize possible systemic effects, we used unique human models for inactivity and 
exercise training. The sudden ULLS inactivation of the active legs of healthy subjects 
is in our opinion best mirrored by the sudden FES activation of the extremely inactive 
legs of subjects with a SCI25, 26. The models for local deconditioning and exercise 
training were successful, since three weeks of ULLS deconditioning decreased calf 
skin temperature and leg circumference, and FES exercise training increased the 
total work performed by the participants. 
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Due to the local nature of our interventions, we did not find a statistically 
significant effect on systemic insulin resistance. Recent studies on more systemic 
types of deconditioning did report an increase in insulin resistance, for example after 
a two week reduction in daily steps4, and after nine days of bed rest3. Subjects with 
SCI have an increased risk for developing insulin resistance and subsequent type 
2 diabetes27, but our local FES exercise training did not alter fasting glucose and 
insulin levels. This is in line with a comparable intervention study, that required 
the administration of one dose of glucose (oral glucose tolerance test) to visualize 
differences in insulin sensitivity28, 29. In addition, they reported an increase in the 
skeletal muscle protein levels of the glucose transporters GLUT1 and GLUT4 after 
intervention. However, we did not confirm this on the gene expression level (1.02 
and 1.06-fold upregulated, respectively). Our study could have been strengthened 
by assessment of local insulin resistance by 2-deoxyglucose uptake or oral glucose 
tolerance tests with concomitant muscle biopsies and subsequent analysis for 
phosphorylation status of insulin-signaling proteins.
 The focus of this study was to identify insulin signaling-related genes that 
changed after both interventions. Of the 112 genes that were downregulated after 
deconditioning as well as upregulated after exercise training, pathway analysis 
identified 18 genes to be involved in insulin action and adipocytokine signaling. 
Expression levels of the three genes with the most contrasting up/downregulation 
(FABP3, HADHB, and SLC25A20) were confirmed using RT-qPCR validation. 
Previous reports on these three genes describe their possible role in 
insulin and adipocytokine signaling. FABP3 (also known as H-FABP) facilitates 
the cytoplasmic transport of fatty acids between intracellular membranes30. It has 
previously been demonstrated in a rat model that hind limb unloading results in FABP3 
downregulation31, while exercise training of humans results in the upregulation of 
FABP3 expression32. Trained athletes also have higher FABP3 expression levels than 
untrained subjects33. In addition, FABP3 is one of the genes demonstrating a positive 
correlation with both maximal oxygen uptake and proportion of skeletal muscle type 
I fibers in men, suggesting a role for FABP3 in muscular aerobic metabolism34. Gene 
and protein expression of muscular FABP3 has been correlated to body weight in 
a diet-induced obesity mouse model, and increased expression in cultured skeletal 
muscle cells resulted in phosphorylation of the protein Akt substrate of 160 kDa 
(AS160) and glucose uptake via activation of AMP-activated protein kinase (AMPK) 
and insulin-dependent Akt activation35. FABP3 thus provides a first link between 
physical activity and insulin resistance.
The fatty acid beta oxidizing enzyme HADH functions in the mitochondrial 
matrix and is commonly used as a marker for skeletal muscle oxidative capacity. 
The protein consists of an alpha and beta subunit, and in our study both were 
downregulated after deconditioning and upregulated after exercise training. This is 
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in line with previous studies that reported a decreased HADH activity after hind 
limb unloading in a rat model36, and HADH activation following exercise training 
programs in both animal and human models37-39. The role of HADH in skeletal 
muscle insulin signaling remains more elusive.
The mitochondrial fatty acid transporter SLC25A20 (also known as CACT) 
is required to translocate fatty acids across the inner mitochondrial membrane into 
the mitochondrial matrix, where fatty acid beta oxidation takes place40. Despite this 
crucial role in the generation of energy in muscle, little is known about the effects 
of deconditioning and exercise on SLC25A20 expression levels. Regarding insulin 
resistance, a significant decrease in muscular SLC25A20 mRNA and protein levels 
has been demonstrated in insulin resistant subjects and in their isolated mitochondria 
the activity of the enzyme was lower compared to healthy subjects41. 
Thus, our results indicate that one of the opposite effects of physical 
deconditioning and exercise training is an altered transport (intracellular FABP3 
and SLC25A20 over the inner mitochondrial membrane) and metabolism (beta 
oxidation by HADH) of fatty acids. This is in line with theories that inactivity-
induced accumulation of intramuscular fatty acids may lead to insulin resistance, 
while exercise induces the beta oxidation of these fatty acids9, 10. Integration of our 
findings with these existing models results in a proposed working mechanism of 
physical activity on insulin resistance as depicted in figure 3. In this model, exercise 
training upregulates FABP3 that transports fatty acids between the cellular plasma 
membrane and the mitochondrial membranes. SLC25A20 is also upregulated 
and transports the fatty acids over the inner mitochondrial membrane. Inside the 
mitochondria, upregulated HADH is involved in the beta oxidation of fatty acids. 
Physical deconditioning, on the other hand, results in downregulation of these genes, 
which leads to the accumulation of intracellular fatty acids. This activates protein 
kinase C (PKC), which inhibits insulin receptor substrate 1/2 (IRS 1/2), resulting in 
less translocation of Glut4 to the cell membrane and thus a reduced insulin-induced 
glucose uptake. However, additional experiments are required to prove the validity 
of this preliminary model.
Apart from the genes that were regulated by both interventions, we 
separately analyzed the lists of genes that were up- and downregulated after the 
individual interventions. Deconditioning resulted in the downregulation of biological 
processes involved in cellular respiration including oxidative phosphorylation. 
This is in line with a previous study that reported a marked downregulation of the 
oxidative phosphorylation (OXPHOS) pathway after bed rest deconditioning3. 
The most significantly downregulated GO term after deconditioning: ‘generation 
of precursor metabolites and energy’, was identical to the single term upregulated 
after exercise training, confirming the opposite effects of physical deconditioning 
and exercise training on the gene expression level. A surprising observation was 
Chapter 4
92
the downregulation of RNA splicing and related gene ontology terms after exercise 
training in SCI individuals. These terms were not significantly upregulated after 
deconditioning of our healthy controls. This suggests that altered RNA splicing may 
be a long-term consequence of spinal cord injury, which is not induced by short-
term deconditioning, but can be counteracted by exercise training. This is supported 
by a recent study in a mouse model for spinal muscular atrophy, which proposes 
that changes in RNA splicing are mainly a secondary effect of the paralysis and 
may be a response to cell stress42. Interestingly, changes in alternative splicing have 
been linked with the development of insulin resistance43 and may thus provide an 
alternative explanation for SCI-induced insulin resistance. Exploring possible other 
(patho-) physiological consequences of this altered alternative splicing machinery 
requires further investigation44.
Figure 3. 
Preliminary representation of the proposed link between physical activity and inactivity and insulin 
signaling in skeletal muscle cells. Exercise training (left panel) results in the upregulation of FABP3 
that transports fatty acids (FAs) between the cellular plasma membrane and the membranes of the 
mitochondria. At the inner mitochondrial membrane, SLC25A20 is upregulated and transports FAs 
over the membrane. Inside the mitochondria, HADH is upregulated and involved in the beta oxidation 
of FAs. Physical deconditioning (right panel), on the contrary, downregulates these key players. This 
results in a reduced FA transport and the subsequent accumulation of intracellular FAs. This activates 
protein kinase C (PKC), which inhibits insulin receptor substrate 1/2 (IRS 1/2), resulting in less 
translocation of Glut4 to the cell membrane and a reduced insulin-induced glucose uptake. Partially 
based on previously published models9, 10.
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Limitations
Gene expression microarrays are a comprehensive approach for the fast 
identification of interesting genes, but also have their limitations. Changes in gene 
expression are only physiologically relevant under the general assumption of a 
good correlation between mRNA and protein levels. However, this is not always the 
case, and validation on the protein level would therefore be a logical follow-up45. 
In addition, protein phosphorylation is a key feature in insulin signal transduction, 
but gene expression levels cannot provide information about protein modifications. 
Unfortunately, additional experiments on the protein level are hampered in this study 
by the limited availability of muscle tissue in the subjects with SCI. Indeed, it has 
been demonstrated that muscle fiber type46, the amount of muscle and percentage of 
intramuscular fat changes dramatically after a SCI47, 48. Therefore, we used most of 
the obtained tissue to isolate sufficient RNA to perform good quality microarrays. 
However, the poor muscle quality in SCI also limited the total number of microarrays 
that could be performed. This drawback has to be acknowledged before SCI can 
serve as a unique and very informative model for physical inactivity.
Conclusions
 Analysis of gene expression levels after local deconditioning versus 
exercise training resulted in the identification of 18 genes that are mainly involved 
in the transport and metabolism of intramuscular fatty acids. These genes, including 
FABP3, HADH, and SLC25A20 provide a link between physical activity levels and 
insulin signaling. 
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Abstract original article
Aerobic interval training versus continuous moderate exercise as a treatment for 
the metabolic syndrome. A pilot study.
Tjønna AE, Lee SJ, Rognmo Ø, Stølen TO, Bye A, Haram PM, Loennechen JP, Al-
Share QY, Skogvoll E, Slørdahl SA, Kemi OJ, Najjar S, Wisløff U.
Background Individuals with the metabolic syndrome are 3 times more 
likely to die of heart disease than healthy counterparts. Exercise training reduces 
several of the symptoms of the syndrome, but the exercise intensity that yields 
the maximal beneficial adaptations is in dispute. We compared moderate and high 
exercise intensity with regard to variables associated with cardiovascular function 
and prognosis in patients with the metabolic syndrome. Methods and Results 
Thirty-two metabolic syndrome patients (age, 52.3±3.7 years; maximal oxygen 
uptake [V˙O2max], 34 mL · kg-1 · min-1) were randomized to equal volumes of either 
moderate continuous moderate exercise (CME; 70% of highest measured heart rate 
[Hfmax]) or aerobic interval training (AIT; 90% of Hfmax) 3 times a week for 16 
weeks or to a control group.V˙O2max increased more after AIT than CME (35% versus 
16%; P<0.01) and was associated with removal of more risk factors that constitute 
the metabolic syndrome (number of factors: AIT, 5.9 before versus 4.0 after; P<0.01; 
CME, 5.7 before versus 5.0 after; group difference, P<0.05). AIT was superior to 
CME in enhancing endothelial function (9% versus 5%; P<0.001), insulin signaling 
in fat and skeletal muscle, skeletal muscle biogenesis, and excitation-contraction 
coupling and in reducing blood glucose and lipogenesis in adipose tissue. The 2 
exercise programs were equally effective at lowering mean arterial blood pressure 
and reducing body weight (-2.3 and -3.6 kg in AIT and CME, respectively) and 
fat. Conclusions Exercise intensity was an important factor for improving aerobic 
capacity and reversing the risk factors of the metabolic syndrome. These findings 
may have important implications for exercise training in rehabilitation programs and 
future studies.
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To the editor
We read with great interest the article by Tjønna et al11 that addressed the 
efficacy of different modes of exercise training to reverse features of the metabolic 
syndrome. The metabolic syndrome, considered an ailment of the 20th century, 
consists of a clustering of risk factors, with insulin resistance still viewed as the 
common pathophysiological pathway.2 We were intrigued by the fact that in patients 
with the metabolic syndrome, aerobic interval training substantially improved 
insulin sensitivity (homeostatic model assessment score increasing from 62.2±8.0% 
to 77.2±4.9%), whereas continuous moderate exercise seemed to decrease insulin 
sensitivity (64.4±5.7% versus 50.2±4.9% before and after training, respectively). 
It should be noted that the homeostatic model assessment score as a derivate index 
for insulin sensitivity has clear limitations.3 The gold standard for measuring insulin 
sensitivity is the euglycemic hyperinsulinemic clamp, with the frequently sampled 
intravenous glucose tolerance test as the second best. Houmard et al4 and Johnson 
et al5 studied the effects of different aerobic training volumes and intensity on 
insulin sensitivity in 154 overweight/obese individuals and 171 individuals with the 
metabolic syndrome, respectively. Both studies demonstrated a clear improvement 
in insulin sensitivity shown by frequently sampled intravenous glucose tolerance test 
after continuous moderate exercise training. These studies4, 5 provide clear evidence 
that training volume is more important than exercise intensity for improvement 
of insulin sensitivity. Although we are still excited about the efficacy of the type 
of aerobic interval training used by Tjønna et al1 on the maximal oxygen uptake 
(exercise capacity) compared with continuous exercise, we think there is currently 
no conclusive evidence for a more favorable effect of aerobic interval training on 
insulin sensitivity in comparison to aerobic continuous exercise. Clearly, additional 
studies comparing the effect of different modes of exercise on insulin sensitivity 
measured by reliable methods are needed.
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Abstract
Aims. Exercise training can effectively improve insulin sensitivity via 
several metabolic adaptations in skeletal muscle tissue but the responsible mechanism 
remains elusive. The aim of this study was to determine changes in insulin sensitivity 
with concomitant changes in the global expression profile of genes after exercise 
training in women with and without the metabolic syndrome. Methods Before and 
after six months of endurance exercise  training, whole body insulin sensitivity 
(euglycaemic clamp) was determined and skeletal muscle biopsies were taken in 18 
women with the metabolic syndrome and in 11 lean control women. Differentially 
expressed genes (Affymetrix GeneChip Human Gene 1.0 ST arrays) after exercise 
training were identified and subsequently pathways analyses was performed. Results 
Eleven women with the metabolic syndrome and ten control women completed the 
training program. The exercise training increased insulin sensitivity by 45% and 
22% in women with the metabolic syndrome and in control women, respectively, 
independent of changes in body weight and/or composition (p<0.05). Pathway 
analyses of genes with a >1.3-fold change in women with the metabolic syndrome 
revealed four enriched pathways, in which insulin-like growth factor 2 (IGF2) 
showed the most significant upregulation. In lean women, pathway analysis revealed 
clustering of genes related to the immune system and inflammatory response. The 
most significantly upregulated gene in these pathways was CD2 molecule (CD2). 
Conclusion Exercise training improves insulin sensitivity in both groups of women, 
independent of changes in body composition. Different molecular mechanisms seem 
involved in the exercise-induced improvements in insulin sensitivity in women with 
and without the metabolic syndrome, which need further delineation.
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Introduction
The metabolic syndrome is a complex of interrelated risk factors resulting 
in an increased risk for the development of diabetes1 and cardiovascular diseases2. 
The pathophysiology of the metabolic syndrome can be characterized by peripheral 
insulin resistance, which may be caused by excessive central adiposity and/or physical 
inactivity. Exercise training can effectively counteract insulin resistance via several 
metabolic adaptations including changes in skeletal muscle tissue such as a fiber 
type transformation3, an increase in the number of mitochondria4, 5 and an increase 
in glucose transporter 4 (GLUT4) protein levels6. Several intracellular signaling 
molecules have been identified as key factors to mediate exercise-induced changes 
in skeletal muscle insulin sensitivity. These include AMP-activated protein kinase 
(AMPK), calcineurin, peroxisome-proliferator-activated Receptor-γ Coactivator 
1α (PGC-1α), atypical protein kinase C (aPKC) and p38 mitogen activated protein 
kinase (p38 MAPK)7. Although the beneficial effects of exercise on insulin resistance 
are well established, the exact molecular mechanisms by which exercise promotes 
these beneficial effects are not fully understood. 
Gene expression microarrays provide the opportunity to analyse the 
expression level of virtually all known genes in a single experiment, and are therefore 
a rapid and comprehensive approach for the first identification of exercise-induced 
molecular changes. Previous studies have assessed mRNA gene expression after 
exercise training in insulin sensitive subjects8 and after a few weeks of exercise 
training in young healthy men9. No previous microarray studies however, have been 
performed in insulin resistant women with the metabolic syndrome who are prone 
to develop diabetes in the nearby future1. Especially these women will benefit from 
exercise training and may show large improvement in insulin resistance.
Therefore, the aim of this study was to determine exercise-induced 
improvement in insulin sensitivity and concomitant changes in the global expression 
of genes after six month, three times a week of endurance exercise training in insulin 
resistant skeletal muscle tissue of women with the metabolic syndrome and in lean 
control women. Identification of key players may increase our understanding of the 
molecular mechanisms by which long-term endurance exercise induces improvement 
in insulin sensitivity. 
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Methods
Participants
Eighteen women with the metabolic syndrome and eleven lean healthy 
control women participated in this study. Metabolic syndrome was defined as 
having at least three out of five criteria as defined in the Joint Scientific Statement 
for Harmonizing the Metabolic Syndrome10, including waist circumference >88 cm, 
triglycerides >1.7 mmol/l, HDL-cholesterol <1.3 mmol/l, hypertension >130/85 
mmHg (systolic/diastolic blood pressure) and/or use of antihypertensive medication, 
and fasting glucose >6.1 mmol/l. Lean women were defined as having a body mass 
index (BMI) < 25 kg/m2 and the absence of all metabolic syndrome criteria. We 
excluded women with a medical history of known diabetes and/or cardiovascular 
diseases, liver or renal diseases, smoking, more than two alcohol consumptions 
(10 g) a day, and performing regular physical activity >2 times a week. Before 
participation, a written informed consent was obtained. This study was approved 
by the Medical Ethical Committee of the Radboud University Nijmegen Medical 
Centre, and was conducted in accordance with the Declaration of Helsinki (2000).
Exercise intervention
Women trained for six months, three times a week under the supervision 
of a professional trainer with preferably one day between subsequent exercise 
bouts. Training consisted of cycling exercise on a ergometer (Lode, Groningen, 
the Netherlands) starting with a 10 minute warming-up, followed by 30 minutes of 
exercise at 65% of the individual heart rate reserve (HRR) and finished off with a 
cooling-down of 5 minutes. As their exercise tolerance improved, the intensity of 
the training was increased by 5% HRR to a maximum of 85% of the HRR. Exercise 
intensity was documented through the use of heart rate monitors (Polar). Women 
had to attend at least 90% of the training sessions during this six month period to be 
eligible for inclusion of the statistical analysis. 
Cardio-respiratory fitness test
Women performed a maximal exercise test on an electrically braked leg-
cycling ergo meter (Lode, Angio 300, Groningen, the Netherlands) using an 
incremental protocol to assess their cardio-respiratory fitness. Workload increased
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 Table 1. Physiological characteristics before and after the exercise intervention.
Women with the metabolic 
syndrome
Healthy control women
Pre Post
P 
value
Pre Post
P 
value
Age, years 53 ± 7 49 ± 10
Body composition
Weight, kg 96.4 ± 11.3 94.8 ± 9.6 0.136
67.0 ± 
6.6
66.9 ± 
6.2
0.909
Body mass index, kg/m2 34.5 ± 3.2 34.0 ± 2.9 0.150
22.8 ± 
1.7
22.7 ± 
1.5
0.901
Waist, cm 109 ± 9 105 ± 8 0.119 80 ± 6 79 ± 5 0.072
Waist-to-hip ratio
0.91 ± 
0.08
0.90 ± 
0.07
0.757
0.80 ± 
0.05
0.78 ± 
0.04
0.115
Body fat, % 40.6 ± 4.4 40.3 ± 4.2 0.505
28.8 ± 
4.7
28.1 ± 
4.2
0.433
Trunk fat, % 41.2 ± 4.6 41.4 ± 3.9 0.841
26.0 ± 
6.9
25.3 ± 
5.9
0.445
Blood variables
Fasting glucose, mmol/l 5.5 ± 0.6 5.7 ± 0.8 0.356 4.5 ± 0.3 4.7 ± 0.4 0.138
Insulin, mE/l
17.4 ± 
10.4
15.4 ± 5.2 0.428 8.9 ± 3.0
10.0 ± 
3.8
0.076
M-value, mg/min/kg 4.0 ± 1.8 5.8 ± 0.9 <0.001 8.1 ± 1.9 9.8 ± 2.0 0.001
HDL-cholesterol, 
mmol/l
1.21 ± 
0.30
1.28 ± 
0.29
0.106
1.59 ± 
0.29
1.58 ± 
0.19
0.831
Triglycerides, mmol/l
1.98 ± 
0.84
1.83 ± 
0.66
0.338
0.87 ± 
0.27
0.93 ± 
0.22
0.316
Free fatty acids, mmol/l
0.58 ± 
0.15
0.45 ± 
0.18
0.008
0.52 ± 
0.16
0.43 ± 
0.23
0.229
Blood pressure, mmHg
Systolic blood pressure 138 ± 11 132 ± 11 0.102 120 ± 9 114 ± 9 0.089
Diastolic blood pressure 84 ± 5 80 ± 7 0.195 76 ± 5 73 ± 6 0.021
Resting heart rate, bpm 68 ± 5 59 ± 7 0.006 60 ± 7 58 ± 5 0.260
Exercise parameters
VO2 max, ml/min/kg 22.8 ± 4.5 25.3 ± 3.8 0.003
32.0 ± 
4.7
35.6 ± 
5.5
0.002
Power, Watt 158 ± 28 185 ± 23 <0.001 180 ± 21 205 ± 27 0.011
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by 10 W per minute, starting at 10 W, until exhaustion. A gas-analyzer was used 
to measure oxygen consumption continuously (Jaeger Benelux BV, Breda, the 
Netherlands). Maximal oxygen consumption (VO
2max
) was analyzed as the mean 
of the last minute of the exercise bout. During the test, heart rate was measured 
continuously. Two minutes after cessation of the test, blood lactate level (Roche 
Diagnostics GmbH, Mannheim, Germany) was measured.
Clinical examinations and insulin sensitivity
Before and after 6 months of endurance exercise training height, weight, 
waist circumference, waist-to-hip ratio, blood pressure, resting heart rate, plasma 
lipids, free fatty acids, and glucose were measured by standard methods. A total body 
DXA scan determined body fat percentage and body fat distribution (QDR 4500 
densitometer, Hologic Inc. Waltham, MA). 
Peripheral tissue sensitivity to exogenous insulin was measured using 
a hyperinsulinaemic euglycaemic clamp as previously described 11, 12. After an 
overnight fast (10-h), with the patient supine in a quiet, temperature controlled 
room (22 – 24 0C), insulin (Actrapid, Novo-Nordisk, Copenhagen, Denmark) was 
infused intravenously in a dose of 430 pmol ∙ m-2 ∙ min-1 (60 mU ∙ m-2 ∙ min-1) for 120 
minutes. Insulin 50 U ∙ ml-1 was diluted in 48 ml NaCl 0.9% with the addition of 2 
ml blood from the subject to a concentration of 1 U∙ml-1. Venous plasma glucose 
concentrations were clamped at 5.0 mmol∙l-1 by a variable glucose 20% infusion rate, 
adjusted depending on venous plasma glucose level measured at 5-minute intervals. 
Venous plasma glucose was measured in duplicate, in samples that were immediately 
centrifuged during 10 seconds, by the glucose oxidation method (Beckman Glucose 
Analyzer 2, Beckman Instruments Inc, Fullerton, CA 92634, USA). Insulin was 
measured in duplicate against International Standard 83/500 by an in-house radio-
immunoassay (RIA) using an anti-human insulin antiserum raised in guinea pig 
and radio-iodinated human insulin as a tracer. Bound/free separation was carried 
out by addition of sheep anti-guinea-pig antiserum and precipitation by means of 
polyethylene glycol (PEG). Between- and within-run coefficients of variation were 
4.6% and 5.8% respectively, at a level of 33mU∙L-1. Whole body glucose disposal 
during the last 30-min of the euglycaemic clamp was calculated as the M-value.
RNA gene expression
Muscle biopsies from the vastus lateralis muscle were taken after a 
standardized 250 kcal breakfast (79 % carbohydrates, 11.2 % protein, 9.8 % fat). 
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From muscle biopsies of 6 women of each group (being a representative sample 
from the total) total RNA was isolated and purified. The characteristics of the array 
‘cohort’ did not differ from the whole group (Table S2). RNA concentration and purity 
were measured with a Nanodrop spectrophotometer (Thermo Scientific, Waltham, 
MA, USA). The 260/280 ratio indicated ‘pure RNA’ quality. RNA integrity was 
analyzed on an Agilent Bioanalyser (Santa Clara, CA, USA) and the average RNA 
integrity number for all muscle samples was 7.8. RNA gene expression profiling 
was performed using Affymetrix GeneChip Human Gene 1.0 ST arrays (Affymetrix 
Inc., Santa Clara, CA, USA), according to the manufacturer’s instruction. The 
Affymetrix GeneChip Whole Transcript Sense Target Labeling Assay was used 
to generate amplified and biotinylated sense-strands DNA targets from the entire 
expressed genome (100 ng of total RNA). The manufacturer’s manual was followed 
for the hybridization, washing, and scanning steps (version 4, P/N 701880 Rev.4). 
Arrays were hybridized by rotating them at 60 rpm in the Affymetrix GeneChip 
hybridization oven at 45 0C for 17 h. After hybridization, the arrays were washed 
in the Affymetrix GeneChip Fluidics station FS 450. Arrays were scanned using the 
GeneChip scanner 3000 7G system. The average fluorescence intensity of all genes 
was calculated using the Robust Multiarray Analysis (RMA) Algorithm13, including 
a quantile normalization and using a background correction for GC-content. To 
check overall data quality, the positive (exonic) and negative (intronic) control probe 
sets were used to calculate the area under the curve which ranged from 0.83 to 0.85, 
indicating good quality samples. The protocol used was compliant with the MIAMI 
guidelines, and data have been submitted to the Gene Expression Omnibus (GEO) 
repository under no. GSE43760.
Statistical analysis
Effects of the exercise intervention on physiological characteristics in women 
with the metabolic syndrome and in lean control women were assessed by a paired 
Student’s t tests (Statistical Package for Social Sciences 18.0, SPSS Inc., Chicago, 
Illinois, USA). Correlations were assessed by a Pearson correlation coefficient. The 
level of statistical significance was defined at α=0.05 and data are presented as mean 
± SD, unless stated otherwise.
The Affymetrix CEL-files were imported into Partek® (Genomic Suite 
Software version 6.4, Partek Inc., St Louis, MO, USA) where only core probe sets 
were extracted and normalized using the RMA logarithm with GC background 
correction. The distribution of the intensity values on the individual arrays was 
visualized in a signal histogram and one outlier in the group of women with the 
metabolic syndrome was detected. This outlier was removed from further data 
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analysis. Transcript summaries were calculated using the mean intensities of the 
corresponding probe sets, representing the quantitative gene expression levels. To 
identify differentially expressed genes after exercise training, the corrected intensity 
of individual genes were used for an one-way analysis of variance (ANOVA). The 
resulting p-values were corrected for multiple-testing with the Benjamini-Hochberg 
false discovery rate procedure14. The p-value together with the fold change of every 
annotated gene, were exported to Microsoft Office Excel. The gene list of interest ( 
>1.3-fold change) was analysed using the Database for Annotation Visualization and 
Integrated Discovery functional annotation tool (DAVID, http:david.abcc.ncifcrf.
gov)) with main focus on the enrichment in GO-terms (Gene Ontology terms) of 
biological processes (GOTERM_BP_FAT)15. 
Results
Effectiveness of the training intervention
Eleven women with the metabolic syndrome and ten healthy control women 
successfully completed the exercise intervention, with a training compliance of 
92%. Cardio-respiratory fitness, determined as maximal oxygen uptake, improved 
significantly by 11% in both exercise groups (Table 1). Seven women with the 
metabolic syndrome and one healthy control woman dropped out of the study; five 
due to medical reasons unrelated to the exercise intervention, one woman dropped 
out as a consequence of social/family circumstances, and two women (one control 
woman) dropped out due to lack of motivation. There were no significant differences 
at baseline between women who successfully completed the study and those who 
dropped out of the study (Table S1). 
Exercise-induced changes in physiological characteristics
Six months of endurance exercise training significantly improved insulin 
sensitivity (M-value) by 45% in women with the metabolic syndrome and by 22% 
in lean control women (Figure 1). After 6 months of exercise cycling training, no 
significant changes were observed in the variables of the metabolic syndrome; waist 
circumference, diastolic or systolic blood pressure, glucose, HDL-cholesterol and 
triglycerides for the whole group (Table 1). Nonetheless, three out of eleven women 
with the metabolic syndrome (27%) did not meet the criteria for the metabolic 
syndrome anymore after the exercise intervention (Table 1). The cycling training 
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did not alter body composition including body weight, total body fat, body mass 
index, waist circumference, or waist-to-hip ratio. In women with the metabolic 
syndrome, resting heart rate and free fatty acid plasma levels decreased significantly 
(Table 1). In lean control women diastolic blood pressure decreased after the training 
intervention (Table 1). 
Figure 1.
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Insulin sensitivity (M-value) before (white bars) en after (blue bars) six months of endurance exercise 
training in women with the metabolic syndrome (MS) and in lean control women (C). 
Exercise-induced changes in skeletal muscle gene expression
Skeletal muscle gene expression levels were compared before and after 
the exercise intervention in five women with the metabolic syndrome and in six 
lean control women. The physiological characteristics of these subgroups were 
representative for the whole group and showed similar statistical significant results 
after the exercise intervention (Table S2).  In both groups, of the 28,870 genes assessed 
on the microarray, no single gene reached statistical significance after stringent 
correction for multiple testing. Therefore, we focused on biological processes and 
pathways that were overrepresented in the list of genes with the highest fold change. 
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All genes with >1.3-fold change were selected for further analysis, resulting in a 
list of 139 upregulated and 193 downregulated genes in women with the metabolic 
syndrome. In these women, the list of upregulated genes was significantly enriched 
for 4 gene ontology (GO) terms as depicted in Table 2. These 4 GO terms consisted 
of 24 unique genes of which insulin-like growth factor 2 (IGF2) showed the highest 
significance (Table 3).
 Table 2. Enrichment of biological process gene ontology (GO) terms in the list of genes 
 with > 1.3-fold upregulation after 6 months of exercise training in women with the  
 metabolic syndrome and in lean control women. F.E. =  Fold Enrichment.
Gene Ontology term F.E. Bonferroni
Women with the metabolic syndrome
GO:0010033 response to organic substance 5.4 0.0001
GO:0051789 response to protein stimulus 15.8 0.0046
GO:0007610 behavior 5.7 0.0167
GO:0009611 response to wounding 5.0 0.0469
Lean control women
GO:0006952 defense response 4.8 <0.001
GO:0006955 immune response 3.7 0.001
GO:0002274 myeloid leukocyte activation 19.6 0.002
GO:0001775 cell activation 5.8 0.003
GO:0045321 leukocyte activation 6.4 0.003
GO:0050900 leukocyte migration 15.8 0.006
GO:0006954 inflammatory response 4.8 0.049
 In lean control women, the gene list of interest (>1.3-fold change) consisted 
of 261 upregulated and 58 downregulated genes. Apparently, exercise training induces 
more transcriptional upregulation than downregulation in lean control women. The 
list of upregulated genes were significantly enriched for GO terms related to the 
immune system (Table 2). These seven immune system related GO terms consisted 
of 38 unique genes as listed in Table 4 of which CD2 molecule (CD2) showed the 
most significant change. In both groups of women, the downregulated genes were 
not significantly enriched for GO-terms. To visualize a possible link of the identified 
genes with insulin sensitivity, we correlated the microarray fluorescence intensity 
with the change in M-value, which did not result in significant correlations.
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 Table 3.  The 24 upregulated genes responsible for the significantly enriched GO terms 
 after exercise training in women with the metabolic syndrome, listed according to 
 significance.
Gene 
symbol
Gene name
P 
value
Fold 
change
IGF2 insulin-like growth factor 2 (somatomedin A) 0.01 1.4
HSPD1 heat shock 60kDa protein 1 (chaperonin) 0.03 1.3
COL1A1 collagen, type I, alpha 1 0.05 1.3
CXCL10 chemokine (C-X-C motif) ligand 10 0.06 1.4
EGR1 early growth response 1 0.09 2.9
DNAJB1 DnaJ (Hsp40) homolog, subfamily B, member 1 0.21 1.7
OSMR oncostatin M receptor 0.21 1.3
CTGF connective tissue growth factor 0.22 1.4
JUNB jun B proto-oncogene 0.22 1.5
NR4A2 nuclear receptor subfamily 4, group A, member 2 0.26 1.7
THBD thrombomodulin 0.26 1.4
FOSB FBJ murine osteosarcoma viral oncogene homolog B 0.26 1.5
FOS v-fos FBJ murine osteosarcoma viral oncogene homolog 0.32 2.4
CXCL2 chemokine (C-X-C motif) ligand 2 0.35 1.3
SERPINE1 serpin peptidase inhibitor, clade E, member 1 0.36 1.4
CCL2 chemokine (C-C motif) ligand 2 0.40 1.7
CYR61 cysteine-rich, angiogenic inducer, 61 0.42 1.7
HSPA6 heat shock 70kDa protein 7 (HSP70B) 0.43 1.6
EGR2 early growth response 2 0.47 1.3
TNC tenascin C 0.49 1.5
IL18 interleukin 18 (interferon-gamma-inducing factor) 0.53 1.3
HBEGF heparin-binding EGF-like growth factor 0.58 1.5
THBS1 thrombospondin 1 0.58 1.6
NR4A3 nuclear receptor subfamily 4, group A, member 3 0.67 1.4
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 Table 4.  The 38 upregulated genes responsible for the significantly enriched GO terms 
 after exercise training in lean control women, listed according to significance.
Gene 
symbol
Gene name
P 
value
Fold 
change
CD2 CD2 molecule <0.01 1.3
ALOX5 arachidonate 5-lipoxygenase 0.01 1.4
PTPRC protein tyrosine phosphatase, receptor type, C 0.01 1.8
TLR6 toll-like receptor 6 0.01 1.3
CD48 CD48 molecule 0.02 1.3
LCP1 lymphocyte cytosolic protein 1 (L-plastin) 0.02 1.7
SELPLG selectin P ligand 0.02 1.3
ITGA6 integrin, alpha 6 0.02 1.3
DOCK2 dedicator of cytokinesis 2 0.02 1.4
IL7R interleukin 7 receptor 0.02 1.7
ITK IL2-inducible T-cell kinase 0.02 1.3
LCP2 lymphocyte cytosolic protein 2 0.03 1.3
SNCA synuclein, alpha (non A4 component of amyloid precursor) 0.03 2.1
CD96 CD96 molecule 0.03 1.3
CXCR1 interleukin 8 receptor, alpha 0.03 1.5
CCL5 chemokine (C-C motif) ligand 5 0.04 1.4
IL2RG interleukin 2 receptor, gamma 0.04 1.4
S100A8 S100 calcium binding protein A8 0.04 1.8
LYZ lysozyme (renal amyloidosis) 0.04 1.5
MYO1F myosin IF 0.05 1.3
KLRK1 killer cell lectin-like receptor subfamily C, member 4 0.05 1.4
PXDN peroxidasin homolog (Drosophila) 0.05 1.4
CORO1A coronin, actin binding protein, 1A 0.06 1.4
CSF3R colony stimulating factor 3 receptor (granulocyte) 0.06 1.4
MNDA myeloid cell nuclear differentiation antigen 0.07 1.5
AQP9 aquaporin 9 0.07 1.8
FCGR3A Fc fragment of IgG, low affinity IIIa, receptor (CD16a) 0.08 1.7
FYB FYN binding protein (FYB-120/130) 0.08 1.5
NCF2 neutrophil cytosolic factor 2 0.08 1.4
CXCR2 interleukin 8 receptor, beta 0.08 1.5
PPBP pro-platelet basic protein (ligand 7) 0.10 1.6
LYN v-yes-1 Yamaguchi sarcoma viral related oncogene homolog 0.11 1.3
S100A9 S100 calcium binding protein A9 0.11 1.3
IGSF6 immunoglobulin superfamily, member 6 0.13 1.3
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SERPINA1 serpin peptidase inhibitor, clade A, member 1 0.17 1.4
COL3A1 collagen, type III, alpha 1 0.20 1.3
S100A12 S100 calcium binding protein A12 0.22 1.3
C7 complement component 7 0.45 1.4
Discussion
The main finding of this study is that six months of endurance exercise 
training significantly improves insulin sensitivity in both women with the metabolic 
syndrome as well as in lean women, independent of changes in body weight and/
or composition. Pathway analysis revealed four enriched pathways in women with 
the metabolic syndrome, in which insulin-like growth factor 2 (IGF2) showed the 
most significant upregulation. In lean women, expression of genes related to the 
immune system and inflammatory response is upregulated, with CD2 molecule 
(CD2) showing the most significant upregulation. These results indicate that different 
molecular mechanisms seem involved in exercise-induced improvements in insulin 
sensitivity in women with and without the metabolic syndrome.
Six months of endurance exercise training significantly improved physical 
fitness in both women with the metabolic syndrome and in lean control women, 
indicating the successful performance of the exercise training program. But more 
important, the exercise training program greatly improved insulin sensitivity in 
both groups. These results are in agreement with previous studies in diabetic 
patients16, 17, obese women with impaired glucose tolerance18 and in lean women18. 
Although exercise training significantly improved insulin sensitivity in both groups, 
the beneficial effects were relatively larger in insulin resistant subjects with the 
metabolic syndrome compared to the more insulin sensitive lean subjects. The extent 
of improvement in insulin resistance after the training program is large compared 
to the effect of glucose lowering medication, such as metformin19, emphasizing the 
beneficial effects of exercise. As noted by previous studies, waist circumference has a 
strong inverse correlation with whole-body insulin sensitivity20. Our results however, 
show that exercise training can improve insulin sensitivity, even independent of 
changes in body weight and/or composition including waist circumference (as 
depicted in Figure 2) and trunk fat mass. This was also observed by Duncan et al. 
who, in middle-aged sedentary adults, noted an 40% increase in insulin sensitivity 
independent of any change in BMI or waist circumference after a moderate-intensity 
walking intervention21. 
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Figure 2. 
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 Correlation of waist circumference with M-value before (dotted line) and after (blue line) 6 months 
of endurance exercise training in women with the metabolic syndrome and in control women.
The effects of endurance exercise training on skeletal muscle insulin 
sensitivity were further investigated using gene expression microarrays. After 
stringent correction for multiple testing, no differentially expressed genes were seen 
after the 6 months of exercise training, despite the large observed improvements in 
insulin sensitivity. Focusing on genes with >1.3-fold change revealed in women with 
the metabolic syndrome four GO-terms, consisting of 24 unique genes. The most 
significant upregulated gene was insulin-like growth factor 2 (IGF2). IGF2 is a key 
factor in human growth and development and shares structural similarity to insulin. 
Only few studies have examined associations between gene expression of IGF2 in 
obesity and type 2 diabetes. These studies show that subjects who are prenatally 
exposed to the Dutch famine have lower methylation of IGF2 in blood and have an 
increased prevalence of obesity, insulin resistance and type 2 diabetes in later life22, 
23. Chen et al., confirmed the lower methylation of IGF2 in muscle tissue of patients 
with type 2 diabetes24. Our results indicate that exercise training can upregulate 
IGF2 expression in skeletal muscle tissue of insulin resistant women. It will thus 
be interesting to further investigate the possible role of IGF2 in exercise-induced 
improvements is insulin resistance. 
In lean control women, those genes with >1.3-fold change after the exercise 
training were overrepresented in GO-terms related to the immune system and 
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inflammatory response. The most significant upregulated gene in lean women was 
CD2, which is an adhesion molecule found on the surface of T cells and natural killer 
(NK) cells. Exercise training is known to induce changes in the immune system 
and function25. Acute exercise induces a stress response with a rapid and profound 
neutrophilia, an increase in circulating NK cells, inflammatory cytokines and 
monocytosis26. Long-term exercise training however, specifically in subjects with 
chronic low-grade inflammation such as the metabolic syndrome, is known to have 
anti-inflammatory and insulin-sensitizing effects27. Our results of an upregulation 
of genes related to the immune system and inflammatory response in lean women 
need further investigation. Despite similar exercise duration and intensity compared 
to women with the metabolic syndrome, lean women may have experienced post-
exercise immune dysfunction due to the continuous, prolonged and high intensity 
exercise training. This may have induced elevated circulating stress hormones and 
alterations in the pro/anti-inflammatory cytokine balance.
Limitations
Unfortunately ~40 % of the subjects with the metabolic syndrome were not 
able to complete the 6-month training period. Only one of these women stopped due 
to a lack of motivation despite repeated encouragement. The other 6 women with 
the metabolic syndrome could not complete the training program due to medical 
reasons, none of which were related to the participation in our study.
Gene expression microarrays are a powerful tool to assess the expression level 
of many genes at once, but do not provide information on the cell type distribution 
in the biopsy. From this study it is not possible to conclude whether one specific cell 
type (e.g. leukocytes or myocytes) was responsible for the increased expression of 
immune and inflammatory genes, or that more cells of a specific type (e.g. natural 
killer cells) infiltrated the muscle tissue.
Conclusion
In conclusion, six months of endurance exercise training improves insulin 
sensitivity in women with and without the metabolic syndrome, independent of 
changes in body weight and/or composition. Different molecular mechanisms seem 
involved in these exercise-induced improvements in insulin sensitivity. We identified 
upregulation of IGF2 expression in women with the metabolic syndrome and found 
that expression of genes in lean women were overrepresented for immune system 
and inflammatory response genes. Further delineation of these genes and exercise 
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intervention studies with multiple time-course assessments of gene expression and 
protein levels should be the next step.
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 Supplement 1. No difference in physical characteristics of women with the 
 metabolic syndrome who successfully completed the study and those who dropped out 
 of the study.
Metabolic syndrome
Successful women 
(n=11)
Drop outs (n=6)
Age, yrs 53 ± 7 50 ± 7
Weight, kg 96.4 ± 11.3 92.4 ± 18.4
BMI, kg/m2 34.5 ± 3.2 34.6 ± 5.2
Waist circumference, cm 109 ± 9 109 ± 11
Systolic pressure, mmHg 138 ± 11 138 ± 12
Diastolic pressure, mmHg 84 ± 5 85 ± 8
Heart Rate rest, bpm 68 ± 5 73 ± 15
Glucose, mmol/l 5.5 ± 0.6 5.4 ±0.8
Triglycerides, mmol/l 1.98 ± 0.84 1.99 ± 0.79
HDL-C, mmol/l 1.21 ± 0.30 1.18 ±0.21
 Values are mean ± SD. 
 Supplement 2. Physical characteristics and M-value of all subjects versus the subjects 
 in the array cohorts.
Metabolic syndrome Controls
All subjects 
(n=11)
Array cohort 
(n=5)
All subjects 
(n=10)
Array cohort 
(n=6)
Age, yrs 53 ± 7 58 ± 5 49 ± 10 50 ± 9
Weight, kg 96.4 ± 11.3 105.8 ± 7.1 67.0 ± 6.6 64.5 ± 6.0
BMI, kg/m2 34.5 ± 3.2 36.7 ± 2.0 22.8 ± 1.7 22.2 ± 1.0
Waist circumference, 
cm
109 ± 9 115 ± 9 80 ± 6 78 ± 4
Waist-to-Hip Ratio, - 0.91 ± 0.08 0.95 ± 0.08 0.80 ± 0.05 0.78 ± 0.04
Systolic pressure, 
mmHg
138 ± 11 143 ± 13 120 ± 9 117 ± 8
Diastolic pressure, 
mmHg
84 ± 5 83 ± 5 76 ± 5 75 ± 5
Heart Rate rest, bpm 68 ± 5 68 ± 4 60 ± 7 59 ± 5
Glucose, mmol/l 5.5 ± 0.6 6.0 ± 0.2 4.5 ± 0.3 4.5 ± 0.2
Triglycerides, mmol/l 1.98 ± 0.84 1.83 ± 0.89 0.87 ± 0.27 0.98 ± 0.23
HDL-C, mmol/l 1.21 ± 0.30 1.28 ± 0.40 1.59 ± 0.29 1.53 ± 0.32
M-value, mg/min/kg 4.0 ± 1.8 3.1 ± 2.0 8.1 ± 1.9 8.6 ± 2.1
 Values are mean ± SD. 
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Abstract 
Women with the metabolic syndrome are prone to develop atherosclerosis 
and subsequently cardiovascular diseases (CVD). Exercise training reduces the 
CVD risk via vascular remodeling including adaptations of arterial wall thickness. 
However, whether this happens similarly in central/peripheral arteries and the 
molecular mechanisms underlying these adaptations are currently unknown. 
Therefore, the aim of this study was to assess the effect of 6-month exercise training 
on vascular wall thickness and diameter (using ultrasound) of central (i.e. carotid 
artery (CA)) and peripheral arteries (i.e. brachial (BA), common femoral (CFA) and 
superficial femoral artery (SFA)), and concomitant changes in gene expression levels 
(microarray; muscle biopsy) in eighteen women with the metabolic syndrome. Eleven 
women completed the training program. Exercise training induced peripheral vascular 
adaptations including an increase in BA and SFA diameter, and a decrease in CFA 
intima-media wall thickness/lumen ratio (all P<0.05). No adaptations were observed 
in  the central CA  diameter or wall thickness. Regarding gene expression levels, 
groups of genes related to vascular remodeling (GO term: vasculature development, 
blood vessel development, blood vessel morphogenesis, and angiogenesis) were 
identified, including enhanced gene expression of delta like protein 4 (DLL4) and 
collagen type 1 alpha 1 (COL1A1). Taken together, exercise training in women with 
the metabolic syndrome leads to vascular remodeling in peripheral, and not central, 
arteries through upregulation of vascular-remodeling pathways, with a dominance 
for DLL4 and COL1A1.
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Introduction
Approximately 25% of the adult population in Western countries fulfills the 
criteria of the metabolic syndrome1 which represents a cluster of cardiovascular risk 
factors.2 Subjects with the metabolic syndrome are prone to develop atherosclerosis3, 
evident through gradual thickening of the arterial wall4 which finally results in the 
development of cardiovascular disease (CVD).5 Exercise training is a powerful tool 
to decrease CVD risk by improving traditional cardiovascular risk factors6, but also 
by inducing arterial adaptations and hence reversing the atherosclerotic process.7 
Assessment of intima-media thickness (IMT) is a validated surrogate marker for 
atherosclerosis8 and an increased carotid IMT has been associated with increased risk 
for both cardio/cerebro-vascular9 and peripheral vascular events.10 Exercise training 
is associated with a smaller arterial wall thickness.11 However, relatively little is 
known whether this occurs in both central and/or peripheral arteries. A recent study 
found a decrease in carotid and femoral artery wall thickness after exercise training 
in healthy young subjects.12 However, longitudinal13 and cross-sectional14 data in 
subjects with cardiovascular risk/disease suggest that remodeling of the arterial wall 
primarily takes place in peripheral, but not in the central arteries (i.e. carotid artery). 
Whether exercise training in women with the metabolic syndrome leads to systemic 
or localized adaptations in wall thickness is currently unknown.
The molecular mechanisms associated with exercise-induced vascular 
remodeling, such as changes in wall thickness and diameter, are gradually 
elucidated.15 Gene expression microarrays are a powerful tool to comprehensively 
study these molecular mechanisms. So far, microarrays have been extensively 
used when studying the impact of exercise bouts and short-term exercise training 
programs, predominantly in healthy men and focused on the muscular pathway.16, 17 
Only one previous study in men linked microarrays with vascular adaptations after 
physical inactivity and exercise training.18 They identified groups of genes including 
the vascular endothelial growth factor pathway, transforming growth factor β1 and 
extracellular matrix proteins which showed associations with vascular adaptations.
The aim of this study was to assess the effects of 6 months  exercise training 
on vascular diameter and wall thickness of central (i.e. carotis artery (CA)) and 
peripheral arteries (i.e. brachial (BA), common femoral (CFA) and superficial femoral 
artery (SFA)), and concomitant changes in gene expression levels in women with the 
metabolic syndrome. We hypothesized to find changes in peripheral but not in central 
arterial structure, accompanied by changes in gene expression level of vascular-
related genes such as growth factors and extra-cellular matrix components. These 
results will enable us to identify key genes that play a role in vascular adaptations 
after exercise training in women with multiple cardiovascular risk factors i.e. the 
metabolic syndrome.
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Methods
Subjects
Eighteen women with the metabolic syndrome participated in this study. 
Metabolic syndrome was defined as having at least three out of five criteria including 
waist circumference >88 cm, triglycerides >1.7 mmol/l, HDL-cholesterol <1.3 
mmol/l, hypertension >130/85 mmHg (systolic/diastolic blood pressure) and/or use 
of antihypertensive medication, and fasting glucose >5.5 mmol/l.2 We excluded 
subjects with a medical history of known diabetes and/or cardiovascular diseases, 
liver or renal diseases, smoking, more than two alcohol consumptions a day, and 
performing regular physical activity >2 times a week. Before participation, a written 
informed consent was obtained. This study was approved by the Medical Ethical 
Committee of the Radboud University Nijmegen Medical Centre, and was conducted 
in accordance with the Declaration of Helsinki (2000). 
 Table 1. Subject characteristics of women with the metabolic syndrome (n=11) before 
 and after training.
Pre Post p-value
Age, yrs 53 ± 7
Weight, kg 96.4 ± 11.3 94.8 ± 9.6 0.14
BMI, kg/m2 34.5 ± 3.2 34.0 ± 2.9 0.15
WHR, - 0.91 ± 0.08 0.90 ± 0.07 0.76
Waist circumference, cm 109 ± 9 105 ± 8 0.12
Systolic pressure, mmHg 138 ± 11 132 ± 11 0.10
Diastolic pressure, mmHg 84 ± 5 80 ± 7 0.19
HRrest, bpm 68 ± 5 59 ± 7 <0.01
Glucose, mmol/l 5.5 ± 0.6 5.7 ± 0.8 0.36
Triglycerides, mmol/l 1.98 ± 0.84 1.83 ± 0.73 0.34
HDL-C, mmol/l 1.21 ± 0.30 1.28 ± 0.29 0.11
LDL-C, mmol/l 4.25 ± 1.03 4.25 ± 0.58 0.99
Incremental exercise test
VO
2max
, ml/min/kg 22.7 ± 4.7 25.3 ± 3.8 <0.01
Workload max, W 158 ± 28 185 ± 23 <0.01
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WHR, waist-to-hip ratio; HR, heart rate, VO2 peak, peak oxygen uptake. 
Values are means ± SD. One woman with the metabolic syndrome did not perform a 
maximal incremental exercise test after the six months of endurance training due to 
acute raised lower back pain one day prior testing.
Study design
Before and after six months of endurance cycling training, subjects visited 
our laboratory on three separate days. On day one, a percutaneous needle muscle 
biopsy (Bergström technique) was taken from the vastus lateralis muscle under local 
anesthesia (2% lidocaine) and the obtained muscle tissue was immediately frozen in 
liquid nitrogen and subsequently stored at -80 0C until analysis. On the second day, 
resting diameter and blood flow of the common carotid artery (CA), brachial artery 
(BA), common femoral artery (CFA), and superficial femoral artery (SFA) were 
measured. In addition, CA and CFA intima-media thickness (IMT) was measured as 
a measure of wall thickness.  On day three, peak oxygen consumption was measured 
during an incremental cycling test. 
Exercise Intervention
Subjects trained for 6 months, three times a week under the supervision of 
a researcher with preferably one day between subsequent exercise bouts. A cycling 
ergometer (Lode, Groningen) was used for cycling exercise. Each session started 
with a 10 minute warming-up followed by 30 minutes of cycling exercise at 65% 
of the individual Heart Rate Reserve (HRR). As their exercise tolerance improved, 
the intensity of the training was increased by 5% HRR to a maximum of 85% of 
the HRR. Exercise intensity was documented through the use of heart rate monitors 
(Polar). Subjects had to attend at least 90% of the training sessions during this six 
month period to be eligible for inclusion of the statistical analysis. 
Experimental Procedures
Cardio-respiratory Exercise Test
Subjects performed a maximal exercise test on an electrically braked 
leg-cycling ergo meter (Lode, Angio 300, Groningen, the Netherlands) using an 
incrementing protocol to assess their cardio-respiratory fitness. Workload increased 
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by 10 W per minute, starting at 10 W, until exhaustion. A gas-analyzer was used 
to measure oxygen consumption continuously (Jaeger Benelux BV, Breda, the 
Netherlands). Peak oxygen consumption (VO2max) was analyzed as the mean 
of the last minute of the exercise bout. During the test, heart rate was measured 
continuously. Two minutes after cessation of the test, blood lactate level (Roche 
Diagnostics GmbH, Mannheim, Germany) was measured. 
Vascular characteristics
Vascular measurements were performed after a 4-hour fast and 12 hours 
of abstinence from caffeine, chocolate, alcohol, kiwi and vitamin supplements in 
a temperature-controlled room by an experienced sonographer.19 After a 20-minute 
supine resting period, baseline diameter of the CA, BA, CFA and SFA and IMT of 
the CA and CFA were measured using high resolution echo ultrasonography (Picus, 
Pie Medical Benelux, Maastricht, the Netherlands or T3000, Terason, Burlington, 
MA, USA). Baseline blood flow (i.e. red blood cell velocity) was measured by the 
Doppler technique (WAKI e, Atys, France or Terason ). Blood flow data was collected 
using the lowest possible insonation angle (<600). The same procedure was used 
before and after training. The CA was measured 2 cm proximal to the bulbus, the 
BA was measured 3 cm proximal of the olecranon process, the CFA was measured 2 
cm proximal of the bifurcation and the SFA was measured 2 to 3 cm distal from the 
bifurcation. IMT was defined as the distance from lumen-intima interface to media-
adventitia interface and was normalized for lumen diameter size (IMT/lumen).20 For 
baseline assessment using the Picus, artery diameter and IMT were measured in 4 
series of 6 consecutive cardiac cycles and stored for later off-line, automated analysis. 
This off-line analysis was performed with an echo tracking system (ART-Laboratory, 
Esaote Europe BV, Eindhoven, the Netherlands) as previously described elsewhere.21 
For baseline assessment using the Terason, artery diameter, IMT and blood flow 
were measured continuously for 1 minute. Post-test analysis was performed using 
custom-designed, edge-detection, and wall tracking software, which is independent 
of investigator bias.22 The echo Doppler signal was real-time encoded and stored as a 
digital file. Subsequent software analysis of this data was performed at 30 Hz using an 
icon-based graphical programming language and toolkit (LabVIEW 6.02, National 
instruments, Austin, TX, USA).  For baseline assessment of blood flow using the 
Waki, flow profiles were analyzed from the Doppler signal by a custom-designed 
program that detects the envelope of the velocity waveform (MatLab, MathWorks 
Inc, USA). Mean blood flow was calculated as (p.(Dmean/2)2) . ((Vmean/2)).60, 
where Vmean (cm/s) is mean blood cell velocity. 
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mRNA Gene Expression
Muscle biopsies from the vastus lateralis muscle were taken after a 
standardized 250 kcal breakfast (79% carbohydrates, 11.2% protein, 9.8% fat). From 
muscle biopsies of 6 women (being a representative sample from the total) with 
the metabolic syndrome total RNA was isolated and purified. The characteristics 
of the array ‘cohort’ did not differ from the whole group (Supplement 2). RNA 
concentration and purity were measured with a Nanodrop spectrophotometer (Thermo 
Scientific, Waltham, MA, USA). The 260/280 ratio indicated ‘pure RNA’ quality. 
RNA integrity was analyzed on an Agilent Bioanalyser (Santa Clara, CA, USA) 
and the average RNA integrity number for all muscle samples was 7.8. RNA gene 
expression profiling was performed using Affymetrix GeneChip Human Gene 1.0 
ST arrays (Affymetrix Inc., Santa Clara, CA, USA), according to the manufacturer’s 
instruction. The Affymetrix GeneChip Whole Transcript Sense Target Labeling 
Assay was used to generate amplified and biotinylated sense-strands DNA targets 
from the entire expressed genome (100 ng of total RNA). The manufacturer’s 
manual was followed for the hybridization, washing, and scanning steps (version 
4, P/N 701880 Rev.4). Arrays were hybridized by rotating them at 60 rpm in the 
Affymetrix GeneChip hybridization oven at 45 0C for 17 h. After hybridization, the 
arrays were washed in the Affymetrix GeneChip Fluidics station FS 450. Arrays were 
scanned using the GeneChip scanner 3000 7G system. The average fluorescence 
intensity of all genes was calculated using the Robust Multiarray Analysis (RMA) 
Algorithm23, including a quantile normalization and using a background correction 
for GC-content. To check overall data quality, the positive (exonic) and negative 
(intronic) control probe sets were used to calculate the area under the curve which 
ranged from 0.83 to 0.85, indicating good quality samples. The Affymetrix CEL-
files were imported into Partek (Genomic Suite Software version 6.4, Partek Inc., 
St Louis, MO, USA) where only core probe sets were extracted and normalized 
using the RMA logarithm with GC background correction. The distribution of the 
intensity values on the individual arrays was visualized in a signal histogram and one 
outlier was detected. This outlier was removed from further data analysis. Transcript 
summaries were calculated using the mean intensities of the corresponding probe 
sets, representing the quantitative gene expression levels. The microarray data have 
been submitted to the Gene Expression Omnibus (GEO) repository under number 
GSE46697.
The Database for Annotation Visualization and Integrated Discovery 
functional annotation tool (DAVID, http:david.abcc.ncifcrf.gov)) was used as an 
integrated biological knowledgebase and analytical tool to systematically extract 
biological meaning from large gene list.24 Gene lists of interest (top 500 positive and 
top 500 negative fold change) were analyzed using DAVID with main focus on the 
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enrichment in GO-terms (Gene Ontology terms) of biological processes (GOTERM_
BP_FAT) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.24 
RT-qPCR Validation
Microarray results were validated by reverse transcription quantitative PCR 
(RT-qPCR). From the 5 microarray subjects, 150 ng total RNA was transcribed 
to cDNA using the superscript III first-strand synthesis supermix for qRT-PCR 
(invitrogen, paisley, UK) according to the manufacturer’s protocol. Based on 
the microarray results, ubiquitin c (UBC) was selected as a stable reference 
gene with relatively high expression levels. Intron-spanning primers were 
designed using NCBI Primer-BLAST and purchased from Biolegio (Malden, the 
Netherlands). Primer nucleotide sequences (5’ > 3’) were as follows: DLL4 forward 
TGTCATTGCCACGGAGGTAT , DLL4 reverse TGAGCAGGGATGTCCAGGTA 
; COL1A1 forward ACATGTTCAGCTTTGTGGACC, 
COL1A1 reverse TGATTGGTGGGATGTCTTCGT; COL3A1 
forward GTTGCACGAAACACACTGGG, COL3A1 reverse 
ACAGCCTTGCGTGTTCGATA; UBC forward TAGTTCCGTCGCAGCCGGGA, 
UBC reverse GCATTGTCAAGTGACGATCACAGCG.  RT-qPCR was performed 
using a CFX96 Real-Time PCR Detection System (Bio-Rad). The PCR reaction 
volume was 12.5 μl, containing 400 nM of each primer, 2.5 μl cDNA (5 ng/μl) 
and 6.25 μl iQ SYBR Green Supermix (Bio-Rad) according to the manufacturer’s 
protocol. The comparative CT quantification (ΔΔCt method) corrected for primer 
efficiency was used to compare changes in gene expression.
Statistical Analysis
Differences in anthropometric and vascular variables in women with the 
metabolic syndrome before and after six months of cycling training were assessed 
by paired student’s t-tests (Statistical Package for Social Sciences 20.0, SPSS Inc., 
Chicago, Illinois, USA). The level of statistical significance was defined at α=0.05 
and data are presented as mean ± SD, unless stated otherwise.
To identify differentially expressed genes after exercise training, the 
corrected intensity of individual genes were used for an one-way analysis of variance 
(ANOVA). The resulting p-values were corrected for multiple-testing with the 
Benjamini-Hochberg false discovery rate procedure.25  With this stringent correction 
for multiple-testing all statistical significances disappeared. Therefore, we used plain 
fold changes to assess enrichment in GO-terms of biological processes since we 
were interested in the physiological meaning of our array results.
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Results
Effectiveness of the training intervention
Eleven women successfully completed the training intervention with a 
training compliance of 92%. Cardio-respiratory fitness, determined as peak oxygen 
uptake, improved significantly by 11% and peak workload increased significantly by 
17% after six months of cycling training (Table 1). Seven women dropped out of the 
study: five due to medical reasons unrelated to the exercise intervention, one dropped 
out as a consequence of social/family circumstances, and one woman dropped out 
due to lack of motivation. There were no significant differences at baseline between 
women who successfully completed the study and those who dropped out of the 
study (Supplement 1). 
After 6 months of exercise cycling training, no significant changes were 
observed in the variables of the metabolic syndrome; waist circumference, diastolic 
or systolic blood pressure,  glucose, HDL-cholesterol and triglycerides for the whole 
group (Table 1). Nonetheless, three out of eleven women (27%) did not meet the 
criteria for the metabolic syndrome anymore (Table 1). The cycling training did not 
alter body weight, body mass index or waist-to-hip ratio. Resting heart rate decreased 
significantly from 68 ± 5 beats per minute to 59 ± 7 beats per minute (Table 1). 
Vascular effects of training
 After 6 months of endurance exercise training, resting baseline diameters of 
the BA and SFA were significantly increased (Table 2 and Figure 1). The diameter of 
the CFA tended to increase (p=0.07) and no significant change was observed in the 
CA diameter. No changes were observed in resting blood flow of the arteries. CFA 
IMT and the IMT/lumen significantly decreased after exercise training (Table 2 and 
Figure 1, respectively). No changes were observed in the IMT and IMT/lumen ratio 
of the CA. 
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 Table 2. Diameters and IMT(/lumen) in women with the metabolic syndrome before 
 and after training.
Pre Post p-value
Carotid artery
Diameter, mm 7.0 ± 0.7 6.9 ± 0.7 0.38
Blood flowrest, ml/min 610 ± 161 572 ± 139 0.52
IMT, μm 726 ± 168 727 ± 194 0.99
IMT/lumen 0.10 ± 0.02 0.11 ± 0.03 0.71
Brachial artery
Diameter, mm 3.8 ± 0.6 4.0 ± 0.6 0.01
Blood flowrest, ml/min 42 ± 27 58 ± 47 0.25
Common femoral artery
Diameter, mm 8.5 ± 1.2 9.1 ± 1.2 0.07
Blood flowrest, ml/min 515 ± 251 500 ± 187 0.80
IMT, μm 798 ± 206 670 ± 164 0.02
IMT/lumen 0.10 ± 0.03 0.07 ± 0.01 <0.01
Superficial femoral 
artery
Diameter, mm 6.4 ± 0.7 6.7 ± 0.6 0.03
 Blood flowrest, ml/min 117 ± 59 146 ± 110 0.43
 IMT, intima-media thickness. Values are means ± SD. Due to technical constraints the baseline   
 diameter and IMT of the carotid artery was not analyzed in one woman.
Changes in gene expression; the identification of biological processes
In order to gain more insight into the biological meaning of the observed 
changes in gene expression, a list of top 500 up- and top 500 down-regulated genes 
was analyzed for overrepresented biological process gene ontology (GO) terms and 
summarized using functional annotation clustering (Table 3). The list of top 500 
up-regulated genes after exercise training was significantly enriched for 27 clusters 
of GO terms. The most significant enriched GO term for the up-regulated genes 
was ’response to organic substance’. More strikingly, four GO terms in the top ten 
of most significant enriched GO terms were related to the vasculature: ‘vasculature 
development’, ‘blood vessel development’, ‘blood vessel morphogenesis’, and 
‘angiogenesis’. These four vascular related GO terms included a total of 17 unique 
genes (Table 4), which demonstrated a response to exercise training in women with 
the metabolic syndrome.
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 Table 3. Enrichment in biological process GO-terms (FAT level) of the top 500 positive 
 fold change in women with the metabolic syndrome before and after training. 
 Listing is according to significance. F.E. = Fold Enrichment.
Term F.E. Benjamini
GO:0010033 response to organic substance 3.6 4.46E-06
GO:0001944 vasculature development 5.9 1.67E-05
GO:0001568 blood vessel development 6.0 1.78E-05
GO:0051789 response to protein stimulus 8.9 1.69E-04
GO:0048514 blood vessel morphogenesis 5.8 3.12E-04
GO:0007167 enzyme linked receptor protein signaling pathway 4.3 5.51E-04
GO:0032570 response to progesterone stimulus 26.0 6.10E-04
GO:0001525 angiogenesis 6.4 1.46E-03
GO:0007610 behavior 3.5 1.50E-03
GO:0007169 transmembrane receptor protein tyrosine kinase sign. 
pathway
5.0 1.59E-03
GO:0009611 response to wounding 3.3 1.74E-03
GO:0008284 positive regulation of cell proliferation 3.6 3.07E-03
GO:0022610 biological adhesion 2.6 1.79E-02
GO:0006986 response to unfolded protein 8.5 1.80E-02
GO:0007155 cell adhesion 2.6 1.90E-02
GO:0042127 regulation of cell proliferation 2.4 2.24E-02
GO:0048870 cell motility 3.7 2.29E-02
GO:0051674 localization of cell 3.7 2.29E-02
GO:0009719 response to endogenous stimulus 3.2 2.31E-02
GO:0032496 response to lipopolysaccharide 7.9 2.34E-02
GO:0030199 collagen fibril organization 15.0 2.53E-02
GO:0016477 cell migration 3.8 2.59E-02
GO:0001501 skeletal system development 3.5 2.59E-02
GO:0006928 cell motion 2.9 2.68E-02
GO:0002237 response to molecule of bacterial origin 7.1 3.18E-02
GO:0030335 positive regulation of cell migration 6.8 3.67E-02
GO:0030334 regulation of cell migration 4.6 4.69E-02
Two genes called delta like protein 4 (DLL4) and collagen 1 type 1 (COL1A1) 
were significantly changed when using the less stringent ANOVA test. Using the 
list of top 500 up-regulated genes after exercise training revealed one significantly 
changed KEGG pathway called ‘hsa04512; extra-cellular matrix(ECM)-receptor 
interaction’ (8.0-fold enrichement; Benjamini 7.14E-05). The list of top 500 down-
regulated genes after exercise was enriched for only the GO term ‘sensory perception 
of taste’.
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 Table 4. All 17 unique genes that included the four vascular GO-terms 
 ‘vasculature development’, ‘blood vessel development’, ‘blood vessel morphogenesis’, 
 and ‘angiogenesis’. F.C. = Fold Change.
Gene symbol Gene Name F.C. p-value
DLL4 delta-like 4 1.27 0.04
COL1A1 collagen, type I, alpha 1 1.31 0.05
COL3A1 collagen, type III, alpha 1 1.26 0.10
ANXA2 annexin A2 1.30 0.10
Bak1 BCL2-antagonist/killer 1 1.22 0.21
BGN biglycan 1.29 0.21
CTGF connective tissue growth factor 1.43 0.22
NRP2 neuropilin 2 1.20 0.22
junb jun B proto-oncogene 1.55 0.22
cyr61 cysteine-rich angiogenic inducer 61 1.74 0.42
IL18 interleukin 18 1.33 0.48
FGF9 fibroblast growth factor 9 1.24 0.49
Itgav Integrin alpha V 1.23 0.53
Klf5 Kruppel-like factor 5 1.28 0.54
TGFB2 transforming growth factor beta 2 1.26 0.58
PLAU plasminogen activator urokinase 1.21 0.61
Thbs1 thrombospondin 1 1.58 0.64
Reverse transcription quantitative PCR (RT-qPCR) validation
Of the 17 identified vascular-related genes, RT-qPCR analysis was performed 
on the three genes that demonstrated the lowest p-value after exercise training. Figure 
2 demonstrates the validated significant expression of DLL4 and COL1A1. 
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Discussion
This study provides a number of findings. First, we found that 6 months 
of leg exercise training in women with the metabolic syndrome leads to a larger 
diameter  and a decrease in wall thickness in peripheral arteries, but not in the central 
area (i.e. CA). Second, microarray analysis demonstrated that exercise training in 
women with the metabolic syndrome induced upregulated expression of genes 
involved in vascular remodeling (GO-term: vasculature development, blood vessel 
development, blood vessel morphogenesis, and angiogenesis), including enhanced 
gene expression of delta like protein 4 (DLL4) and collagen 1 type 1 (COL1A1). 
Taken together, this study demonstrates that exercise training in women with the 
metabolic syndrome leads to vascular remodeling in peripheral, but not central, 
arteries through upregulation of vascular remodeling-pathways, with a dominance 
for DLL4 and COL1A1.
  
After 6 months of exercise training, physical fitness level of the women 
with the metabolic syndrome is improved by 11%, which is comparable to previous 
endurance training programs in men and women with the metabolic syndrome of 
similar duration.26, 27 This indicates the successful performance of exercise training in 
our group. On the vascular level, the training induced structural changes in peripheral 
conduit arteries supplying both the active leg regions (i.e. CFA and SFA) as well as 
Figure 2. 
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the inactive arm regions (i.e. BA). As indicated in previous studies, exercise-induced 
arterial remodeling in diameter is believed to depend on local, shear-dependent 
processes, while adaptations in wall thickness more likely depends on systemic, rather 
than local stimuli during repeated bouts of exercise.28-30.  Interestingly, we also found 
the brachial artery diameter to adapt despite leg cycling exercise. This is probably 
the result of thermoregulatory responses during exercise that can lead to significant 
elevations in brachial artery blood flow.31, 32 Our findings of increased peripheral 
artery diameter are in accordance with previous aerobic exercise intervention studies 
in healthy women33. Our study extends these observations with the finding of a 
decrease in peripheral artery wall thickness (i.e. IMT CFA). In marked contrast to 
the remodeling in peripheral arteries, no significant changes were observed in the 
central CA diameter and wall thickness, suggesting that exercise training has a more 
pronounced effect on remodeling of the arterial wall of peripheral conduit arteries 
than on the central artery. One potential explanation relates the potential impact of 
cardiovascular risk factors on the ability of peripheral and central conduit arteries 
to adapt. Indeed, studies in healthy subjects suggest the presence of remodelling 
in response to training in peripheral and central arteries.12 However, the effects 
of exercise training on remodeling of peripheral and central arteries in those with 
increased cardiovascular risk may be different.13 Although the exact mechanisms 
for this disparity in arterial remodelling between vessels is unknown, we found 
that in women with the metabolic syndrome, who have multiple CVD risk factors, 
exercise training induces systemic peripheral vascular changes in conduit arteries, 
but not in a central artery. 
The beneficial adaptations in peripheral arterial structure after exercise 
training depend on local and systemic stimuli on the endothelial cells lining the 
inner vascular wall. Gene expression microarray analysis was performed as a fast 
and comprehensive method to assess changes in gene expression levels that are 
associated with the observed vascular adaptations. Those genes with the highest 
fold-change after exercise training were analyzed for overrepresented biological 
process gene ontology (GO) terms. We identified four significant enriched GO-
terms related to vascular remodeling including ‘vasculature development’, ‘blood 
vessel development’, ‘blood vessel morphogenesis’ and ‘angiogenesis’. These GO-
terms included a total of 17 unique genes. RT-qPCR validation of the expression of 
genes with the most prominent changes confirmed the microarray data. The most 
significant changed gene is DLL4, an endothelial cell-specific Notch ligand which 
once activated by vascular endothelial growth factor (VEGF) can induce Notch 
signaling. Notch signaling is known to play a critical role in physiological arterial 
remodeling.34 Recently, it has been suggested that DLL4 expression acts as a switch 
from the proliferative phase of angiogenesis to the maturation and stabilization of 
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endothelial cells.35, 36 We demonstrated a possible role of DLL4 in exercise-induced 
adaptations in arterial wall structure in humans. Well-controlled regulation of 
arterial remodeling is important for preventing excessive vascular growth. The other 
significant up-regulated gene after 6 months of exercise is COL1A1. COL1A1 is an 
extra-cellular matrix component, which contributes to the stiffness of an artery.37 
Initially degradation of the extra-cellular matrix surrounding the artery is necessary 
to allow outward arterial remodeling. When a new stable arterial structure has been 
established strengthening of the extracellular matrix occurs.38 KEGG pathways 
analysis supported this notion by our identification of the extracellular matrix 
(ECM)-receptor interaction pathway. 
Clinical relevance
Our findings have important clinical relevance. First, the smaller femoral 
artery wall thickness is of clinical importance, as there is growing evidence that 
peripheral artery wall thickness (e.g. FA) has clinical and prognostic value.39, 
40 Moreover, the observation that 6 months of exercise training is effective to 
reverse the metabolic syndrome in 3 women is of clinical importance. This effect 
was independent of a generalized effect of exercise training on the individual risk 
factors of the metabolic syndrome. This observation is in agreement with various 
other studies, which demonstrate that prolonged exercise training has no or a modest 
impact on traditional cardiovascular risk factors such as weight, blood pressure and 
cholesterol.41-43 Therefore, our findings reinforce the multi-target effects and benefits 
of exercise training, with the important clinical message that emphasis on a single 
outcome measure after exercise training can be misleading. 
Study limitations
Unfortunately ~40 % of the subjects with the metabolic syndrome were not 
able to complete the 6-month training period. Only one of these women stopped due 
to a lack of motivation despite repeated encouragement. The other 6 women with 
the metabolic syndrome could not complete the training program due to medical 
reasons, none of which were related to the participation in our study.  
Unfortunately, direct sampling of the arterial wall is limited in human 
in vivo studies. Muscle biopsies are a good and valid alternative, since it is the 
primary organ affected by exercise training, is highly vascularized en surrounds the 
peripheral vasculature. There is growing evidence, which points to a strong relation 
between muscle capillary development and large arterial structural adaptations.44-46 
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Furthermore, it has been demonstrated that exercise-induced muscle-derived factors 
(i.e. IL-6 and VEGF) can induce elevated blood plasma levels47, 48 and can even 
induce gene expression in another organ via blood plasma.49 This supports our 
assumption that changes in muscular gene expression reflect genes involved in 
arterial adaptations. 
In conclusion, this study showed that 6 months of exercise training in women 
with the metabolic syndrome induces arterial remodeling of peripheral conduit 
arteries including an increase in diameter and decrease in arterial wall thickness. 
Interestingly, such remodeling was not present in central arteries, suggesting 
remodeling in response to exercise training occurs more rapidly in peripheral arteries. 
Gene expression microarray analysis identified four molecular pathways related to 
vascular remodeling including enhanced gene expression of DLL4 and COL1A1. 
Both DLL4 and COL1A1 are involved in stabilizing the arterial wall and are for the 
first time identified as possible factors in exercise-induced vascular remodeling in 
humans. 
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 Supplement 1. No difference in physical characteristics of women with the 
 metabolic syndrome who successfully completed the study and those who dropped
 out of the study.
Metabolic syndrome
Successful women 
(n=11)
Drop outs (n=6)
Age, yrs 53 ± 7 50 ± 7
Weight, kg 96.4 ± 11.3 92.4 ± 18.4
BMI, kg/m2 34.5 ± 3.2 34.6 ± 5.2
Waist circumference, cm 109 ± 9 109 ± 11
Systolic pressure, mmHg 138 ± 11 138 ± 12
Diastolic pressure, mmHg 84 ± 5 85 ± 8
Heart Raterest, bpm 68 ± 5 73 ± 15
Glucose, mmol/l 5.5 ± 0.6 5.4 ±0.8
Triglycerides, mmol/l 1.98 ± 0.84 1.99 ± 0.79
HDL-C, mmol/l 1.21 ± 0.30 1.18 ±0.21
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 Supplement 2. Physical and vascular characteristics of all subjects versus 
 the subjects in the array cohort.
All subjects (n=11)
Array subject cohort 
(n=6)
Age, yrs 53 ± 7 58 ± 5
Weight, kg 96.4 ± 11.3 105.8 ± 7.1
BMI, kg/m2 34.5 ± 3.2 36.7 ± 2.0
Waist circumference, cm 109 ± 9 115 ± 9
Waist-to-Hip Ratio, - 0.91 ± 0.08 0.95 ± 0.08
Systolic pressure, mmHg 138 ± 11 143 ± 13
Diastolic pressure, mmHg 84 ± 5 83 ± 5
Heart Rate rest, bpm 68 ± 5 68 ± 4
Glucose, mmol/l 5.5 ± 0.6 6.0 ± 0.2
Triglycerides, mmol/l 1.98 ± 0.84 1.83 ± 0.89
HDL-C, mmol/l 1.21 ± 0.30 1.28 ± 0.40
Vascular characteristics
Common carotid artery
Diameter, mm 7.0 ± 0.7 7.3 ± 0.4
Blood flowrest, ml/min 610 ± 161 631 ± 198
IMT, μm 726  ± 168 783 ± 163
IMT/lumen 0.10 ± 0.02 0.11 ± 0.02
Brachial artery
Diameter, mm 3.8 ± 0.6 4.0 ± 0.6
Blood flowrest, ml/min 42 ± 27 49 ± 10
Common femoral artery
Diameter, mm 8.7 ± 1.2 9.2 ± 0.8
Blood flowrest, ml/min 515 ± 251 565 ± 314
IMT, μm 798 ± 206 855 ± 247
IMT/lumen 0.09 ± 0.03 0.09 ± 0.03
Superficial femoral artery
Diameter, mm 6.4 ± 0.7 6.4 ± 0.4
 Blood flowrest, ml/min 117 ± 59 140 ± 71
 Bpm=beats per minute; IMT= intima-media thickness
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Chapter 7
General discussion and future perspectives 
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With the ever expanding pandemic of obesity, millions of people are at 
increased risk of developing type 2 diabetes and cardiovascular diseases (CVD)1, 
2, which is a serious threat to human health. Insulin resistance in obese subjects 
results from impaired post-receptor insulin-signaling, causing reduced insulin-
induced glucose uptake. Recent studies have demonstrated a strong link between 
chronic low-grade inflammation and the development of insulin resistance3, 4, but 
the underlying mechanism remains elusive. Exercise training is a well-established 
method to improve insulin resistance and obesity-associated cardiovascular risk 
factors. Although the beneficial effects of exercise training on the human metabolic 
and cardiovascular system are strongly established, the mechanisms behind the 
positive effects of exercise training are still largely unknown5. In this thesis, we 
first explored molecular mechanisms related to insulin resistance and subsequently 
studied the molecular mechanisms involved in exercise-induced improvements in 
insulin resistance and vascular remodeling. Our population of interest consisted of 
women with the metabolic syndrome. In this final chapter, results are summarized, 
related to previous studies, and future perspectives are discussed.
Molecular mechanisms of insulin resistance
The most commonly accepted hypothesis in the pathophysiology of the 
metabolic syndrome is insulin resistance6, which may be caused by excessive central 
obesity and/or physical inactivity. Activation of the immune system in adipose tissue 
of obese subjects results in chronic low-grade inflammation. It is hypothesized 
that adipose tissue-secreted inflammatory signals affect target organs like skeletal 
muscle and thereby explain the link between obesity and insulin resistance 3, 7, 8. 
In chapter 2, we indeed found that expression of genes involved in inflammatory 
pathways is upregulated in skeletal muscle of women with the metabolic syndrome, 
who are insulin resistant and have chronic low-grade systemic inflammation. The 
upregulated genes were significantly enriched for the gene ontology (GO) term 
‘inflammatory response’, and expression levels of three genes, interleukin 6 receptor 
(IL6R), histone deacetylase 9 (HDAC9), and CD97 molecule (CD97), correlated 
with insulin resistance. This suggests an important role of these genes in the 
development of skeletal muscle insulin resistance. Interleukin 6 (IL-6) plasma levels 
are elevated in subjects with the metabolic syndrome9. In contrast to our findings of 
an IL6R up-regulation on the mRNA level, a recent study reported a marked down-
regulation of the IL-6 receptor protein in skeletal muscle tissue of obese subjects 
with and without diabetes10. This apparent discrepancy between IL-6 receptor 
mRNA and protein levels has previously been noticed in human exercise physiology 
studies11, 12. HDAC9 has been associated with inflammation13 and seems to have 
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an important role in the transcriptional regulation of skeletal muscle fiber type14, 
15. HDAC9 can bind to transcription factor myocyte enhancing factor 2 (MEF2), 
thereby inhibiting its normal function of maintaining slow (type I) muscle fiber type. 
CD97 is mainly expressed on activated lymphocytes at sites of tissue inflammation. 
To our knowledge, CD97 has not directly been linked with insulin resistance yet, and 
also the role of lymphocytes in the development of skeletal muscle insulin signaling 
remains elusive. Infiltration of lymphocytes may represent an important initial step 
in tissue inflammation and the subsequent development of insulin resistance16. 
Taken together, these results lead to the concept (as depicted in Figure 2, left 
panel) in which central adiposity and associated chronic low-grade inflammation 
results in chronic elevated levels of circulating inflammatory markers. This probably 
also includes IL-6 and the IL-6 receptor. At the same time, a transition from slow 
insulin sensitive to fast, more insulin resistant, skeletal muscle fibers occurs. In 
addition, lymphocytes infiltrate the muscle and initiate tissue inflammation, which , 
similar to adipose tissue inflammation, is likely to play a role in the development of 
insulin resistance.
Metabolically healthy obese phenotype
Approximately 30% of obese subjects have a ‘metabolically healthy obese 
phenotype’17. Following the same lines of reasoning as in our first study, we wondered 
whether metabolically healthy obese women have a different metabolic activity of 
fat tissue i.e. low-grade inflammatory profile, compared to obese women with the 
metabolic syndrome. The metabolic syndrome may be caused by excessive obesity 
and/or physical inactivity, so we extended the study by including physical fitness as 
a potential explanation for the metabolically healthy obese phenotype. In chapter 3, 
we found that metabolically healthy obese women have a higher cardio-respiratory 
fitness (VO2max) compared to age- and weight-matched obese women with the 
metabolic syndrome. They also appeared physically more active as they tended to 
take more steps per day. In addition, we found lower circulating TNF-α levels and a 
tendency for lower circulating hsCRP levels in obese women with the metabolically 
healthy obese phenotype, despite corresponding levels of adipose tissue mass in both 
groups of obese women. This findings are consistent with a lower inflammatory 
profile of fat tissue. The lower TNF-α levels found in our metabolically healthy 
obese women could not be explained by their quantity of fat tissue or degree of 
insulin resistance since both variables did not differ between groups. Our results 
suggest that in obese women TNF-α levels are influenced by cardio-respiratory 
fitness (VO2max), which corresponds with the observation that exercise training can 
lower TNF-α levels in diabetic patients 18. Taken together, our results show that a 
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higher physical fitness and lower circulating TNF-α levels may partly explain why 
metabolically healthy obese women are protected against the detrimental effects of 
obesity. 
Physical fitness levels seem more important for a the metabolic phenotype 
than for body composition (chapter 3). This is in agreement with results of a large 
observational cohort study, which showed that unfit-lean subjects have a higher 
cardiovascular risk than fit-obese subjects19.  When pooling data of all investigated 
women in this thesis (metabolic syndrome n=18; metabolic healthy obese n=10; lean 
women n=11), we found a significant positive correlation between physical fitness 
(VO2max) and insulin sensitivity (gold standard M-value), as depicted in Figure 1. 
Figure 1. 
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While physical inactivity seems associated with the development of insulin 
resistance, exercise training effectively counteracts this development by stimulating 
the insulin-signaling cascade. To gain more insight into the mechanisms of insulin 
resistance, we compared in chapter 4 muscle gene expression levels after physical 
deconditioning to gene expression levels after exercise training. When we analyzed 
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the subset of genes that were downregulated after deconditioning and upregulated 
after exercise training, we found two significantly enriched pathways, namely 
‘insulin action’ and ‘adipocytokine signaling’. These pathways included 18 unique 
genes of which muscle fatty acid binding protein 3 (FABP3), the fatty acid oxidizing 
enzyme hydroxyacyl-CoA dehydrogenase (HADH), and the mitochondrial fatty 
acid transporter solute carrier 25 family member A20 (SLC25A20) showed the most 
contrasting expression levels. Integrating our findings with existing models results 
in a proposed working mechanism of physical activity on insulin resistance, as 
depicted in Figure 2; right panel. Exercise training upregulates FABP3, the enzyme 
that transports fatty acids from the cellular plasma membrane to the mitochondrial 
membranes. SLC25A20 is also upregulated and transports the fatty acids over the 
inner mitochondrial membrane. Inside the mitochondria, upregulated HADH is 
involved in the beta oxidation of fatty acids. Physical deconditioning, on the other 
hand, results in downregulation of these genes, which leads to the accumulation 
of intracellular fatty acids (Figure 2; middle panel). This activates protein kinase 
C (PKC), which inhibits insulin receptor substrate 1/2 (IRS 1/2), resulting in less 
translocation of Glut4 to the cell membrane and thus a reduced insulin-induced 
glucose uptake. Additional experiments and measurements at the protein level are 
required to prove the validity of this model.
Exercise in women with the metabolic syndrome 
Six months/three times a week of endurance leg exercise training improved 
cardiorespiratory fitness (VO2max) by 11% in both women with the metabolic 
syndrome as well as in healthy lean women (Figure 3A)(chapter 5 and 6). The 
endurance exercise training reversed the metabolic syndrome in three out of 
eleven women, which is in accordance with previous studies20-24 (Chapter 5 and 
6). Approximately 60% of the beneficial effects of exercise training on total CVD 
risk can be explained by improvements of traditional CVD risk factors, including 
glucose levels, haemostatic and inflammation factors, lipid profile, and body 
weight5. Several hypothesis have been postulated about the remaining ~40%, the so 
called ‘risk factor gap’ (Figure 5). In chapter 5 and chapter 6 we used microarrays 
to analyse expression levels of virtually all known genes after six months of exercise 
training. This provided the opportunity to identify whole genome transcriptional 
responses to exercise training and subsequently generated new hypothesis regarding 
the beneficial effects of exercise training that may partly explain the ‘risk factor gap’. 
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Molecular mechanisms of exercise training on insulin resistance
 On the metabolic level, as expected, six months of endurance exercise 
training significantly improved insulin sensitivity (M-value) in both insulin resistant 
women (45%) with the metabolic syndrome as well as in insulin sensitive lean 
women (22%), even without changes in body weight and/or composition (Figure 
3B) (chapter 5). The extent of this improvement in insulin resistance after the 
training program is large compared to the effect of  glucose lowering medication, 
such as metformin25.  This emphasizes the beneficial effects of exercise. Although, as 
described in chapter 2, we found an upregulation of expression of genes involved in 
inflammatory pathways in women with the metabolic syndrome, the exercise training 
program did not result in a downregulation of these pathways and identified genes 
(Chapter 5). We actually found an upregulation of expression of genes involved 
in the immune- and inflammatory response in insulin sensitive lean women. These 
apparent contradictory findings require further investigation.
Figure 3. 
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Effects of six months endurance exercise on A, physical fitness; and  B, insulin sensitivity in women 
with the metabolic syndrome (MS) and lean control women (C). Mean ± SEM. *p<0.05.
Molecular mechanisms of exercise training on vascular remodeling
On the vascular level, six months of leg exercise training in women with 
the metabolic syndrome induced structural changes in peripheral conduit arteries 
supplying both the active leg regions (i.e. wall thickness (IMT) common femoral 
artery (CFA) and diameter (D) superficial femoral artery (SFA)) as well as the 
inactive arm regions (i.e. diameter brachial artery (BA)) (chapter 6) (Figure 4). Our 
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findings of an increase in peripheral artery diameter are in accordance with previous 
aerobic exercise intervention studies of similar duration in healthy women26. 
Our study extend these observations with the finding of a decrease in peripheral 
artery wall thickness (i.e. IMT CFA) after exercise training. In marked contrast to 
remodeling in peripheral arteries, no significant changes were observed in the central 
carotid artery diameter and wall thickness, suggesting that exercise training has more 
effect on remodeling of the arterial wall of peripheral conduit arteries than on central 
arteries27. 
Figure 4. 
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Effect of six months endurance exercise on Intima-media Thickness (IMT) of the carotid 
artery (CA) and common femoral artery (CFA) in women with the metabolic syndrome. 
Mean ± SEM. *p<0.05.
After the exercise training program, we found in skeletal muscle tissue 
surrounding the peripheral vasculature, an upregulation of genes which were enriched 
for gene ontology (GO) terms related to vascular remodeling including ‘vasculature 
development’, ‘blood vessel development’, ‘blood vessel morphogenesis’ and 
‘angiogenesis’, which included a total of 17 unique genes. The most significantly 
changed gene was delta like protein 4 (DLL4), an endothelial cell-specific Notch 
ligand which, once activated by vascular endothelial growth factor (VEGF), can 
induce Notch signaling. Notch signaling is known to play a critical role in physiological 
arterial remodeling28 via maturation and stabilization of endothelial cells29, 30. Our 
study is the first to suggest a role of DLL4 in exercise-induced adaptations in arterial 
wall structure in humans. The other significantly upregulated gene after exercise 
training was collagen type 1 alpha 1 (COL1A1). COL1A1 is an extra-cellular matrix 
component which contributes to the stiffness of an artery.31 Initial degradation of the 
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extra-cellular matrix surrounding the artery is necessary to allow outward arterial 
remodeling. When a new stable arterial structure has been established strengthening 
of the extracellular matrix occurs.32 
 Taken together, six months of leg exercise training improves cardio-
respiratory fitness in women with the metabolic syndrome. But more importantly, 
it improves insulin resistance and leads to arterial remodeling including a decrease 
in wall thickness (i.e IMT CFA) in peripheral arteries. These physiological 
improvements may substantially reduce the risk for future development of diabetes 
and CVD. In relation to the ‘risk factor gap’ mentioned before, we propose change 
in arterial wall thickness (IMT) as a potential explanation for the ‘risk factor gap’ 
(Figure 5) By comparing skeletal muscle gene expression (RNA microarrays), 
we identified several key genes with enhanced expression after exercise training 
including those genes related to the transport and metabolism of fatty acids (chapter 
3: FABP3, HADH, SLC25A20), inflammatory and immune response signals (chapter 
5), and Notch signaling (chapter 6: DLL4). Obviously, additional measurements at 
the protein levels of the identified genes are required to prove the validity of the 
proposed factors.
Figure 5. 
Exercise-induced improvements in previously established risk factors associated with a 
reduction in CVD events5 extended with factors identified in studies performed in this 
thesis.
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Future perspectives 
 Results of this thesis show that physical fitness plays an important role in 
metabolic and cardiovascular health. Higher physical fitness levels seem, at least 
partly, able to prevent obesity-associated risk factors and diseases such as diabetes. 
Investigating people with obesity who are metabolically healthy can provide more 
insight into the pathophysiological emergence of metabolic risk factors and diseases. 
Future studies should focus on the physiological phenotype of metabolically healthy 
obese subjects, such as the activity of visceral adipose tissue including adipocytokines 
and immunological markers. At the same time modern high-throughput genetic 
techniques can contribute to the discovery of gene single-nucleotide polymorphisms 
associated with the interesting metabolically healthy obese phenotype. 
 Besides prevention of obesity-associated metabolic and cardiovascular risk 
factors, increasing physical fitness levels with an exercise training program can 
improve the obesity-associated risk factors, as described in this thesis. In our studies 
we focused on long term endurance exercise training. It is however known, that 
approximately 5-10% of the general population does not respond to this type of 
exercise training33. Future studies should focus on other training strategies such as 
resistance training, interval training or a combination of these to optimize beneficial 
training effects. We investigated the effects of exercise training on insulin resistance 
and vascular structure. Since there is growing awareness and scientific evidence for 
the involvement of adipose tissue, adipocytokines and the immune response system, 
future studies may aim for these topics.   
 Despite large physiological differences in insulin resistance between 1) 
lean and obese women (cross-sectional) and, 2) the inter-individual variation 
in improvement in insulin resistance after the training program, the RNA gene 
expression differences were surprisingly small. The highest fold-change in our 
studies was 3.15, with the annotation that after stringent correction for multiple 
testing, no single gene reached statistical significance. Although there is probably a 
publication bias regarding negative outcome gene expression studies, other research 
groups also found relative small gene expression differences in skeletal muscle 
tissue after an exercise training program. There are several explanations for these 
small gene expression differences. First, in particular initial exercise training stimuli 
and changes in physical activity levels may induce larger changes in RNA gene 
expression, which in turn contribute to the formation of relevant proteins responsible 
for the initial adaptation process. After several weeks or months of training, a new 
equilibrium may have been and reversal of the increase in gene expression. Thus, 
after longer exercise training periods, final changes in gene expression may be 
minimal. This phenomenon was noticed in a study from Egan et al.34 who performed 
time-course analysis during an exercise training program in human skeletal muscle. 
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Second, exercise training may result in the formation of more stable proteins with 
lower degradation rates, and in that way less RNA transcription.  Third, the intra-
individual gene expression differences in skeletal muscle tissue may be much larger 
than the effect of an intervention, whereby studies with small subject numbers in 
combination with the stringent statistical correction for multiple testing may fail to 
detect significant differences. Stringent correction for multiple testing prevents type 
1 errors (false positive results) to occur but too stringent correction may introduce 
type 2 errors (false negative results). Longitudinal exercise intervention studies with 
multiple time-course assessments of gene expression and protein levels should be 
a next step. To reach statements of causality between changes in gene expression 
level and whole body physiological effects, innovative research is needed in which 
conditions at the gene level are controlled and manipulated, while measuring at the 
functional physiological level, and vice versa. 
New techniques such as next generation RNA/DNA sequencing will 
allow faster, cheaper and more in-depth analysis and holds promises for even 
more reliable expression level analysis. In the future, a combination of in vivo and 
whole body (patho-)physiological scientific research should ideally lead to optimal 
individualized patient-specific treatment options to prevent the massive medical, 
social and economic burden of risk factors such as physical inactivity and obesity.
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Summary
Obesity is an enormous world-wide health threat. It leads to insulin 
resistance, hypertension, low-grade inflammation and dyslipidemia, and ultimately 
results in type 2 diabetes mellitus and cardiovascular diseases. It is caused by a 
complex interplay between genetic predisposition, nutrient overconsumption and 
a sedentary lifestyle. Lifestyle modification by increasing physical fitness level is 
a well-established intervention to improve these obesity-associated risk factors, 
including insulin resistance. However, the molecular mechanisms behind the 
positive effects of improved physical fitness level are still largely unknown. Gene 
expression microarray analysis, a modern technology in human genetic research, can 
be used as a rapid and comprehensive approach for the first identification of exercise-
induced molecular changes. Therefore, the general aim of this thesis was to perform 
human, translational studies which would provide more insight into the molecular 
mechanism of insulin resistance and into the molecular mechanisms of exercise-
induced improvements in insulin resistance and arterial remodeling in obesity, with 
a special interest in women with the metabolic syndrome. 
Obese women often show insulin resistance. In chapter 2 we investigated the 
link between obesity-induced insulin resistance and chronic low-grade inflammation 
in skeletal muscle tissue. In comparison to healthy controls, in insulin resistant women 
with the metabolic syndrome the expression of genes involved in inflammatory 
pathways was upregulated. The three most significantly upregulated inflammatory 
genes we identified were Histone Deacetylase 9 (Hdac9), Interleukin-6 Receptor 
(Il6r), and CD97 molecule (Cd97); all three genes showed a correlation with insulin 
resistance. Hdac9 gene expression plays a role in the transcriptional regulation of 
skeletal muscle fiber type, where Hdac9 upregulation induces a transition from 
slow insulin-sensitive skeletal muscle fibers to fast, more insulin-resistant, skeletal 
muscle fibers. Elevated plasma levels of interleukin-6, a pro-inflammatory cytokine, 
has been associated with insulin resistance, but a discrepancy between IL-6 receptor 
mRNA and protein levels exists in human exercise physiology studies. The Cd97 
molecule has never before been linked to insulin resistance. It is expressed on 
activated lymphocytes and its overexpression in this subject group may represent 
an important step in tissue inflammation and the subsequent development of insulin 
resistance in skeletal muscle. 
Interestingly, some 30% of women with obesity have a metabolically 
healthy phenotype. In chapter 3 we examined the role of physical fitness level and 
low-grade systemic inflammation profile as an explanation for this healthy obese 
phenotype. In comparison to corresponding obese women with the metabolic 
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syndrome, metabolically healthy obese women had higher cardio-respiratory fitness 
levels and lower circulating TNF-α levels, suggesting a lower inflammatory profile 
of adipose tissue. Our regression model revealed that cardio-respiratory fitness was 
the strongest predictor for having the metabolically healthy obese phenotype.
To gain more insight into the molecular mechanisms underlying the 
prevention and development of insulin resistance, in chapter 4 we compared 
skeletal muscle gene expression in two subject groups: after physical deconditioning 
and after an exercise training program. The most interesting subset of genes were 
those that were both downregulated after deconditioning as well as upregulated 
after exercise training. This subset contained 18 genes related to both the ‘insulin 
action’ and ‘adipocytokine signaling’ pathway. Of these genes, the three with the 
strongest upregulation after exercise as well as downregulation after deconditioning 
were the muscular fatty acid binding protein 3 (FABP3), the fatty acid oxidizing 
enzyme hydroxyacyl-CoA dehydrogenase (HADH), and the mitochondrial fatty 
acid transporter solute carrier 25 family member A20 (SLC25A20). These results 
indicate an important role for decreased transport and metabolism of fatty acids in 
skeletal muscle tissue,  providing a possible molecular link between physical activity 
levels and insulin signaling. 
  
In chapter 5 we subsequently analysed exercise-induced changes in 
insulin sensitivity with concomitant changes in the global gene expression profile 
in women with, and without metabolic syndrome. Six months of exercise training 
improved the insulin sensitivity in both groups. In obese women with the metabolic 
syndrome insulin sensitivity improved by 45% and in lean control women by 22%. 
This improvement was independent of changes in body weight and/or composition. 
Pathway analysis revealed four enriched pathways in women with the metabolic 
syndrome, in which insulin-like growth factor 2 (IGF2) showed the most significant 
upregulation after the training program. In contrast, in lean women, expression 
of genes related to the immune system and inflammatory response were most 
upregulated. These results indicate that different molecular mechanisms are involved 
in exercise-induced improvements in insulin sensitivity in women with and without 
the metabolic syndrome.
In the penultimate chapter (chapter 6), we investigated the effects of an 
exercise training program on central and peripheral arterial remodeling with 
simultaneous assessment of (muscle) gene expression in women with the metabolic 
syndrome. Six months of endurance leg exercise training induced structural changes 
in the peripheral conduit arteries supplying both the active leg regions (i.e. common 
femoral artery wall thickness and superficial femoral artery diameter) as well as the 
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inactive arm regions (i.e. brachial artery diameter). In marked contrast to remodeling 
in peripheral arteries, no significant changes were observed in the central carotid 
artery diameter and wall thickness, suggesting that exercise training has more effect 
on remodeling of the arterial wall of peripheral conduit arteries than on central arteries. 
Microarray analyses identified upregulation of genes enriched for molecular pathways 
related to arterial remodeling (Gene Ontology term: vasculature development, blood 
vessel development, blood vessel morphogenesis, and angiogenesis), including 17 
unique genes. Two of the unique genes showed upregulated expression, namely 
delta-like-protein-4 (DLL4) and collagen-type-1-alpha-1 (COL1A1).  Both DLL4 
and COL1A1 are involved in stabilizing the arterial wall and are for the first time 
identified as possible factors in exercise-induced arterial remodeling in humans.
In chapter 7, current knowledge of the molecular mechanisms of insulin 
resistance and the effects of exercise training on insulin resistance and arterial 
remodeling was reviewed and discussed in conjunction with the novel data from this 
thesis. We speculated on the potential molecular mechanisms of exercise-induced 
improvements in insulin resistance and arterial remodeling, with a special focus on 
obese women with the metabolic syndrome. Although obesity is strongly correlated 
with several cardiovascular and metabolic risk factors, the level of physical fitness 
seems crucial. Being obese but physically fit is associated with a metabolically 
healthy phenotype, lowering the risk for developing diabetes and cardiovascular 
diseases. Finally, we provide molecular and physiological evidence for the powerful 
therapeutic effects exercise training has on insulin resistance and arterial remodeling.
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In dit hoofdstuk wordt een overzicht gegeven van de resultaten van de 
studies die worden beschreven in dit proefschrift. Daarbij worden medisch-
wetenschappelijke termen zoveel mogelijk achterwege gelaten en beschrijf ik de 
onderzoeksresultaten voor zover mogelijk in begrijpelijke alledaagse taal.
Ernstig overgewicht, ook wel obesitas genoemd, leidt vaak tot een verstoorde 
suikerstofwisseling (hierna genoemd insulineresistentie), een verhoogde bloeddruk, 
laaggradige ontsteking en een verstoord vetspectrum in het bloed. Veel mensen met 
obesitas ontwikkelen dan ook uiteindelijk suikerziekte en/of hart- en vaatziekten. 
Obesitas wordt veroorzaakt door een complexe interactie tussen genetische aanleg, 
de overconsumptie van voeding en een inactieve levensstijl. Aanpassing van de 
levensstijl door te sporten, en dientengevolge een verbetering van de lichamelijke 
conditie, is een bewezen methode om de obesitas-geassocieerde risicofactoren 
waaronder insulineresistentie te verbeteren. Het is echter nog grotendeels onbekend 
wat het precieze werkingsmechanisme van het positieve effect van sporten is. 
Moderne genetische technologieën, waaronder microarrays, kunnen worden 
ingezet voor een snelle en complete analyse van het werkingsmechanisme op het 
niveau van lichaamscellen. Iedere cel in ons lichaam bevat hetzelfde genetische 
DNA materiaal. Het DNA vormt de genetische code voor het maken van eiwitten, 
welke de vorm en functie van een cel bepalen. RNA zorgt voor het kopiëren van 
de genetische informatie die is opgeslagen in het DNA en zorgt uiteindelijk voor 
de vertaling naar een eiwit. Met behulp van een microarray kan het totale patroon 
van RNA genexpressie in een cel zichtbaar worden gemaakt en kunnen verschillen 
in genexpressie tussen weefsels worden opgespoord maar ook in hetzelfde weefsel 
voor en na een periode van sporten. Het doel van dit proefschrift was om meer 
inzicht te krijgen in het werkingsmechanisme van insulineresistentie en meer inzicht 
in het werkingsmechanisme van een sportprogramma op insulineresistentie en de 
structuur van een slagader. Hiertoe hebben wij obese vrouwen, die tenminste drie 
obesitas-geassocieerde risicofactoren hadden, onderzocht. Deze vrouwen hebben het 
zo genoemde metabool syndroom.
Vrouwen met obesitas zijn vaak resistent voor insuline. In hoofdstuk 2 
onderzochten we het verband tussen obesitas-geïnduceerde insulineresistentie 
en chronische laaggradige ontsteking in spierweefsel. In vergelijking met het 
spierweefsel van gezonde slanke vrouwen, komen in spierweefsel van insuline 
resistente vrouwen met het metabool syndroom genen tot expressie die betrokken 
zijn bij ontstekings-pathways. De drie meest significante genen die tot expressie 
kwamen waren histondeacetylase 9 (HDAC9), interleukine-6 receptor (IL-6R) en 
het CD97 molecuul (CD97). Alle drie deze genen lieten een correlatie zien met 
insulineresistentie. Expressie van het HDAC9 gen speelt een rol bij de regulatie van 
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spiervezeltypering. Meer expressie van het HDAC9 gen veroorzaakt een verschuiving 
van langzame, insuline-gevoelige spiervezels naar snelle, insulineresistente 
spiervezels. Interleukine-6 is een pro-inflammatie cytokine die geassocieerd is 
met insulineresistentie. Er bestaat op dit moment echter een wetenschappelijke 
discrepantie tussen genexpressie van deze cytokine en de eiwitconcentraties. Het 
CD97 molecuul is nog nooit eerder in verband gebracht met insulineresistentie. 
Het molecuul komt tot expressie op geactiveerde witte bloedcellen en zou op deze 
manier een rol kunnen spelen bij spierweefselontsteking en dientengevolge bij het 
ontstaan van insulineresistentie in spierweefsel.  
Opmerkelijk is dat ongeveer 30% van de vrouwen met obesitas geen obesitas-
geassocieerde risicofactoren heeft, zij hebben een metabool gezond fenotype. In 
hoofdstuk 3 hebben we onderzocht wat hier een mogelijke verklaring voor zou 
kunnen zijn. Vergeleken met obese vrouwen met het metabool syndroom hebben 
vrouwen met dezelfde mate van obesitas, maar met een metabool gezond fenotype, 
een betere lichamelijk conditie en lagere bloedwaarde van de ontstekings cytokine 
TNF-α. Dit geeft een indicatie dat het vetweefsel van obese vrouwen met een gezond 
fenotype mogelijk een lagere ontstekingsactiviteit heeft. De sterkste voorspeller voor 
een metabool gezond obees fenotype was het niveau van de lichamelijke conditie.
Om meer inzicht te krijgen in het werkingsmechanisme van insulineresistentie 
hebben we in hoofdstuk 4 de genexpressie in spierweefsel na een periode van fysieke 
inactiviteit vergeleken met de genexpressie na een sportprogramma. De meest 
interessante genen zijn de genen die minder tot expressie komen na een periode van 
lichamelijke inactiviteit en meer tot expressie komen na een sportprogramma. Op 
deze manier identificeerden we 18 genen welke gerelateerd bleken aan het ‘insulin 
action’ en ‘adipocytokine signaling’ pathway. Die genen met de hoogste opwaartse 
expressie na sporten en hoogste neerwaartse expressie na een periode van lichamelijke 
inactiviteit waren muscular fatty acid binding protein 3 (FABP3), de fatty acid 
oxidizing enzyme hydroxyacyl-CoA dehydrogenase (HADH) en de mitochondrial 
fatty acid transporter solute carrier 25 family member A20 (SLC25A20). Deze 
resultaten wijzen op een belangrijke rol voor een verminderd transport en metabolisme 
van vetzuren in spierweefsel, wat mogelijk een moleculaire verklaring zou kunnen 
zijn voor de relatie tussen lichamelijke activiteit en insulineresistentie.
In hoofdstuk 5 hebben we vervolgens gekeken naar het effect van een 
zes maanden durend sportprogramma op de insulineresistentie en gelijktijdige 
veranderingen in genexpressie in het spierweefsel van vrouwen met en zonder 
het metabool syndroom. Ondanks de afwezigheid van gewichtsverlies verbeterde 
het sportprogramma de insulineresistentie aanzienlijk in zowel vrouwen met het 
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metabool syndroom (-45%) als in slanke vrouwen (-22%). Tegelijkertijd bleken 
in het spierweefsel van vrouwen met het metabool syndroom geselecteerde genen 
verrijkt aanwezig te zijn in 4 ‘pathways’, waarbij insulin-like growth factor 2 (IGF2) 
de hoogste opwaartse genexpressie liet zien. In het spierweefsel van slanke vrouwen 
daarentegen kwamen genen tot verhoogde expressie die betrokken zijn bij het 
immuunsysteem en onstekingsreacties. Deze resultaten duiden op een verschillend 
werkingsmechanisme van sporten tussen slanke vrouwen en vrouwen met het 
metabool syndroom. 
 In hoofdstuk 6 onderzochten we het effect van een sportprogramma op 
de diameter en wanddikte van slagaders bij vrouwen met het metabool syndroom. 
De dikte van een slagaderwand wordt bepaald door de mate van aderverkalking 
(atherosclerose), waarbij een dikkere wand duidt op meer aderverkalking. 
Wederom beoordeelden we tegelijkertijd de effecten van het sportprogramma 
op genexpressieveranderingen in spierweefsel. Zes maanden intensief sporten 
induceerde een toename in de diameter van de slagaders en een afname van de 
wanddikte van de slagader in het been. Er was geen veranderingen opgetreden in 
de structuur van de halsslagader. Dit suggereert dat sporten meer invloed heeft op 
de structuur van slagaders in de actieve ledematen dan in de halsslagaders. In het 
spierweefsel kwamen na afloop van het sportprogramma genen tot expressie die 
gerelateerd zijn aan de ontwikkeling van bloedvaten (‘vasculature development’; 
‘blood vessel development’; ‘blood vessel morphogenesis’; ‘angiogenesis’). De 
genen met de hoogste opwaartse expressie waren delta-like protein-4 (Dll4) en 
collageen type-1-alfa-1 (COL1A1). Zowel Dll4 en COL1A1 zijn betrokken bij het 
stabiliseren van de structuur van een bloedvat en zijn nu voor het eerst geïdentificeerd 
als mogelijke genen betrokken bij aanpassingen in de structuur van een bloedvat 
door sporten. 
 In hoofdstuk 7 wordt een samenvatting gegeven van de huidige kennis, 
inclusief resultaten van studies uit dit proefschrift, met betrekking tot het 
werkingsmechanisme van insulineresistentie en het effect van een sportprogramma 
op de insulineresistentie en structuur van een slagader. We speculeerden over 
mogelijke werkingsmechanismen betrokken bij de door het sporten-geïnduceerde 
verbeteringen in insulineresistentie en structuur van een slagader. Ondanks het feit 
dat obesitas sterk gecorreleerd is met verscheidene metabole en cardiovasculaire 
risicofactoren, lijkt het hebben van een goede fysieke conditie cruciaal. Obese 
vrouwen met een metabool gezond fenotype bleken namelijk een betere lichamelijke 
conditie te hebben en hebben uiteindelijk dus een lager risico op het ontwikkelen van 
suikerziekte en hart- en vaatziekten. Tevens is het verbeteren van de lichamelijke 
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conditie door een sportprogramma uiterst effectief als therapie voor insulineresistentie 
en verbetering van de dikte van de slagaderwand.
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Het einde van dit proefschrift en mijn promotie traject is genaderd. Nog het 
laatste hoofdstuk schrijven en het boek kan letterlijk en figuurlijk dicht. Wat een 
tijd in mijn leven. Blijkbaar heeft het zo moeten zijn dat alle life-events in pak ‘m 
beet 8 jaar moesten gebeuren; afstuderen en mijn eerste baan als arts, de opleiding 
beginnen tot medisch specialist, een huis kopen, moeder worden, trouwen,  mijn 
geliefde verliezen en dan ook nog eens proberen te promoveren. Dit proefschrift 
stond om eerlijk te zijn af en toe als laatste op mijn ‘to do list’. Zonder de hulp van 
een heleboel mensen was dit proefschrift er dan ook niet gekomen. Mijn dank gaat 
uit naar iedereen die aan de totstandkoming ervan heeft bijgedragen en een aantal wil 
ik in het bijzonder noemen.
Drie volle onderzoeksdagen voorafgaand aan de trainingen, drie volle 
onderzoeksdagen na afloop van de trainingen, 6 maanden lang - 3 keer per week 
- 45 minuten fietsen. Als proefpersoon meedoen aan mijn promotieonderzoek 
vergde veel fysieke inzet en mentaal doorzettingsvermogen. Mijn dank gaat dan ook 
allereerst uit naar de deelnemende proefpersonen, zonder wie de onderzoeken niet 
plaats hadden kunnen vinden. Bedankt voor jullie waardevolle tijd, enthousiasme en 
soms ook geduld!
Prof. dr. M.T.E. Hopman, beste Maria, ondertussen alweer heel wat jaren 
geleden hebben we elkaar leren kennen toen ik als student bewegingswetenschappen 
aan je vroeg of jij eventueel een stageplek voor me had in het buitenland. Ik kwam 
terecht in Hamilton (Canada) bij Maureen MacDonald. Nadien ben ik altijd de Heintje 
Davids van de afdeling Fysiologie gebleven. Mijn dank is groot voor je enthousiasme 
voor mijn onderzoek, maar met name voor de vrijheid die je me hebt gegeven en  je 
onvoorwaardelijke geloof in de goede afloop van mijn promotieonderzoek. 
Prof. dr. C.J. Tack, beste Cees, tijdens mijn allerlaatste coschap interne 
geneeskunde was jij mijn beoordelaar, niet wetende dat we elkaar daarna nog veel 
vaker zouden treffen. Ik heb het altijd fijn gevonden om met je samen te werken en 
te luisteren naar je bevlogen verhalen over ons vakgebied. Dank voor je altijd snelle 
respons op mijn vragen, je betrokkenheid en medisch wetenschappelijke kunde. 
Mede op jou aanraden heb ik toch maar besloten deze promotie groots te vieren.
De manuscript commissie bestaande uit professor J.W.A. Smit, professor 
J.A. Veltman en professor M.K.C. Hesselink wil ik bedanken voor hun kritische 
beschouwing en enthousiaste goedkeuring van het manuscript.
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Alle collega’s van de afdeling Fysiologie met wie ik in de loop der jaren heb 
samengewerkt wil ik bedanken voor de inhoudelijke discussies maar ook om wie 
jullie zijn. 
Gerwen, ik vind het geweldig dat je mijn copromotor bent geworden 
gedurende het traject. Je bent, samen met Linda, van onschatbare waarde geweest 
dankzij je kennis en kunde op moleculair fysiologisch gebied. Dankzij jullie is het 
gelukt om deze onderzoekslijn op te zetten en tot enkele mooie publicaties te komen, 
dank daarvoor. Beste Bregina, bedankt voor alle echo-metingen die je hebt verricht 
bij mijn proefpersonen, maar nog meer voor je vrolijkheid en je aanstekelijke 
schaterlach. Jos, jij bént fysiologie en ondanks je afscheid na het bereiken van je 
pensioenleeftijd, bleef je enthousiast betrokken bij de trainingen van de deelnemers. 
Noortje, als partner op dezelfde onderzoekslijn en ook als “het altijd in te huren 
biopten duo” wil ik je bedanken voor de prettige samenwerking. Als er iemand een 
doorzetter is, dan ben jij het wel Madelijn! Vaak was je ontzettend serieus met je 
eigen promotie bezig maar op de ontspannen momenten kun jij het hardste lachen 
van ons allemaal. Ik vond het een eer je paranimf te mogen zijn. Tim, de grapjas 
van de afdeling met zijn angstaanjagende T-shirts. In het begin kon ik je niet goed 
inschatten, maar na de eerste indruk heb ik een bijzonder iemand leren kennen. 
Bedankt voor het geouwehoer maar ook voor de serieuze gesprekken over het leven 
en de liefde.  Ralph, Matthijs, Martijn, Joost, Nathalie en Rebecca, heel veel succes 
en plezier bij het afronden van jullie promotieonderzoek. Dick, Thijs, Jan, Patricia, 
Michiel en Miriam jullie zijn mijn voorbeeld en inspiratie als onderzoekers geweest. 
Dank voor de collegialiteit en gezellige momenten. Tevens wil ik alle studenten die 
bij mijn projecten betrokken waren bedanken voor hun inzet: Sanne, Anke, Anne, 
Margo, Paul en Duby. Veel succes met jullie eigen carrières. Anja en Karin van de 
afdeling Klinische Fysiologie wil ik bedanken voor alle hulp en inzet bij de insuline 
clamp studies.  
Beste collega’s van de afdeling Interne Geneeskunde van het RadboudUMC 
en het Slingeland ziekenhuis. Graag wil ik jullie bedanken voor de betrokkenheid 
bij mijn promotie en privé leven. De gezamenlijke carpool tochten van en naar 
Doetinchem waren uitermate heilzaam voor mijn geestelijke gezondheid en met een 
grote glimlach denk ik hieraan terug. In het bijzonder wil ik professor J. de Graaf 
bedanken, Jacqueline dank voor je warme hart en betrokkenheid van de afgelopen 
jaren. 
Yvonne en Ben, met name het laatste jaar hebben we weer veel contact en ik 
waardeer het erg dat ik op jullie kan rekenen en dat Elise altijd bij jullie terecht kan. 
Stijn, bedankt voor al je goede promotie adviezen en de gezellige diners samen met 
Malaika. Douwe, ooit, lang geleden zijn we samen begonnen aan ons studentenleven. 
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Fijn dat je nu, samen met Dorien, mijn paranimf wilt zijn op deze bijzondere dag. 
Eindelijk de definitieve afsluiting van mijn ‘studenten’ periode.
Mijn liefste vriendinnen Dorien, Heleen en Jorien. Vanaf het eerste jaar 
van onze studies zijn we dikke mik en delen we lief en (soms helaas teveel) leed 
met elkaar. Ik vind het heerlijk om bij jullie te zijn en beschouw onze band als 
onvoorwaardelijk. Ik hoop jullie te blijven zien en in mijn leven te hebben totdat we 
allemaal oud, grijs, tandeloos en gerimpeld zijn.
 
Evelyn en Ineke, veel mensen vragen me vaak of ik nog contact met jullie 
heb na het overlijden van Koen. Wat een vraag! De afgelopen tien jaar is onze band 
zeer hecht geworden en ik zou wel tien van zulke schoonmoeders willen hebben. 
Zonder de steun van mijn lieve familie zou ik veel minder bereikt hebben dan 
mogelijk was geweest. Pap en mam, jullie lieten me altijd vrij om mijn eigen keuzes 
te maken. De voltooiing van dit proefschrift was niet gelukt zonder jullie praktische 
en emotionele steun.  Het is altijd fijn om naar het oosten te rijden voor complete 
ontspanning en vertroeteling. Ome Hans, bedankt voor het prachtige ontwerp van de 
cover en je vormgevingsadviezen.
En dan mijn lieve meisje Elise. Het is niet voor te stellen wat wij samen in de 
relatief korte periode van je leven al hebben meegemaakt. Jij bent mijn vrolijkheid 
met je grapjes, het altijd maar willen stoeien en oneindig knutselen met eierdozen, 
loom bandjes en WC rollen. Ik hou van je zoals je bent en zult worden.
Lieve Koen, ondanks dat ik cognitief weet dat je er niet meer bent, 
ben je elke dag bij mij. Ik weet dat je ontzettend trots op mij en Elise zult zijn 
geweest en dat geeft me de kracht om door te gaan en nog iets moois van mijn 
leven te maken. Ik mis je elke dag en hou van je. 
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